
1: Hiasa H, Shea ME.
DNA Gyrase-mediated Wrapping of the DNA Strand Is Required for the Replication
Fork Arrest by the DNA Gyrase-Quinolone-DNA Ternary Complex.
J Biol Chem. 2000 Nov 3;275(44):34780-34786.
[Record as supplied by publisher]
PMID: 11053451


2: Heaton VJ, Ambler JE, Fisher LM.
Potent antipneumococcal activity of gemifloxacin is associated with dual
targeting of gyrase and topoisomerase IV, an In vivo target preference for
gyrase, and enhanced stabilization of cleavable complexes In vitro.
Antimicrob Agents Chemother. 2000 Nov;44(11):3112-7.
[MEDLINE record in process]
PMID: 11036032; UI: 20493121


3: Wang ZX, Li SM, Heide L.
Identification of the coumermycin A(1) biosynthetic gene cluster of streptomyces
rishiriensis DSM 40489.
Antimicrob Agents Chemother. 2000 Nov;44(11):3040-8.
[MEDLINE record in process]
PMID: 11036020; UI: 20493109


4: Jorgensen JH, Weigel LM, Swenson JM, Whitney CG, Ferraro MJ, Tenover FC.
Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin
against recent clinical isolates of levofloxacin-resistant streptococcus
pneumoniae.
Antimicrob Agents Chemother. 2000 Nov;44(11):2962-8.
[MEDLINE record in process]
PMID: 11036007; UI: 20493096


5: Schneider R, Travers A, Muskhelishvili G.
The expression of the escherichia coli fis gene is strongly dependent on the
superhelical density of DNA.
Mol Microbiol. 2000 Oct;38(1):167-75.
[MEDLINE record in process]
PMID: 11029698; UI: 20485616


6: Petmitr PC, Ramdja M, Kajorndechakiat S.
In vitro sensitivity of Trichomonas vaginalis to DNA topoisomerase II
inhibitors.
Southeast Asian J Trop Med Public Health. 2000 Mar;31(1):118-22.
[MEDLINE record in process]
PMID: 11023077; UI: 20475914


7: Woodnutt G.
Pharmacodynamics to combat resistance.
J Antimicrob Chemother. 2000 Jul;46 Suppl T1:25-31.
[MEDLINE record in process]
PMID: 10997596; UI: 20450402


8: Bebear CM, Grau O, Charron A, Renaudin H, Gruson D, Bebear C.
Cloning and nucleotide sequence of the DNA gyrase (gyrA) gene from mycoplasma
hominis and characterization of quinolone-resistant mutants selected In vitro
with trovafloxacin.
Antimicrob Agents Chemother. 2000 Oct;44(10):2719-27.
[MEDLINE record in process]
PMID: 10991851; UI: 20448743


9: Gorlitzer K, Kramer C, Boyle C.
[Gyrase inhibitors. 3. Synthesis and reactions of
1,4-dihydro-4-oxo-(1)benzothieno(3,2-b)pyridin-3-carboxylic acid esters].
Pharmazie. 2000 Aug;55(8):595-600. German.
PMID: 10989837; UI: 20445039


10: Hooper DC.
Mechanisms of action and resistance of older and newer fluoroquinolones.
Clin Infect Dis. 2000 Aug;31 Suppl 2:S24-8.
[MEDLINE record in process]
PMID: 10984324; UI: 20440032


11: Pato ML, Banerjee M.
Genetic analysis of the strong gyrase site (SGS) of bacteriophage Mu:
localization of determinants required for promoting Mu replication.
Mol Microbiol. 2000 Aug;37(4):800-10.
PMID: 10972802; UI: 20430105


12: Yasuda M, Fukuda H, Yokoi S, Ishihara S, Kawada Y, Deguchi T.
In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring
alterations in DNA gyrase and topoisomerase IV.
J Urol. 2000 Sep;164(3 Pt 1):847-51.
PMID: 10953166; UI: 20411384


13: Marcu MG, Chadli A, Bouhouche I, Catelli M, Neckers LM.
The heat shock protein 90 antagonist novobiocin interacts with a previously
unrecognized ATP-binding domain in the C-terminus of the chaperone.
J Biol Chem. 2000 Aug 16 [epub ahead of print]
[Record as supplied by publisher]
PMID: 10945979


14: Hiasa H, Shea ME.
DNA Gyrase-mediated Wrapping of the DNA Strand Is Required for the Replication
Fork Arrest by the DNA Gyrase-Quinolone-DNA Ternary Complex.
J Biol Chem. 2000 Aug 16 [epub ahead of print]
[Record as supplied by publisher]
PMID: 10945973


15: Khodursky AB, Peter BJ, Schmid MB, DeRisi J, Botstein D, Brown PO,
Cozzarelli NR.
Analysis of topoisomerase function in bacterial replication fork movement: use
of DNA microarrays.
Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9419-24.
PMID: 10944214; UI: 20402549


16: Prodromou C, Panaretou B, Chohan S, Siligardi G, O'Brien R, Ladbury JE, Roe
SM, Piper PW, Pearl LH.
The ATPase cycle of hsp90 drives a molecular 'clamp' via transient dimerization
of the N-terminal domains.
EMBO J. 2000 Aug 15;19(16):4383-92.
[MEDLINE record in process]
PMID: 10944121; UI: 20402344


17: Greene SR, Stamm LV.
Molecular characterization of the gyrB region of the oral spirochete, Treponema
denticola.
Gene. 2000 Aug 8;253(2):259-69.
PMID: 10940564; UI: 20400350


18: Lopez-Garcia P, Forterre P, van der Oost J, Erauso G.
Plasmid pGS5 from the hyperthermophilic archaeon Archaeoglobus profundus is
negatively supercoiled.
J Bacteriol. 2000 Sep;182(17):4998-5000.
PMID: 10940047; UI: 20398188


19: Musicki B, Periers AM, Laurin P, Ferroud D, Benedetti Y, Lachaud S,
Chatreaux F, Haesslein JL, Iltis A, Pierre C, Khider J, Tessot N, Airault M,
Demassey J, Dupuis-Hamelin C, Lassaigne P, Bonnefoy A, Vicat P, Klich M.
Improved antibacterial activities of coumarin antibiotics bearing
5',5'-dialkylnoviose: biological activity of RU79115.
Bioorg Med Chem Lett. 2000 Aug 7;10(15):1695-9.
[MEDLINE record in process]
PMID: 10937727; UI: 20391506


20: El Hanafi D, Bossi L.
Activation and silencing of leu-500 promoter by transcription-induced DNA
supercoiling in the Salmonella chromosome.
Mol Microbiol. 2000 Aug;37(3):583-94.
PMID: 10931352; UI: 20392213


21: Park JY, Ahn B.
Effect of DNA topology on plasmid DNA repair in vivo.
FEBS Lett. 2000 Jul 7;476(3):174-8.
PMID: 10913608; UI: 20374943


22: Fournier B, Zhao X, Lu T, Drlica K, Hooper DC.
Selective targeting of topoisomerase IV and DNA gyrase in Staphylococcus aureus:
different patterns of quinolone-induced inhibition of DNA synthesis.
Antimicrob Agents Chemother. 2000 Aug;44(8):2160-5.
PMID: 10898691; UI: 20356919


23: Boehm HJ, Boehringer M, Bur D, Gmuender H, Huber W, Klaus W, Kostrewa D,
Kuehne H, Luebbers T, Meunier-Keller N, Mueller F.
Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit
validation by biophysical methods, and 3D guided optimization. A promising
alternative to random screening.
J Med Chem. 2000 Jul 13;43(14):2664-74.
PMID: 10893304; UI: 20353481


24: Abd-Allah AR, Gannam BB, Hamada FM.
The impact of ofloxacin on rat testicular DNA: application of image analysis.
Pharmacol Res. 2000 Aug;42(2):145-150.
[Record as supplied by publisher]
PMID: 10887043


25: Besnard V, Federighi M, Cappelier JM.
Development of a direct viable count procedure for the investigation of VBNC
state in Listeria monocytogenes.
Lett Appl Microbiol. 2000 Jul;31(1):77-81.
PMID: 10886620; UI: 20344504


26: Hammonds TR, Foster SR, Maxwell A.
Increased sensitivity to quinolone antibacterials can be engineered in human
topoisomerase IIalpha by selective mutagenesis.
J Mol Biol. 2000 Jul 14;300(3):481-91.
PMID: 10884345; UI: 20344912


27: Marshall DG, Bowe F, Hale C, Dougan G, Dorman CJ.
DNA topology and adaptation of Salmonella typhimurium to an intracellular
environment.
Philos Trans R Soc Lond B Biol Sci. 2000 May 29;355(1397):565-74.
[MEDLINE record in process]
PMID: 10874730; UI: 20332904


28: Benedetti P, Baldi MI, Mattoccia E, Tocchini-Valentini GP.
Purification and characterization of Xenopus laevis topoisomerase II.
EMBO J. 1983;2(8):1303-8.
PMID: 10872324; UI: 20331128


29: Hu B, Zhu J, Shen SC, Yu GQ.
A promoter region binding protein and DNA gyrase regulate anaerobic
transcription of nifLA in Enterobacter cloacae.
J Bacteriol. 2000 Jul;182(14):3920-3.
PMID: 10869067; UI: 20327569


30: Blance SJ, Williams NL, Preston ZA, Bishara J, Smyth MS, Maxwell A.
Temperature-sensitive suppressor mutations of the Escherichia coli DNA gyrase B
protein.
Protein Sci. 2000 May;9(5):1035-7.
[MEDLINE record in process]
PMID: 10850814; UI: 20306987


31: Baliga NS, Dassarma S.
Saturation mutagenesis of the haloarchaeal bop gene promoter: identification of
DNA supercoiling sensitivity sites and absence of TFB recognition element and
UAS enhancer activity.
Mol Microbiol. 2000 Jun;36(5):1175-83.
PMID: 10844701; UI: 20305059


32: Vogel BF, Venkateswaran K, Christensen H, Falsen E, Christiansen G, Gram L.
Polyphasic taxonomic approach in the description of Alishewanella fetalis gen.
nov., sp. nov., isolated from a human foetus.
Int J Syst Evol Microbiol. 2000 May;50 Pt 3:1133-42.
PMID: 10843055; UI: 20300041


33: Klaus W, Ross A, Gsell B, Senn H.
Letter to the editor: Backbone resonance assignment of the N-terminal 24 kDa
fragment of the gyrase B subunit from S. aureus complexed with novobiocin.
J Biomol NMR. 2000 Apr;16(4):357-8. No abstract available.
PMID: 10826892; UI: 20285168


34: Morrissey I, George JT.
Purification of pneumococcal type II topoisomerases and inhibition by
gemifloxacin and other quinolones.
J Antimicrob Chemother. 2000 Apr;45 Suppl 1:101-6.
PMID: 10824040; UI: 20285515


35: Sharma SK, Tandon M, Lown JW.
Design and synthesis of novel thiazole-containing cross-linked polyamides
related to the antiviral antibiotic distamycin.
J Org Chem. 2000 Feb 25;65(4):1102-7.
PMID: 10814060; UI: 20275811


36: Shea ME, Hiasa H.
Distinct effects of the UvrD helicase on topoisomerase-quinolone-DNA ternary
complexes.
J Biol Chem. 2000 May 12;275(19):14649-58.
PMID: 10799552; UI: 20261598


37: Pestova E, Millichap JJ, Noskin GA, Peterson LR.
Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones.
J Antimicrob Chemother. 2000 May;45(5):583-90.
PMID: 10797078; UI: 20259457


38: Lubbers T, Angehrn P, Gmunder H, Herzig S, Kulhanek J.
Design, synthesis, and structure-activity relationship studies of ATP analogues
as DNA gyrase inhibitors.
Bioorg Med Chem Lett. 2000 Apr 17;10(8):821-6.
PMID: 10782694; UI: 20242788


39: Taganov KD, Gushchin AE, Akopian TA, Oparina NIu, Abramycheva NIu, Govorun
VM.
[Analysis of genes, coding for DNA gyrase from the mycoplasma Acholeplasma
laidlawii PG-8B].
Mol Biol (Mosk). 2000 Mar-Apr;34(2):292-9. Russian. No abstract available.
PMID: 10779957; UI: 20242229


40: O'Farrell AM, Parry DA, Zindy F, Roussel MF, Lees E, Moore KW, Mui AL.
Stat3-dependent induction of p19INK4D by IL-10 contributes to inhibition of
macrophage proliferation.
J Immunol. 2000 May 1;164(9):4607-15.
PMID: 10779764; UI: 20243560


41: Ji S.
Free energy and information contents of conformons in proteins and DNA.
Biosystems. 2000 Jan;54(3):107-30. Review.
PMID: 10774555; UI: 20234588


42: Giraud E, Cloeckaert A, Kerboeuf D, Chaslus-Dancla E.
Evidence for active efflux as the primary mechanism of resistance to
ciprofloxacin in Salmonella enterica serovar typhimurium.
Antimicrob Agents Chemother. 2000 May;44(5):1223-8.
PMID: 10770755; UI: 20233588


43: Simon H, Kittler L, Baird E, Dervan P, Zimmer C.
Selective inhibition of DNA gyrase in vitro by a GC specific eight-ring hairpin
polyamide at nanomolar concentration.
FEBS Lett. 2000 Apr 14;471(2-3):173-6.
PMID: 10767417; UI: 20231707


44: Kwok Y, Sun D, Clement JJ, Hurley LH.
The quinobenzoxazines: relationship between DNA binding and biological activity.
Anticancer Drug Des. 1999 Oct;14(5):443-50.
PMID: 10766299; UI: 20227366


45: Chatterji M, Unniraman S, Maxwell A, Nagaraja V.
The additional 165 amino acids in the B protein of Escherichia coli DNA gyrase
have an important role in DNA binding.
J Biol Chem. 2000 Jul 28;275(30):22888-94.
PMID: 10764756; UI: 20390040


46: Bono JL, Elias AF, Kupko JJ 3rd, Stevenson B, Tilly K, Rosa P.
Efficient targeted mutagenesis in Borrelia burgdorferi.
J Bacteriol. 2000 May;182(9):2445-52.
PMID: 10762244; UI: 20225841


47: Venkateswaran K, Dohmoto N.
Pseudoalteromonas peptidolytica sp. nov., a novel marine mussel-thread-degrading
bacterium isolated from the Sea of Japan.
Int J Syst Evol Microbiol. 2000 Mar;50 Pt 2:565-74.
PMID: 10758862; UI: 20222161


48: Declais AC, Marsault J, Confalonieri F, de La Tour CB, Duguet M.
Reverse gyrase, the two domains intimately cooperate to promote positive
supercoiling.
J Biol Chem. 2000 Jun 30;275(26):19498-504.
PMID: 10748189; UI: 20347848


49: Kuroda A, Ohtake H.
Molecular analysis of polyphosphate accumulation in bacteria.
Biochemistry (Mosc). 2000 Mar;65(3):304-8. Review.
PMID: 10739472; UI: 20204404


50: Brino L, Urzhumtsev A, Mousli M, Bronner C, Mitschler A, Oudet P, Moras D.
Dimerization of Escherichia coli DNA-gyrase B provides a structural mechanism
for activating the ATPase catalytic center.
J Biol Chem. 2000 Mar 31;275(13):9468-75.
PMID: 10734094; UI: 20200440


51: Forterre P, Bouthier De La Tour C, Philippe H, Duguet M.
Reverse gyrase from hyperthermophiles: probable transfer of a thermoadaptation
trait from archaea to bacteria.
Trends Genet. 2000 Apr;16(4):152-4. Review. No abstract available.
PMID: 10729828; UI: 20196029


52: Speciale A, Musumeci R, Blandino G, Caccamo F, Siracusa V, Renis M.
Molecular mechanisms of resistance in Pseudomonas aeruginosa to
fluoroquinolones.
Int J Antimicrob Agents. 2000 Mar;14(2):151-6.
PMID: 10720806; UI: 20188046


53: Modai J.
High-dose intravenous fluoroquinolones in the treatment of severe infections.
J Chemother. 1999 Dec;11(6):478-85. Review.
PMID: 10678789; UI: 20142257


54: Knight SW, Kimmel BJ, Eggers CH, Samuels DS.
Disruption of the Borrelia burgdorferi gac gene, encoding the naturally
synthesized GyrA C-terminal domain.
J Bacteriol. 2000 Apr;182(7):2048-51.
PMID: 10715016; UI: 20179825


55: Zechiedrich EL, Khodursky AB, Bachellier S, Schneider R, Chen D, Lilley DM,
Cozzarelli NR.
Roles of topoisomerases in maintaining steady-state DNA supercoiling in
Escherichia coli.
J Biol Chem. 2000 Mar 17;275(11):8103-13.
PMID: 10713132; UI: 20179919


56: Wasinger VC, Pollack JD, Humphery-Smith I.
The proteome of Mycoplasma genitalium. Chaps-soluble component.
Eur J Biochem. 2000 Mar;267(6):1571-82.
PMID: 10712586; UI: 20177680


57: Lebeau L, Nuss S, Schultz P, Oudet P, Mioskowski C.
Self-assembly of soluble proteins on functionalized lipid layers: a tentative
correlation between the fluidity properties of the lipid film and protein
ordering.
Chem Phys Lipids. 1999 Dec;103(1-2):37-46.
PMID: 10701078; UI: 20165905


58: Snyder RD.
Use of catalytic topoisomerase II inhibitors to probe mechanisms of
chemical-induced clastogenicity in Chinese hamster V79 cells.
Environ Mol Mutagen. 2000;35(1):13-21.
PMID: 10692223; UI: 20156221


59: Durand JM, Dagberg B, Uhlin BE, Bjork GR.
Transfer RNA modification, temperature and DNA superhelicity have a common
target in the regulatory network of the virulence of Shigella flexneri: the
expression of the virF gene.
Mol Microbiol. 2000 Feb;35(4):924-35.
PMID: 10692168; UI: 20156684


60: Goerke C, Campana S, Bayer MG, Doring G, Botzenhart K, Wolz C.
Direct quantitative transcript analysis of the agr regulon of Staphylococcus
aureus during human infection in comparison to the expression profile in vitro.
Infect Immun. 2000 Mar;68(3):1304-11.
PMID: 10678942; UI: 20143741


61: Periers AM, Laurin P, Ferroud D, Haesslein JL, Klich M, Dupuis-Hamelin C,
Mauvais P, Lassaigne P, Bonnefoy A, Musicki B.
Coumarin inhibitors of gyrase B with N-propargyloxy-carbamate as an effective
pyrrole bioisostere.
Bioorg Med Chem Lett. 2000 Jan 17;10(2):161-5.
PMID: 10673102; UI: 20135657


62: Sawitzke JA, Austin S.
Suppression of chromosome segregation defects of Escherichia coli muk mutants by
mutations in topoisomerase I.
Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1671-6.
PMID: 10660686; UI: 20144099


63: Inouye K, Mizutani S, Koide H, Kaziro Y.
Formation of the Ras dimer is essential for Raf-1 activation.
J Biol Chem. 2000 Feb 11;275(6):3737-40.
PMID: 10660519; UI: 20127839


64: Jalal S, Wretlind G, Gotoh N, Wretlind B.
Rapid identification of mutations in a multidrug efflux pump in Pseudomonas
aeruginosa.
APMIS. 1999 Dec;107(12):1109-16.
PMID: 10660141; UI: 20123537


65: Marcu MG, Schulte TW, Neckers L.
Novobiocin and related coumarins and depletion of heat shock protein
90-dependent signaling proteins.
J Natl Cancer Inst. 2000 Feb 2;92(3):242-8.
PMID: 10655441; UI: 20122518


66: Soini H, Pan X, Amin A, Graviss EA, Siddiqui A, Musser JM.
Characterization of Mycobacterium tuberculosis isolates from patients in
Houston, Texas, by spoligotyping.
J Clin Microbiol. 2000 Feb;38(2):669-76.
PMID: 10655365; UI: 20122442


67: Simon H, Fortsch I, Burckhardt G, Gabrielyan A, Birch-Hirschfeld E, Stelzner
A, Prevot-Halter I, Leumann C, Zimmer C.
Triple helix formation inhibits DNA gyrase activity.
Antisense Nucleic Acid Drug Dev. 1999 Dec;9(6):527-31.
PMID: 10645778; UI: 20108376


68: Ramaswamy S, Musser JM.
Molecular genetic basis of antimicrobial agent resistance in Mycobacterium
tuberculosis: 1998 update.
Tuber Lung Dis. 1998;79(1):3-29. Review.
PMID: 10645439; UI: 20110034


69: Alovero FL, Pan XS, Morris JE, Manzo RH, Fisher LM.
Engineering the specificity of antibacterial fluoroquinolones:
benzenesulfonamide modifications at C-7 of ciprofloxacin change its primary
target in Streptococcus pneumoniae from topoisomerase IV to gyrase.
Antimicrob Agents Chemother. 2000 Feb;44(2):320-5.
PMID: 10639357; UI: 20106976


70: Gushchin AE, Ladygina VG, Govorun VM.
[Role of mutations in parC and gyrA in forming resistance of Mycoplasma hominis
to fluoroquinolones].
Mol Gen Mikrobiol Virusol. 1999;(4):19-24. Russian.
PMID: 10621934; UI: 20087814


71: Unniraman S, Nagaraja V.
Regulation of DNA gyrase operon in Mycobacterium smegmatis: a distinct mechanism
of relaxation stimulated transcription.
Genes Cells. 1999 Dec;4(12):697-706.
PMID: 10620015; UI: 20087459


72: Massey RC, Rainey PB, Sheehan BJ, Keane OM, Dorman CJ.
Environmentally constrained mutation and adaptive evolution in Salmonella.
Curr Biol. 1999 Dec 16-30;9(24):1477-80.
PMID: 10607591; UI: 20076699


73: Muller-Serieys C.
[Epidemiology of resistance to antibiotics in respiratory tract infections].
Presse Med. 1999 Nov 27;28 Suppl 3:37-42. Review. French.
PMID: 10605468; UI: 20073401


74: Oethinger M, Kern WV, Jellen-Ritter AS, McMurry LM, Levy SB.
Ineffectiveness of topoisomerase mutations in mediating clinically significant
fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB
efflux pump.
Antimicrob Agents Chemother. 2000 Jan;44(1):10-3.
PMID: 10602715; UI: 20068668


75: Jacobs MR.
Activity of quinolones against mycobacteria.
Drugs. 1999;58 Suppl 2:19-22. Review.
PMID: 10553700; UI: 20019128


76: Piddock LJ.
Mechanisms of fluoroquinolone resistance: an update 1994-1998.
Drugs. 1999;58 Suppl 2:11-8. Review.
PMID: 10553699; UI: 20019127


77: Hooper DC.
Mode of action of fluoroquinolones.
Drugs. 1999;58 Suppl 2:6-10. Review.
PMID: 10553698; UI: 20019126


78: Schneider R, Travers A, Kutateladze T, Muskhelishvili G.
A DNA architectural protein couples cellular physiology and DNA topology in
Escherichia coli.
Mol Microbiol. 1999 Dec;34(5):953-64.
PMID: 10594821; UI: 20063143


79: Marshall DG, Sheehan BJ, Dorman CJ.
A role for the leucine-responsive regulatory protein and integration host factor
in the regulation of the Salmonella plasmid virulence (spv ) locus in Salmonella
typhimurium.
Mol Microbiol. 1999 Oct;34(1):134-45.
PMID: 10540292; UI: 20010121


80: Tavio M, Vila J, Ruiz J, Martin-Sanchez AM, de Anta MT.
Mechanisms involved in the development of resistance to fluoroquinolones in
Escherichia coli isolates.
J Antimicrob Chemother. 1999 Dec;44(6):735-42.
PMID: 10590273; UI: 20059774


81: Onodera Y, Uchida Y, Tanaka M, Sato K.
Dual inhibitory activity of sitafloxacin (DU-6859a) against DNA gyrase and
topoisomerase IV of Streptococcus pneumoniae.
J Antimicrob Chemother. 1999 Oct;44(4):533-6.
PMID: 10588315; UI: 20053536


82: Jensen PR, Van Der Weijden CC, Jensen LB, Westerhoff HV, Snoep JL.
Extensive regulation compromises the extent to which DNA gyrase controls DNA
supercoiling and growth rate of Escherichia coli.
Eur J Biochem. 1999 Dec;266(3):865-77.
PMID: 10583380; UI: 20050598


83: Lu T, Zhao X, Drlica K.
Gatifloxacin activity against quinolone-resistant gyrase: allele-specific
enhancement of bacteriostatic and bactericidal activities by the C-8-methoxy
group.
Antimicrob Agents Chemother. 1999 Dec;43(12):2969-74.
PMID: 10582891; UI: 20049927


84: Brino L, Bronner C, Oudet P, Mousli M.
Isoleucine 10 is essential for DNA gyrase B function in Escherichia coli.
Biochimie. 1999 Oct;81(10):973-80.
PMID: 10575351; UI: 20044408


85: Rattan A.
Mechanisms of resistance to fluoroquinolones.
Natl Med J India. 1999 Jul-Aug;12(4):162-4. Review.
PMID: 10573971; UI: 20041266


86: Williams NL, Maxwell A.
Locking the DNA gate of DNA gyrase: investigating the effects on DNA cleavage
and ATP hydrolysis.
Biochemistry. 1999 Oct 26;38(43):14157-64.
PMID: 10571989; UI: 20042571


87: Fernandes PB, Menzel R, Hardy DJ, Tse-Dinh YC, Warren A, Elsemore DA.
Microbial resistance: novel screens for a contemporary problem.
Med Res Rev. 1999 Nov;19(6):559-68. Review.
PMID: 10557370; UI: 20028391


88: Suzuki M, Nakagawa Y, Harayama S, Yamamoto S.
Phylogenetic analysis of genus Marinilabilia and related bacteria based on the
amino acid sequences of gyrB and emended description of Marinilabilia
salmonicolor with Marinilabilia agarovorans as its subjective synonym.
Int J Syst Bacteriol. 1999 Oct;49 Pt 4:1551-7.
PMID: 10555336; UI: 20023036


89: Bowker-Kinley M, Popov KM.
Evidence that pyruvate dehydrogenase kinase belongs to the ATPase/kinase
superfamily.
Biochem J. 1999 Nov 15;344 Pt 1:47-53.
PMID: 10548532; UI: 20018014


90: Kampranis SC, Howells AJ, Maxwell A.
The interaction of DNA gyrase with the bacterial toxin CcdB: evidence for the
existence of two gyrase-CcdB complexes.
J Mol Biol. 1999 Oct 29;293(3):733-44.
PMID: 10543963; UI: 20013081


91: Morrissey I, George J.
Activities of fluoroquinolones against Streptococcus pneumoniae type II
topoisomerases purified as recombinant proteins.
Antimicrob Agents Chemother. 1999 Nov;43(11):2579-85.
PMID: 10543732; UI: 20011158


92: Stankova IG, Videnov GI, Golovinsky EV, Jung G.
Synthesis of thiazole, imidazole and oxazole containing amino acids for peptide
backbone modification.
J Pept Sci. 1999 Sep;5(9):392-8.
PMID: 10526881; UI: 99454005


93: Ferroud D, Collard J, Klich M, Dupuis-Hamelin C, Mauvais P, Lassaigne P,
Bonnefoy A, Musicki B.
Synthesis and biological evaluation of coumarincarboxylic acids as inhibitors of
gyrase B. L-rhamnose as an effective substitute for L-noviose.
Bioorg Med Chem Lett. 1999 Oct 4;9(19):2881-6.
PMID: 10522711; UI: 99450546


94: Laurin P, Ferroud D, Schio L, Klich M, Dupuis-Hamelin C, Mauvais P,
Lassaigne P, Bonnefoy A, Musicki B.
Structure-activity relationship in two series of aminoalkyl substituted coumarin
inhibitors of gyrase B.
Bioorg Med Chem Lett. 1999 Oct 4;9(19):2875-80.
PMID: 10522710; UI: 99450545


95: Williams NL, Maxwell A.
Probing the two-gate mechanism of DNA gyrase using cysteine cross-linking.
Biochemistry. 1999 Oct 12;38(41):13502-11.
PMID: 10521257; UI: 99452691


96: Guillemin I, Sougakoff W, Cambau E, Revel-Viravau V, Moreau N, Jarlier V.
Purification and inhibition by quinolones of DNA gyrases from Mycobacterium
avium, Mycobacterium smegmatis and Mycobacterium fortuitum bv. peregrinum.
Microbiology. 1999 Sep;145 ( Pt 9):2527-32.
PMID: 10517605; UI: 99445193


97: Drlica K.
Mechanism of fluoroquinolone action.
Curr Opin Microbiol. 1999 Oct;2(5):504-8. Review.
PMID: 10508721; UI: 99440019


98: Kenny GE, Young PA, Cartwright FD, Sjostrom KE, Huang WM.
Sparfloxacin selects gyrase mutations in first-step Mycoplasma hominis mutants,
whereas ofloxacin selects topoisomerase IV mutations.
Antimicrob Agents Chemother. 1999 Oct;43(10):2493-6.
PMID: 10508030; UI: 99437789


99: Onodera Y, Sato K.
Molecular cloning of the gyrA and gyrB genes of Bacteroides fragilis encoding
DNA gyrase.
Antimicrob Agents Chemother. 1999 Oct;43(10):2423-9.
PMID: 10508019; UI: 99437778


100: Widdowson CA, Klugman KP.
Molecular mechanisms of resistance to commonly used non-betalactam drugs in
Streptococcus pneumoniae.
Semin Respir Infect. 1999 Sep;14(3):255-68. Review.
PMID: 10501313; UI: 99429421


101: Frank KE, Devasthale PV, Gentry EJ, Ravikumar VT, Keschavarz-Shokri A,
Mitscher LA, Nilius A, Shen LL, Shawar R, Baker WR.
A simple, inexpensive apparatus for performance of preparative scale solution
phase multiple parallel synthesis of drug analogs. II. Biological evaluation of
a retrospective library of quinolone antiinfective agents.
Comb Chem High Throughput Screen. 1998 Jun;1(2):89-99.
PMID: 10500768; UI: 99430555


102: Strumberg D, Nitiss JL, Dong J, Kohn KW, Pommier Y.
Molecular analysis of yeast and human type II topoisomerases. Enzyme-DNA and
drug interactions.
J Biol Chem. 1999 Oct 1;274(40):28246-55.
PMID: 10497180; UI: 99428490


103: Takahashi N, Hieda K, Morohoshi F, Munakata N.
Base substitution spectra of nalidixylate resistant mutations induced by
monochromatic soft X and 60Co gamma-rays in Bacillus subtilis spores.
J Radiat Res (Tokyo). 1999 Jun;40(2):115-24.
PMID: 10494143; UI: 99423916


104: Simpson KL, Markham A.
Ofloxacin otic solution: a review of its use in the management of ear
infections.
Drugs. 1999 Sep;58(3):509-31. Review.
PMID: 10493278; UI: 99421021


105: Dale GE, Kostrewa D, Gsell B, Stieger M, D'Arcy A.
Crystal engineering: deletion mutagenesis of the 24 kDa fragment of the DNA
gyrase B subunit from Staphylococcus aureus.
Acta Crystallogr D Biol Crystallogr. 1999 Sep;55 ( Pt 9):1626-9.
PMID: 10489469; UI: 99420445


106: D'Arcy A, Stihle M, Kostrewa D, Dale G.
Crystal engineering: a case study using the 24 kDa fragment of the DNA gyrase B
subunit from Escherichia coli.
Acta Crystallogr D Biol Crystallogr. 1999 Sep;55 ( Pt 9):1623-5.
PMID: 10489468; UI: 99420444


107: Lopez-Garcia P.
DNA supercoiling and temperature adaptation: A clue to early diversification of
life?
J Mol Evol. 1999 Oct;49(4):439-52.
PMID: 10486002; UI: 99415848


108: Pato ML, Banerjee M.
Replacement of the bacteriophage Mu strong gyrase site and effect on Mu DNA
replication.
J Bacteriol. 1999 Sep;181(18):5783-9.
PMID: 10482521; UI: 99412279


109: Hojgaard A, Szerlong H, Tabor C, Kuempel P.
Norfloxacin-induced DNA cleavage occurs at the dif resolvase locus in
Escherichia coli and is the result of interaction with topoisomerase IV.
Mol Microbiol. 1999 Sep;33(5):1027-36.
PMID: 10476036; UI: 99406909


110: Giraud E, Brisabois A, Martel JL, Chaslus-Dancla E.
Comparative studies of mutations in animal isolates and experimental in vitro-
and in vivo-selected mutants of Salmonella spp. suggest a counterselection of
highly fluoroquinolone-resistant strains in the field.
Antimicrob Agents Chemother. 1999 Sep;43(9):2131-7.
PMID: 10471553; UI: 99402666


111: Knight SW, Samuels DS.
Natural synthesis of a DNA-binding protein from the C-terminal domain of DNA
gyrase A in Borrelia burgdorferi.
EMBO J. 1999 Sep 1;18(17):4875-81.
PMID: 10469665; UI: 99400631


112: Laurin P, Ferroud D, Klich M, Dupuis-Hamelin C, Mauvais P, Lassaigne P,
Bonnefoy A, Musicki B.
Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of
gyrase B.
Bioorg Med Chem Lett. 1999 Jul 19;9(14):2079-84.
PMID: 10450985; UI: 99378194


113: Lopez-Garcia P, Forterre P.
Control of DNA topology during thermal stress in hyperthermophilic archaea: DNA
topoisomerase levels, activities and induced thermotolerance during heat and
cold shock in Sulfolobus.
Mol Microbiol. 1999 Aug;33(4):766-77.
PMID: 10447886; UI: 99377129


114: Nakanishi A, Imajoh-Ohmi S.
[DNA gyrase inhibitor (GyrI) of Escherichia coli].
Seikagaku. 1999 Jun;71(6):442-8. Review. Japanese. No abstract available.
PMID: 10432838; UI: 99361403


115: Hethke C, Bergerat A, Hausner W, Forterre P, Thomm M.
Cell-free transcription at 95 degrees: thermostability of transcriptional
components and DNA topology requirements of Pyrococcus transcription.
Genetics. 1999 Aug;152(4):1325-33.
PMID: 10430563; UI: 99359407


116: Pestova E, Beyer R, Cianciotto NP, Noskin GA, Peterson LR.
Contribution of topoisomerase IV and DNA gyrase mutations in Streptococcus
pneumoniae to resistance to novel fluoroquinolones.
Antimicrob Agents Chemother. 1999 Aug;43(8):2000-4.
PMID: 10428926; UI: 99359264


117: Gootz TD, Zaniewski RP, Haskell SL, Kaczmarek FS, Maurice AE.
Activities of trovafloxacin compared with those of other fluoroquinolones
against purified topoisomerases and gyrA and grlA mutants of Staphylococcus
aureus.
Antimicrob Agents Chemother. 1999 Aug;43(8):1845-55.
PMID: 10428901; UI: 99359239


118: Tanabe K, Kondo T, Onodera Y, Furusawa M.
A conspicuous adaptability to antibiotics in the Escherichia coli mutator
strain, dnaQ49.
FEMS Microbiol Lett. 1999 Jul 1;176(1):191-6.
PMID: 10418146; UI: 99346700


119: Kampranis SC, Bates AD, Maxwell A.
A model for the mechanism of strand passage by DNA gyrase.
Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8414-9.
PMID: 10411889; UI: 99342032


120: Jariyawat S, Sekine T, Takeda M, Apiwattanakul N, Kanai Y, Sophasan S,
Endou H.
The interaction and transport of beta-lactam antibiotics with the cloned rat
renal organic anion transporter 1.
J Pharmacol Exp Ther. 1999 Aug;290(2):672-7.
PMID: 10411577; UI: 99340168


121: Southworth MW, Amaya K, Evans TC, Xu MQ, Perler FB.
Purification of proteins fused to either the amino or carboxy terminus of the
Mycobacterium xenopi gyrase A intein.
Biotechniques. 1999 Jul;27(1):110-4, 116, 118-20.
PMID: 10407673; UI: 99336011


122: Weigelt J, Brown SE, Miles CS, Dixon NE, Otting G.
NMR structure of the N-terminal domain of E. coli DnaB helicase: implications
for structure rearrangements in the helicase hexamer.
Structure Fold Des. 1999 Jun 15;7(6):681-90.
PMID: 10404597; UI: 99332676


123: Dubin DT, Fitzgibbon JE, Nahvi MD, John JF.
Topoisomerase sequences of coagulase-negative staphylococcal isolates resistant
to ciprofloxacin or trovafloxacin.
Antimicrob Agents Chemother. 1999 Jul;43(7):1631-7.
PMID: 10390214; UI: 99318589


124: Saiki AY, Shen LL, Chen CM, Baranowski J, Lerner CG.
DNA cleavage activities of Staphylococcus aureus gyrase and topoisomerase IV
stimulated by quinolones and 2-pyridones.
Antimicrob Agents Chemother. 1999 Jul;43(7):1574-7.
PMID: 10390205; UI: 99318580


125: Hombrouck C, Capmau ML, Moreau N.
Overexpression, purification and photoaffinity labeling with a 3H-analogue of
norfloxacin, of the GyrA and GyrB subunits of the DNA gyrase.
Cell Mol Biol (Noisy-le-grand). 1999 May;45(3):347-52.
PMID: 10386791; UI: 99313362


126: Schedletzky H, Wiedemann B, Heisig P.
The effect of moxifloxacin on its target topoisomerases from Escherichia coli
and Staphylococcus aureus.
J Antimicrob Chemother. 1999 May;43 Suppl B:31-7.
PMID: 10382873; UI: 99310246


127: Kume A, Ito K, Ueda Y, Hasegawa M, Urabe M, Mano H, Ozawa K.
A G-CSF receptor-gyrase B fusion gene: A new type of molecular switch for
expansion of genetically modified hematopoietic cells.
Biochem Biophys Res Commun. 1999 Jun 24;260(1):9-12.
PMID: 10381335; UI: 99310561


128: Tabarrini O, Cecchetti V, Fravolini A, Nocentini G, Barzi A, Sabatini S,
Miao H, Sissi C.
Design and synthesis of modified quinolones as antitumoral acridones.
J Med Chem. 1999 Jun 17;42(12):2136-44.
PMID: 10377219; UI: 99307292


129: Grenert JP, Johnson BD, Toft DO.
The importance of ATP binding and hydrolysis by hsp90 in formation and function
of protein heterocomplexes.
J Biol Chem. 1999 Jun 18;274(25):17525-33.
PMID: 10364185; UI: 99292709


130: Kwok Y, Zeng Q, Hurley LH.
Structural insight into a quinolone-topoisomerase II-DNA complex. Further
evidence for a 2:2 quinobenzoxazine-mg2+ self-assembly model formed in the
presence of topoisomerase ii.
J Biol Chem. 1999 Jun 11;274(24):17226-35.
PMID: 10358081; UI: 99287929


131: Ashizawa Y, Yokochi T, Ogata Y, Shobuike Y, Kato J, Ikeda H.
Mechanism of DNA gyrase-mediated illegitimate recombination: characterization of
Escherichia coli gyrA mutations that confer hyper-recombination phenotype.
J Mol Biol. 1999 Jun 11;289(3):447-58.
PMID: 10356321; UI: 99286279


132: Masse E, Drolet M.
Escherichia coli DNA topoisomerase I inhibits R-loop formation by relaxing
transcription-induced negative supercoiling.
J Biol Chem. 1999 Jun 4;274(23):16659-64.
PMID: 10347234; UI: 99278445


133: Sinha Roy R, Kelleher NL, Milne JC, Walsh CT.
In vivo processing and antibiotic activity of microcin B17 analogs with varying
ring content and altered bisheterocyclic sites.
Chem Biol. 1999 May;6(5):305-18.
PMID: 10322125; UI: 99257378


134: Forterre P, Confalonieri F, Knapp S.
Identification of the gene encoding archeal-specific DNA-binding proteins of the
Sac10b family.
Mol Microbiol. 1999 May;32(3):669-70. No abstract available.
PMID: 10320587; UI: 99255700


135: Manna D, Higgins NP.
Phage Mu transposition immunity reflects supercoil domain structure of the
chromosome.
Mol Microbiol. 1999 May;32(3):595-606.
PMID: 10320581; UI: 99255694


136: Pan XS, Fisher LM.
Streptococcus pneumoniae DNA gyrase and topoisomerase IV: overexpression,
purification, and differential inhibition by fluoroquinolones.
Antimicrob Agents Chemother. 1999 May;43(5):1129-36.
PMID: 10223925; UI: 99240355


137: Xiong YQ, Yeaman MR, Bayer AS.
In vitro antibacterial activities of platelet microbicidal protein and
neutrophil defensin against Staphylococcus aureus are influenced by antibiotics
differing in mechanism of action.
Antimicrob Agents Chemother. 1999 May;43(5):1111-7.
PMID: 10223922; UI: 99240352


138: Braga PC, Sala MT, Dal Sasso M.
Pharmacodynamic effects of subinhibitory concentrations of rufloxacin on
bacterial virulence factors.
Antimicrob Agents Chemother. 1999 May;43(5):1013-9.
PMID: 10223908; UI: 99240338


139: Xia Y, Yang ZY, Morris-Natschke SL, Lee KH.
Recent advances in the discovery and development of quinolones and analogs as
antitumor agents.
Curr Med Chem. 1999 Mar;6(3):179-94. Review.
PMID: 10219099; UI: 99238530


140: Jovanovic M, Lilic M, Janjusevic R, Jovanovic G, Savic DJ, Milija J.
tRNA synthetase mutants of Escherichia coli K-12 are resistant to the gyrase
inhibitor novobiocin.
J Bacteriol. 1999 May;181(9):2979-83.
PMID: 10217798; UI: 99235787


141: Okuhara K, Ohta K, Seo H, Shioda M, Yamada T, Tanaka Y, Dohmae N, Seyama Y,
Shibata T, Murofushi H.
A DNA unwinding factor involved in DNA replication in cell-free extracts of
Xenopus eggs.
Curr Biol. 1999 Apr 8;9(7):341-50.
PMID: 10209116; UI: 99227348


142: Kidwai M, Misra P, Kumar R.
The fluorinated quinolones.
Curr Pharm Des. 1998 Apr;4(2):101-18. Review.
PMID: 10197035; UI: 99212784


143: Bahassi EM, O'Dea MH, Allali N, Messens J, Gellert M, Couturier M.
Interactions of CcdB with DNA gyrase. Inactivation of Gyra, poisoning of the
gyrase-DNA complex, and the antidote action of CcdA.
J Biol Chem. 1999 Apr 16;274(16):10936-44.
PMID: 10196173; UI: 99214166


144: Yamada S, Ohashi E, Agata N, Venkateswaran K.
Cloning and nucleotide sequence analysis of gyrB of Bacillus cereus, B.
thuringiensis, B. mycoides, and B. anthracis and their application to the
detection of B. cereus in rice.
Appl Environ Microbiol. 1999 Apr;65(4):1483-90.
PMID: 10103241; UI: 99203101


145: Bebear CM, Renaudin J, Charron A, Renaudin H, de Barbeyrac B, Schaeverbeke
T, Bebear C.
Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone
resistance in clinical isolates of Mycoplasma hominis.
Antimicrob Agents Chemother. 1999 Apr;43(4):954-6.
PMID: 10103208; UI: 99216913


146: el Amin NA, Jalal S, Wretlind B.
Alterations in GyrA and ParC associated with fluoroquinolone resistance in
Enterococcus faecium.
Antimicrob Agents Chemother. 1999 Apr;43(4):947-9.
PMID: 10103206; UI: 99216911


147: Choi H, Lee HJ, Lee Y.
A mutation in QRDR in the ParC subunit of topoisomerase IV was responsible for
fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
Yonsei Med J. 1998 Dec;39(6):541-5.
PMID: 10097681; UI: 99197754


148: Park YH, Yoo JH, Huh DH, Cho YK, Choi JH, Shin WS.
Molecular analysis of fluoroquinolone-resistance in Escherichia coli on the
aspect of gyrase and multiple antibiotic resistance (mar) genes.
Yonsei Med J. 1998 Dec;39(6):534-40.
PMID: 10097680; UI: 99197753


149: Maxwell A.
DNA gyrase as a drug target.
Biochem Soc Trans. 1999 Feb;27(2):48-53. Review. No abstract available.
PMID: 10093705; UI: 99193665


150: Jaxel C, Duguet M, Nadal M.
Analysis of DNA cleavage by reverse gyrase from Sulfolobus shibatae B12.
Eur J Biochem. 1999 Feb;260(1):103-11.
PMID: 10091589; UI: 99191689


151: Kim D, Lee IS, Jung JH, Yang SI.
Psammaplin A, a natural bromotyrosine derivative from a sponge, possesses the
antibacterial activity against methicillin-resistant Staphylococcus aureus and
the DNA gyrase-inhibitory activity.
Arch Pharm Res. 1999 Feb;22(1):25-9.
PMID: 10071955; UI: 99170171


152: Strumberg D, Nitiss JL, Rose A, Nicklaus MC, Pommier Y.
Mutation of a conserved serine residue in a quinolone-resistant type II
topoisomerase alters the enzyme-DNA and drug interactions.
J Biol Chem. 1999 Mar 12;274(11):7292-301.
PMID: 10066792; UI: 99167496


153: Martinez JL, Alonso A, Gomez-Gomez JM, Baquero F.
Quinolone resistance by mutations in chromosomal gyrase genes. Just the tip of
the iceberg?
J Antimicrob Chemother. 1998 Dec;42(6):683-8. Review. No abstract available.
PMID: 10052889; UI: 99160254


154: Zhao BY, Pine R, Domagala J, Drlica K.
Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis:
effects of a C-8 methoxyl group on survival in liquid media and in human
macrophages.
Antimicrob Agents Chemother. 1999 Mar;43(3):661-6.
PMID: 10049284; UI: 99169772


155: Akasaka T, Onodera Y, Tanaka M, Sato K.
Cloning, expression, and enzymatic characterization of Pseudomonas aeruginosa
topoisomerase IV.
Antimicrob Agents Chemother. 1999 Mar;43(3):530-6.
PMID: 10049263; UI: 99169751


156: Yamamoto S, Bouvet PJ, Harayama S.
Phylogenetic structures of the genus Acinetobacter based on gyrB sequences:
comparison with the grouping by DNA-DNA hybridization.
Int J Syst Bacteriol. 1999 Jan;49 Pt 1:87-95.
PMID: 10028249; UI: 99152575


157: Kampranis SC, Gormley NA, Tranter R, Orphanides G, Maxwell A.
Probing the binding of coumarins and cyclothialidines to DNA gyrase.
Biochemistry. 1999 Feb 16;38(7):1967-76.
PMID: 10026280; UI: 99151985


158: Bilwes AM, Alex LA, Crane BR, Simon MI.
Structure of CheA, a signal-transducing histidine kinase.
Cell. 1999 Jan 8;96(1):131-41.
PMID: 9989504; UI: 99142610


159: Jalal S, Wretlind B.
Mechanisms of quinolone resistance in clinical strains of Pseudomonas
aeruginosa.
Microb Drug Resist. 1998 Winter;4(4):257-61.
PMID: 9988043; UI: 99140542


160: Gushchin AE, Taganov KD, Topol' IuIu, Govorun VM.
[Use of a method of single-stranded DNA fragment conformation polymorphism
(SSCP) for detecting resistance of Mycoplasm hominis to fluoroquinolones].
Mol Gen Mikrobiol Virusol. 1998;(4):37-40. Russian.
PMID: 9987752; UI: 99142225


161: Beck R, van Keyserlingk J, Fischer U, Guthoff R, Drewelow B.
Penetration of ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor
using different topical application modes.
Graefes Arch Clin Exp Ophthalmol. 1999 Feb;237(2):89-92.
PMID: 9987622; UI: 99142095


162: Stieger M, Wohlgensinger B, Kamber M, Rolf Lutz, Keck W.
Integrational plasmids for the tetracycline-regulated expression of genes in
Streptococcus pneumoniae.
Gene. 1999 Jan 21;226(2):243-51.
PMID: 9931496; UI: 99132297


163: Fukuda H, Hiramatsu K.
Primary targets of fluoroquinolones in Streptococcus pneumoniae.
Antimicrob Agents Chemother. 1999 Feb;43(2):410-2.
PMID: 9925547; UI: 99143921


164: Jorgensen JH, Weigel LM, Ferraro MJ, Swenson JM, Tenover FC.
Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical
isolates including those with mutations in the gyrA, parC, and parE loci.
Antimicrob Agents Chemother. 1999 Feb;43(2):329-34.
PMID: 9925527; UI: 99143901


165: Varon E, Janoir C, Kitzis MD, Gutmann L.
ParC and GyrA may be interchangeable initial targets of some fluoroquinolones in
Streptococcus pneumoniae.
Antimicrob Agents Chemother. 1999 Feb;43(2):302-6.
PMID: 9925523; UI: 99143897


166: Zlotos G, Oehlmann M, Nickel P, Holzgrabe U.
Determination of protein binding of gyrase inhibitors by means of continuous
ultrafiltration.
J Pharm Biomed Anal. 1998 Dec;18(4-5):847-58.
PMID: 9919987; UI: 99116715


167: Loris R, Dao-Thi MH, Bahassi EM, Van Melderen L, Poortmans F, Liddington R,
Couturier M, Wyns L.
Crystal structure of CcdB, a topoisomerase poison from E. coli.
J Mol Biol. 1999 Jan 29;285(4):1667-77.
PMID: 9917404; UI: 99141409


168: Tkachenko AG, Pshenichnov MR, Salakhetdinova OIa, Nesterova LIu.
[Role of putrescine and potassium transport in regulating the topological state
of DNA during adaptation of Escherichia coli to temperature stress].
Mikrobiologiia. 1998 Sep-Oct;67(5):601-6. Russian.
PMID: 9891292; UI: 99108441


169: Ohno H, Kohno S.
[Mechanisms of drug-resistance in mycobacteria].
Nippon Rinsho. 1998 Dec;56(12):3023-9. Review. Japanese.
PMID: 9883603; UI: 99100056


170: Choi KH, Baek MC, Kim BK, Choi EC.
Resistance mechanism of Acinetobacter spp. strains resistant to DW-116, a new
quinolone.
Arch Pharm Res. 1998 Jun;21(3):310-4.
PMID: 9875449; UI: 99092608


171: Lee S, Park T, Lee Y.
Structure-activity relationship of fluoroquinolone in Escherichia coli.
Arch Pharm Res. 1998 Apr;21(2):106-12.
PMID: 9875416; UI: 99092575


172: Li Q, Wang W, Berst KB, Claiborne A, Hasvold L, Raye K, Tufano M, Nilius A,
Shen LL, Flamm R, Alder J, Marsh K, Crowell D, Chu DT, Plattner JJ.
Synthesis and structure-activity relationships of 2-pyridones: II.
8-(Fluoro-substituted pyrrolidinyl)-2-pyridones as antibacterial agents.
Bioorg Med Chem Lett. 1998 Aug 4;8(15):1953-8.
PMID: 9873465; UI: 99090151


173: Weinder-Wells MA, Altom J, Fernandez J, Fraga-Spano SA, Hilliard J, Ohemeng
K, Barrett JF.
DNA gyrase inhibitory activity of ellagic acid derivatives.
Bioorg Med Chem Lett. 1998 Jan 6;8(1):97-100.
PMID: 9871636; UI: 99088802


174: Mouneimne H, Robert J, Jarlier V, Cambau E.
Type II topoisomerase mutations in ciprofloxacin-resistant strains of
Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1999 Jan;43(1):62-6.
PMID: 9869566; UI: 99087756


175: Chu YW, Houang ET, Cheng AF.
Novel combination of mutations in the DNA gyrase and topoisomerase IV genes in
laboratory-grown fluoroquinolone-resistant Shigella flexneri mutants.
Antimicrob Agents Chemother. 1998 Nov;42(11):3051-2. No abstract available.
PMID: 9867794; UI: 99056880


176: Ohno H, Koga H, Kohno S.
[Multidrug-resistant tuberculosis. 2. Mechanisms of drug-resistance in
Mycobacterium tuberculosis--genetic mechanisms of drug-resistance].
Kekkaku. 1998 Nov;73(11):657-63. Review. Japanese.
PMID: 9866928; UI: 99084160


177: Mohi MG, Arai Ki, Watanabe S.
Activation and functional analysis of Janus kinase 2 in BA/F3 cells using the
coumermycin/gyrase B system.
Mol Biol Cell. 1998 Dec;9(12):3299-308.
PMID: 9843570; UI: 99060129


178: Gardiner LP, Roper DI, Hammonds TR, Maxwell A.
The N-terminal domain of human topoisomerase IIalpha is a DNA-dependent ATPase.
Biochemistry. 1998 Dec 1;37(48):16997-7004.
PMID: 9836594; UI: 99055177


179: Li Z, Deguchi T, Yasuda M, Kawamura T, Kanematsu E, Nishino Y, Ishihara S,
Kawada Y.
Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of DNA
topoisomerase IV in quinolone-resistant clinical isolates of Staphylococcus
epidermidis.
Antimicrob Agents Chemother. 1998 Dec;42(12):3293-5.
PMID: 9835531; UI: 99054882


180: Ban C, Yang W.
Crystal structure and ATPase activity of MutL: implications for DNA repair and
mutagenesis.
Cell. 1998 Nov 13;95(4):541-52.
PMID: 9827806; UI: 99043508


181: Liao VH, Freedman JH.
Cadmium-regulated genes from the nematode Caenorhabditis elegans. Identification
and cloning of new cadmium-responsive genes by differential display.
J Biol Chem. 1998 Nov 27;273(48):31962-70.
PMID: 9822667; UI: 99041962


182: Hershberger PM, Switzer AG, Yelm KE, Coleman MC, Devries CA, Rourke FJ,
Davis BW, Kraft WG, Twinem TL, Koenigs PM, Paule SM, Siehnel RJ, Zoutendam PH,
Imbus R, Demuth TP Jr.
Preparation and antimicrobial assessment of 2-thioether-linked
quinolonyl-carbapenems.
J Antibiot (Tokyo). 1998 Sep;51(9):857-71.
PMID: 9820237; UI: 99036123


183: Govorun VM, Gushchin AE, Ladygina VG, Abramycheva NIu, Topol' IuIu.
[Formation of M. hominis and A. laidlawii resistance to fluoroquinolones].
Mol Gen Mikrobiol Virusol. 1998;(3):16-9. Russian.
PMID: 9819821; UI: 99037256


184: Misawa N, Allos BM, Blaser MJ.
Differentiation of Campylobacter jejuni serotype O19 strains from non-O19
strains by PCR.
J Clin Microbiol. 1998 Dec;36(12):3567-73.
PMID: 9817874; UI: 99036760


185: Obermann WM, Sondermann H, Russo AA, Pavletich NP, Hartl FU.
In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis.
J Cell Biol. 1998 Nov 16;143(4):901-10.
PMID: 9817749; UI: 99034582


186: Tanaka T, Saha SK, Tomomori C, Ishima R, Liu D, Tong KI, Park H, Dutta R,
Qin L, Swindells MB, Yamazaki T, Ono AM, Kainosho M, Inouye M, Ikura M.
NMR structure of the histidine kinase domain of the E. coli osmosensor EnvZ.
Nature. 1998 Nov 5;396(6706):88-92.
PMID: 9817206; UI: 99032118


187: Yigit H, Reznikoff WS.
Escherichia coli DNA topoisomerase I and suppression of killing by Tn5
transposase overproduction: topoisomerase I modulates Tn5 transposition.
J Bacteriol. 1998 Nov;180(22):5866-74.
PMID: 9811643; UI: 99030307


188: Sissi C, Andreolli M, Cecchetti V, Fravolini A, Gatto B, Palumbo M.
Mg(2+)-mediated binding of 6-substituted quinolones to DNA: relevance to
biological activity.
Bioorg Med Chem. 1998 Sep;6(9):1555-61.
PMID: 9801827; UI: 99018635


189: Shanado Y, Kato J, Ikeda H.
Escherichia coli HU protein suppresses DNA-gyrase-mediated illegitimate
recombination and SOS induction.
Genes Cells. 1998 Aug;3(8):511-20.
PMID: 9797453; UI: 99016250


190: Dong Y, Xu C, Zhao X, Domagala J, Drlica K.
Fluoroquinolone action against mycobacteria: effects of C-8 substituents on
growth, survival, and resistance.
Antimicrob Agents Chemother. 1998 Nov;42(11):2978-84.
PMID: 9797236; UI: 99013582


191: Ison CA, Woodford PJ, Madders H, Claydon E.
Drift in susceptibility of Neisseria gonorrhoeae to ciprofloxacin and emergence
of therapeutic failure.
Antimicrob Agents Chemother. 1998 Nov;42(11):2919-22.
PMID: 9797226; UI: 99013572


192: Battisti JM, Smitherman LS, Samuels DS, Minnick MF.
Mutations in Bartonella bacilliformis gyrB confer resistance to coumermycin A1.
Antimicrob Agents Chemother. 1998 Nov;42(11):2906-13.
PMID: 9797224; UI: 99013570


193: Pan XS, Fisher LM.
DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in
Streptococcus pneumoniae.
Antimicrob Agents Chemother. 1998 Nov;42(11):2810-6.
PMID: 9797208; UI: 99013554


194: Gonzalez I, Georgiou M, Alcaide F, Balas D, Linares J, de la Campa AG.
Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of
clinical isolates of viridans group streptococci.
Antimicrob Agents Chemother. 1998 Nov;42(11):2792-8.
PMID: 9797205; UI: 99013551


195: Chan PF, Foster SJ.
The role of environmental factors in the regulation of virulence-determinant
expression in Staphylococcus aureus 8325-4.
Microbiology. 1998 Sep;144 ( Pt 9):2469-79.
PMID: 9782494; UI: 98455814


196: Staczek P, Higgins NP.
Gyrase and Topo IV modulate chromosome domain size in vivo.
Mol Microbiol. 1998 Sep;29(6):1435-48.
PMID: 9781880; UI: 98453141


197: Khodursky AB, Cozzarelli NR.
The mechanism of inhibition of topoisomerase IV by quinolone antibacterials.
J Biol Chem. 1998 Oct 16;273(42):27668-77.
PMID: 9765303; UI: 98438548


198: Kampranis SC, Maxwell A.
Hydrolysis of ATP at only one GyrB subunit is sufficient to promote supercoiling
by DNA gyrase.
J Biol Chem. 1998 Oct 9;273(41):26305-9.
PMID: 9756859; UI: 98434531


199: Takei M, Fukuda H, Yasue T, Hosaka M, Oomori Y.
Inhibitory activities of gatifloxacin (AM-1155), a newly developed
fluoroquinolone, against bacterial and mammalian type II topoisomerases.
Antimicrob Agents Chemother. 1998 Oct;42(10):2678-81.
PMID: 9756776; UI: 98443466


200: Weigel LM, Steward CD, Tenover FC.
gyrA mutations associated with fluoroquinolone resistance in eight species of
Enterobacteriaceae.
Antimicrob Agents Chemother. 1998 Oct;42(10):2661-7.
PMID: 9756773; UI: 98443463


201: Dessus-Babus S, Bebear CM, Charron A, Bebear C, de Barbeyrac B.
Sequencing of gyrase and topoisomerase IV quinolone-resistance-determining
regions of Chlamydia trachomatis and characterization of quinolone-resistant
mutants obtained In vitro.
Antimicrob Agents Chemother. 1998 Oct;42(10):2474-81.
PMID: 9756744; UI: 98443434


202: Kreuzer KN.
Bacteriophage T4, a model system for understanding the mechanism of type II
topoisomerase inhibitors.
Biochim Biophys Acta. 1998 Oct 1;1400(1-3):339-47. Review.
PMID: 9748648; UI: 98422370


203: Levine C, Hiasa H, Marians KJ.
DNA gyrase and topoisomerase IV: biochemical activities, physiological roles
during chromosome replication, and drug sensitivities.
Biochim Biophys Acta. 1998 Oct 1;1400(1-3):29-43. Review.
PMID: 9748489; UI: 98422351


204: Tse-Dinh YC.
Bacterial and archeal type I topoisomerases.
Biochim Biophys Acta. 1998 Oct 1;1400(1-3):19-27. Review.
PMID: 9748482; UI: 98422350


205: Herman-Antosiewicz A, Wegrzyn A, Taylor K, Wegrzyn G.
DnaA-mediated regulation of phage lambda-derived replicons in the absence of pR
and Cro function.
Virology. 1998 Sep 15;249(1):98-107.
PMID: 9740781; UI: 98414642


206: Bebear CM, Renaudin H, Charron A, Bove JM, Bebear C, Renaudin J.
Alterations in topoisomerase IV and DNA gyrase in quinolone-resistant mutants of
Mycoplasma hominis obtained in vitro.
Antimicrob Agents Chemother. 1998 Sep;42(9):2304-11.
PMID: 9736554; UI: 98409722


207: Venkateswaran K, Dollhopf ME, Aller R, Stackebrandt E, Nealson KH.
Shewanella amazonensis sp. nov., a novel metal-reducing facultative anaerobe
from Amazonian shelf muds.
Int J Syst Bacteriol. 1998 Jul;48 Pt 3:965-72.
PMID: 9734053; UI: 98404564


208: Yamamoto S, Harayama S.
Phylogenetic relationships of Pseudomonas putida strains deduced from the
nucleotide sequences of gyrB, rpoD and 16S rRNA genes.
Int J Syst Bacteriol. 1998 Jul;48 Pt 3:813-9.
PMID: 9734035; UI: 98404546


209: Couturier M, Bahassi el-M, Van Melderen L.
Bacterial death by DNA gyrase poisoning.
Trends Microbiol. 1998 Jul;6(7):269-75. Review.
PMID: 9717215; UI: 98382943


210: Andersson P, Annila A, Otting G.
An alpha/beta-HSQC-alpha/beta experiment for spin-state selective editing of IS
cross peaks.
J Magn Reson. 1998 Aug;133(2):364-7.
[Record as supplied by publisher]
PMID: 9716480


211: Kampranis SC, Maxwell A.
The DNA gyrase-quinolone complex. ATP hydrolysis and the mechanism of DNA
cleavage.
J Biol Chem. 1998 Aug 28;273(35):22615-26.
PMID: 9712890; UI: 98380487


212: Kampranis SC, Maxwell A.
Conformational changes in DNA gyrase revealed by limited proteolysis.
J Biol Chem. 1998 Aug 28;273(35):22606-14.
PMID: 9712889; UI: 98380486


213: Hooper DC.
Bacterial topoisomerases, anti-topoisomerases, and anti-topoisomerase
resistance.
Clin Infect Dis. 1998 Aug;27 Suppl 1:S54-63. Review.
PMID: 9710672; UI: 98376531


214: Funatsuki K, Tanaka R, Inagaki S, Konno H, Katoh K, Nakamura H.
Quinolone-resistant mutations of DNA gyrase increase sensitivity to acriflavine.
Biol Pharm Bull. 1998 Jul;21(7):667-72.
PMID: 9703246; UI: 98366806


215: Andersson P, Gsell B, Wipf B, Senn H, Otting G.
HMQC and HSQC experiments with water flip-back optimized for large proteins.
J Biomol NMR. 1998 Apr;11(3):279-88.
PMID: 9691276; UI: 98356281


216: Guillemin I, Jarlier V, Cambau E.
Correlation between quinolone susceptibility patterns and sequences in the A and
B subunits of DNA gyrase in mycobacteria.
Antimicrob Agents Chemother. 1998 Aug;42(8):2084-8.
PMID: 9687411; UI: 98353339


217: Bebear CM, Charron A, Bove JM, Bebear C, Renaudin J.
Cloning and nucleotide sequences of the topoisomerase IV parC and parE genes of
Mycoplasma hominis.
Antimicrob Agents Chemother. 1998 Aug;42(8):2024-31.
PMID: 9687401; UI: 98353329


218: Fukuda H, Hori S, Hiramatsu K.
Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly
developed fluoroquinolone, against sequentially acquired quinolone-resistant
mutants and the norA transformant of Staphylococcus aureus.
Antimicrob Agents Chemother. 1998 Aug;42(8):1917-22.
PMID: 9687384; UI: 98353312


219: Liu Q, Wang JC.
Identification of active site residues in the "GyrA" half of yeast DNA
topoisomerase II.
J Biol Chem. 1998 Aug 7;273(32):20252-60.
PMID: 9685374; UI: 98352061


220: Li S, Waters R.
Escherichia coli strains lacking protein HU are UV sensitive due to a role for
HU in homologous recombination.
J Bacteriol. 1998 Aug;180(15):3750-6.
PMID: 9683467; UI: 98348432


221: Sui Z, Altom J, Nguyen VN, Fernandez J, Bernstein JI, Hiliard JJ, Barrett
JF, Podlogar BL, Ohemeng KA.
Synthesis and inhibitory activity of novel tri- and tetracyclic quinolines
against topoisomerases.
Bioorg Med Chem. 1998 Jun;6(6):735-42.
PMID: 9681139; UI: 98346117


222: Couling VW, Fischer P, Klenerman D, Huber W.
Ultraviolet resonance Raman study of drug binding in dihydrofolate reductase,
gyrase, and catechol O-methyltransferase.
Biophys J. 1998 Aug;75(2):1097-106.
PMID: 9675211; UI: 98342213


223: Smith CV, Maxwell A.
Identification of a residue involved in transition-state stabilization in the
ATPase reaction of DNA gyrase.
Biochemistry. 1998 Jul 7;37(27):9658-67.
PMID: 9657678; UI: 98322067


224: Gibson DP, Ma X, Switzer AG, Murphy VA, Aardema MJ.
Comparative genotoxicity of quinolone and quinolonyl-lactam antibacterials in
the in vitro micronucleus assay in Chinese hamster ovary cells.
Environ Mol Mutagen. 1998;31(4):345-51.
PMID: 9654244; UI: 98316816


225: Gotoh Y, Cooper JA.
Reactive oxygen species- and dimerization-induced activation of apoptosis
signal-regulating kinase 1 in tumor necrosis factor-alpha signal transduction.
J Biol Chem. 1998 Jul 10;273(28):17477-82.
PMID: 9651337; UI: 98316309


226: Paitan Y, Boulton N, Ron EZ, Rosenberg E, Orr E.
Molecular analysis of the DNA gyrB gene from Myxococcus xanthus.
Microbiology. 1998 Jun;144 ( Pt 6):1641-7.
PMID: 9639935; UI: 98304088


227: Torres C, Creus A, Marcos R.
Genotoxic activity of four inhibitors of DNA topoisomerases in larval cells of
Drosophila melanogaster as measured in the wing spot assay.
Mutat Res. 1998 Mar 16;413(2):191-203.
PMID: 9639703; UI: 98306173


228: Alovero F, Nieto M, Mazzieri MR, Then R, Manzo RH.
Mode of action of sulfanilyl fluoroquinolones.
Antimicrob Agents Chemother. 1998 Jun;42(6):1495-8.
PMID: 9624501; UI: 98287597


229: Balas D, Fernandez-Moreira E, De La Campa AG.
Molecular characterization of the gene encoding the DNA gyrase A subunit of
Streptococcus pneumoniae.
J Bacteriol. 1998 Jun;180(11):2854-61.
PMID: 9603872; UI: 98268998


230: Kopp MU, Mello AJ, Manz A.
Chemical amplification: continuous-flow PCR on a chip.
Science. 1998 May 15;280(5366):1046-8.
PMID: 9582111; UI: 98248605


231: Haluska P Jr, Saleem A, Edwards TK, Rubin EH.
Interaction between the N-terminus of human topoisomerase I and SV40 large T
antigen.
Nucleic Acids Res. 1998 Apr 1;26(7):1841-7.
PMID: 9512561; UI: 98181093


232: Hu T, Chang S, Hsieh T.
Identifying Lys359 as a critical residue for the ATP-dependent reactions of
Drosophila DNA topoisomerase II.
J Biol Chem. 1998 Apr 17;273(16):9586-92.
PMID: 9545289; UI: 98211986


233: Chute IC, Hu Z, Liu XQ.
A topA intein in Pyrococcus furiosus and its relatedness to the r-gyr intein of
Methanococcus jannaschii.
Gene. 1998 Mar 27;210(1):85-92.
PMID: 9524230; UI: 98192543


234: Akasaka T, Kurosaka S, Uchida Y, Tanaka M, Sato K, Hayakawa I.
Antibacterial activities and inhibitory effects of sitafloxacin (DU-6859a) and
its optical isomers against type II topoisomerases.
Antimicrob Agents Chemother. 1998 May;42(5):1284-7.
PMID: 9593169; UI: 98254001


235: Li TK, Liu LF.
Modulation of gyrase-mediated DNA cleavage and cell killing by ATP.
Antimicrob Agents Chemother. 1998 May;42(5):1022-7.
PMID: 9593120; UI: 98253952


236: Fonstein M, Nikolskaya T, Kogan Y, Haselkorn R.
Genome encyclopedias and their use for comparative analysis of Rhodobacter
capsulatus strains.
Electrophoresis. 1998 Apr;19(4):469-77. Review.
PMID: 9588789; UI: 98248203


237: Huang WM, Libbey JL, van der Hoeven P, Yu SX.
Bipolar localization of Bacillus subtilis topoisomerase IV, an enzyme required
for chromosome segregation.
Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4652-7.
PMID: 9539793; UI: 98208596


238: Burckhardt G, Walter A, Triebel H, Storl K, Simon H, Storl J, Opitz A,
Roemer E, Zimmer C.
Binding of 2-azaanthraquinone derivatives to DNA and their interference with the
activity of DNA topoisomerases in vitro.
Biochemistry. 1998 Apr 7;37(14):4703-11.
PMID: 9537985; UI: 98206885


239: Wegrzyn A, Herman-Antosiewicz A, Taylor K, Wegrzyn G.
Molecular mechanism of heat shock-provoked disassembly of the coliphage lambda
replication complex.
J Bacteriol. 1998 May;180(9):2475-83.
PMID: 9573201; UI: 98233745


240: Sinha Roy R, Belshaw PJ, Walsh CT.
Mutational analysis of posttranslational heterocycle biosynthesis in the gyrase
inhibitor microcin B17: distance dependence from propeptide and tolerance for
substitution in a GSCG cyclizable sequence.
Biochemistry. 1998 Mar 24;37(12):4125-36.
PMID: 9521734; UI: 98189989


241: Figueroa-Bossi N, Guerin M, Rahmouni R, Leng M, Bossi L.
The supercoiling sensitivity of a bacterial tRNA promoter parallels its
responsiveness to stringent control.
EMBO J. 1998 Apr 15;17(8):2359-67.
PMID: 9550733; UI: 98302823


242: Inagaki T, Kaneda K, Suzuki Y, Hirai H, Nomura E, Sakakibara T, Yamauchi Y,
Huang LH, Norcia M, Wondrack LM, Sutcliffe JA, Kojima N.
CJ-12,373, a novel topoisomerase II inhibitor: fermentation, isolation,
structure elucidation and biological activities.
J Antibiot (Tokyo). 1998 Feb;51(2):112-6.
PMID: 9544930; UI: 98204491


243: Kanematsu E, Deguchi T, Yasuda M, Kawamura T, Nishino Y, Kawada Y.
Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of DNA
topoisomerase IV associated with quinolone resistance in Enterococcus faecalis.
Antimicrob Agents Chemother. 1998 Feb;42(2):433-5.
PMID: 9527801; UI: 98139042


244: Zlotos G, Bucker A, Kinzig-Schippers M, Sorgel F, Holzgrabe U.
Plasma protein binding of gyrase inhibitors.
J Pharm Sci. 1998 Feb;87(2):215-20.
PMID: 9519156; UI: 98179680


245: Freudenreich CH, Chang C, Kreuzer KN.
Mutations of the bacteriophage T4 type II DNA topoisomerase that alter
sensitivity to antitumor agent 4'-(9-acridinylamino)methanesulfon-m-anisidide
and an antibacterial quinolone.
Cancer Res. 1998 Mar 15;58(6):1260-7.
PMID: 9515814; UI: 98175567


246: Sieradzki K, Tomasz A.
Suppression of beta-lactam antibiotic resistance in a methicillin-resistant
Staphylococcus aureus through synergic action of early cell wall inhibitors and
some other antibiotics.
J Antimicrob Chemother. 1997 May;39 Suppl A:47-51.
PMID: 9511062; UI: 98172052


247: Oethinger M, Kern WV, Goldman JD, Levy SB.
Association of organic solvent tolerance and fluoroquinolone resistance in
clinical isolates of Escherichia coli.
J Antimicrob Chemother. 1998 Jan;41(1):111-4.
PMID: 9511045; UI: 98172035


248: Takahashi H, Kikuchi T, Shoji S, Fujimura S, Lutfor AB, Tokue Y, Nukiwa T,
Watanabe A.
Characterization of gyrA, gyrB, grlA and grlB mutations in
fluoroquinolone-resistant clinical isolates of Staphylococcus aureus.
J Antimicrob Chemother. 1998 Jan;41(1):49-57.
PMID: 9511037; UI: 98172027


249: Bailly C, Colson P, Houssier C.
The orientation of norfloxacin bound to double-stranded DNA.
Biochem Biophys Res Commun. 1998 Feb 24;243(3):844-8.
PMID: 9501014; UI: 98162625


250: Sander P, Alcaide F, Richter I, Frischkorn K, Tortoli E, Springer B,
Telenti A, Bottger EC.
Inteins in mycobacterial GyrA are a taxonomic character.
Microbiology. 1998 Feb;144 ( Pt 2):589-91.
PMID: 9493395; UI: 98154446


251: Stabb EV, Handelsman J.
Genetic analysis of zwittermicin A resistance in Escherichia coli: effects on
membrane potential and RNA polymerase.
Mol Microbiol. 1998 Jan;27(2):311-22.
PMID: 9484887; UI: 98143418


252: Brino L, Mousli M, Oudet P, Weiss E.
Expression in Escherichia coli of Y5 mutant and N-terminal domain-deleted DNA
gyrase B proteins affects strongly plasmid maintenance.
Plasmid. 1998;39(1):21-34.
PMID: 9473443; UI: 98154295


253: Venkateswaran K, Dohmoto N, Harayama S.
Cloning and nucleotide sequence of the gyrB gene of Vibrio parahaemolyticus and
its application in detection of this pathogen in shrimp.
Appl Environ Microbiol. 1998 Feb;64(2):681-7.
PMID: 9464408; UI: 98125684


254: Alice AF, Sanchez-Rivas C.
DNA supercoiling and osmoresistance in Bacillus subtilis 168.
Curr Microbiol. 1997 Nov;35(5):309-15.
PMID: 9462962; UI: 98057092


255: Zhao X, Xu C, Domagala J, Drlica K.
DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding
bacterial resistance.
Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13991-6.
PMID: 9391140; UI: 98054348


256: Critchlow SE, O'Dea MH, Howells AJ, Couturier M, Gellert M, Maxwell A.
The interaction of the F plasmid killer protein, CcdB, with DNA gyrase:
induction of DNA cleavage and blocking of transcription.
J Mol Biol. 1997 Nov 7;273(4):826-39.
PMID: 9367775; UI: 98035723


257: Kaatz GW, Seo SM.
Topoisomerase mutations in fluoroquinolone-resistant and methicillin-susceptible
and -resistant clinical isolates of Staphylococcus aureus.
Antimicrob Agents Chemother. 1998 Jan;42(1):197-8.
PMID: 9449288; UI: 98109342


258: Kim JH, Cho EH, Kim KS, Kim HY, Kim YM.
Cloning and nucleotide sequence of the DNA gyrase gyrA gene from Serratia
marcescens and characterization of mutations in gyrA of quinolone-resistant
clinical isolates.
Antimicrob Agents Chemother. 1998 Jan;42(1):190-3.
PMID: 9449286; UI: 98109340


259: Fournier B, Hooper DC.
Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel
pleiotropic effects on quinolone and coumarin activity.
Antimicrob Agents Chemother. 1998 Jan;42(1):121-8.
PMID: 9449271; UI: 98109325


260: Golubnitchaya-Labudova O, Horecka T, Kapalla M, Perecko D, Kutejova E,
Lubec G.
Thioredoxin from Streptomyces aureofaciens controls coiling of plasmid DNA.
Life Sci. 1998;62(5):397-412.
PMID: 9449230; UI: 98109284


261: Schulz M, Schmoldt A.
Therapeutic and toxic blood concentrations of more than 500 drugs.
Pharmazie. 1997 Dec;52(12):895-911. Review.
PMID: 9442555; UI: 98104648


262: Nakanishi A, Oshida T, Matsushita T, Imajoh-Ohmi S, Ohnuki T.
Identification of DNA gyrase inhibitor (GyrI) in Escherichia coli.
J Biol Chem. 1998 Jan 23;273(4):1933-8.
PMID: 9442027; UI: 98113149


263: Bouthier de la Tour C, Portemer C, Kaltoum H, Duguet M.
Reverse gyrase from the hyperthermophilic bacterium Thermotoga maritima:
properties and gene structure.
J Bacteriol. 1998 Jan;180(2):274-81.
PMID: 9440516; UI: 98101466


264: Klabunde T, Sharma S, Telenti A, Jacobs WR Jr, Sacchettini JC.
Crystal structure of GyrA intein from Mycobacterium xenopi reveals structural
basis of protein splicing.
Nat Struct Biol. 1998 Jan;5(1):31-6.
PMID: 9437427; UI: 98100080


265: Brino L, Mousli M, Oudet P, Weiss E.
Expression in Escherichia coli of Y5-mutant and N-terminal domain-deleted DNA
gyrase B proteins affects strongly plasmid maintenance.
Plasmid. 1997;38(3):188-201.
PMID: 9435021; UI: 98096690


266: Weissig V, Vetro-Widenhouse TS, Rowe TC.
Topoisomerase II inhibitors induce cleavage of nuclear and 35-kb plastid DNAs in
the malarial parasite Plasmodium falciparum.
DNA Cell Biol. 1997 Dec;16(12):1483-92.
PMID: 9428797; UI: 98089073


267: Espeli O, Boccard F.
In vivo cleavage of Escherichia coli BIME-2 repeats by DNA gyrase: genetic
characterization of the target and identification of the cut site.
Mol Microbiol. 1997 Nov;26(4):767-77.
PMID: 9427406; UI: 98087278


268: Ward D, Newton A.
Requirement of topoisomerase IV parC and parE genes for cell cycle progression
and developmental regulation in Caulobacter crescentus.
Mol Microbiol. 1997 Dec;26(5):897-910.
PMID: 9426128; UI: 98086097


269: Li W, Wang JC.
Footprinting of yeast DNA topoisomerase II lysyl side chains involved in
substrate binding and interdomainal interactions.
J Biol Chem. 1997 Dec 5;272(49):31190-5.
PMID: 9388273; UI: 98049595


270: Kaatz GW, Seo SM.
Mechanisms of fluoroquinolone resistance in genetically related strains of
Staphylococcus aureus.
Antimicrob Agents Chemother. 1997 Dec;41(12):2733-7.
PMID: 9420048; UI: 98080215


271: Deguchi T, Yasuda M, Nakano M, Ozeki S, Kanematsu E, Nishino Y, Ishihara S,
Kawada Y.
Detection of mutations in the gyrA and parC genes in quinolone-resistant
clinical isolates of Enterobacter cloacae.
J Antimicrob Chemother. 1997 Oct;40(4):543-9.
PMID: 9372424; UI: 98039693


272: Brantl S, Wagner EG.
Dual function of the copR gene product of plasmid pIP501.
J Bacteriol. 1997 Nov;179(22):7016-24.
PMID: 9371448; UI: 98037499


273: Sugar AM, Liu XP, Chen RJ.
Effectiveness of quinolone antibiotics in modulating the effects of antifungal
drugs.
Antimicrob Agents Chemother. 1997 Nov;41(11):2518-21.
PMID: 9371359; UI: 98037410


274: Tanaka M, Onodera Y, Uchida Y, Sato K, Hayakawa I.
Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV
purified from Staphylococcus aureus.
Antimicrob Agents Chemother. 1997 Nov;41(11):2362-6.
PMID: 9371334; UI: 98037385


275: Conter A, Menchon C, Gutierrez C.
Role of DNA supercoiling and rpoS sigma factor in the osmotic and growth
phase-dependent induction of the gene osmE of Escherichia coli K12.
J Mol Biol. 1997 Oct 17;273(1):75-83.
PMID: 9367747; UI: 98035042


276: Ulitzur S, Matin A, Fraley C, Meighen E.
H-NS protein represses transcription of the lux systems of Vibrio fischeri and
other luminous bacteria cloned into Escherichia coli.
Curr Microbiol. 1997 Dec;35(6):336-42.
PMID: 9353217; UI: 98063521


277: Horowitz S, Maor R, Priel E.
Characterization of DNA topoisomerase activity in two strains of Mycoplasma
fermentans and in Mycoplasma pirum.
J Bacteriol. 1997 Nov;179(21):6626-32.
PMID: 9352909; UI: 98012958


278: Chilukuri LN, Fortes PA, Bartlett DH.
High pressure modulation of Escherichia coli DNA gyrase activity.
Biochem Biophys Res Commun. 1997 Oct 20;239(2):552-6.
PMID: 9344868; UI: 98008877


279: Ohemeng KA, Podlogar BL, Nguyen VN, Bernstein JI, Krause HM, Hilliard JJ,
Barrett JF.
DNA gyrase inhibitory and antimicrobial activities of some diphenic acid
monohydroxamides.
J Med Chem. 1997 Sep 26;40(20):3292-6.
PMID: 9379449; UI: 98021284


280: Schmitz FJ, MacKenzie CR, Geisel R, Wagner S, Idel H, Verhoef J, Hadding U,
Heinz HP.
Methicillin resistant Staphylococcus aureus strains in the greater Dusseldorf
area.
Eur J Epidemiol. 1997 Sep;13(6):709-17.
PMID: 9324219; UI: 97464398


281: Scheirer KE, Higgins NP.
The DNA cleavage reaction of DNA gyrase. Comparison of stable ternary complexes
formed with enoxacin and CcdB protein.
J Biol Chem. 1997 Oct 24;272(43):27202-9.
PMID: 9341164; UI: 98001699


282: Sato M, Ishida R, Narita T, Kato J, Ikeda H, Fukazawa H, Andoh T.
Interaction of the DNA topoisomerase II catalytic inhibitor
meso-2,3-bis(3,5-dioxopiperazine-1-yl)butane (ICRF-193), a bisdioxopiperazine
derivative, with the conserved region(s) of eukaryotic but not prokaryotic
enzyme.
Biochem Pharmacol. 1997 Sep 1;54(5):545-50.
PMID: 9337070; UI: 97477007


283: Zechiedrich EL, Khodursky AB, Cozzarelli NR.
Topoisomerase IV, not gyrase, decatenates products of site-specific
recombination in Escherichia coli.
Genes Dev. 1997 Oct 1;11(19):2580-92.
PMID: 9334322; UI: 97475833


284: Nishino Y, Deguchi T, Yasuda M, Kawamura T, Nakano M, Kanematsu E, Ozeki S,
Kawada Y.
Mutations in the gyrA and parC genes associated with fluoroquinolone resistance
in clinical isolates of Citrobacter freundii.
FEMS Microbiol Lett. 1997 Sep 15;154(2):409-14.
PMID: 9311142; UI: 97457204


285: Guipaud O, Marguet E, Noll KM, de la Tour CB, Forterre P.
Both DNA gyrase and reverse gyrase are present in the hyperthermophilic
bacterium Thermotoga maritima.
Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10606-11.
PMID: 9380682; UI: 98021416


286: Zhang S, Meyer R.
The relaxosome protein MobC promotes conjugal plasmid mobilization by extending
DNA strand separation to the nick site at the origin of transfer.
Mol Microbiol. 1997 Aug;25(3):509-16.
PMID: 9302013; UI: 97445725


287: Drlica K, Zhao X.
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Microbiol Mol Biol Rev. 1997 Sep;61(3):377-92. Review.
PMID: 9293187; UI: 97438700


288: Sreevatsan S, Pan X, Stockbauer KE, Connell ND, Kreiswirth BN, Whittam TS,
Musser JM.
Restricted structural gene polymorphism in the Mycobacterium tuberculosis
complex indicates evolutionarily recent global dissemination.
Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9869-74.
PMID: 9275218; UI: 97420776


289: Morais Cabral JH, Jackson AP, Smith CV, Shikotra N, Maxwell A, Liddington
RC.
Crystal structure of the breakage-reunion domain of DNA gyrase.
Nature. 1997 Aug 28;388(6645):903-6.
PMID: 9278055; UI: 97422287


290: Vlcek C, Paces V, Maltsev N, Paces J, Haselkorn R, Fonstein M.
Sequence of a 189-kb segment of the chromosome of Rhodobacter capsulatus SB1003.
Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9384-8.
PMID: 9256491; UI: 97404404


291: Holdgate GA, Tunnicliffe A, Ward WH, Weston SA, Rosenbrock G, Barth PT,
Taylor IW, Pauptit RA, Timms D.
The entropic penalty of ordered water accounts for weaker binding of the
antibiotic novobiocin to a resistant mutant of DNA gyrase: a thermodynamic and
crystallographic study.
Biochemistry. 1997 Aug 12;36(32):9663-73.
PMID: 9245398; UI: 97392632


292: Burckhardt G, Simon H, Storl K, Triebel H, Walter A, Lown JW, Zimmer C.
DNA binding studies and influence on the activity of DNA topoisomerases of
bis-netropsins: different effects of analogs containing cis and trans ethylene
linkers.
J Biomol Struct Dyn. 1997 Aug;15(1):81-95.
PMID: 9283982; UI: 97429666


293: Lizondo M, Pons M, Gallardo M, Estelrich J.
Physicochemical properties of enrofloxacin.
J Pharm Biomed Anal. 1997 Aug;15(12):1845-9.
PMID: 9278889; UI: 97424776


294: Stamm LV, Greene SR, Barnes NY.
Identification and characterization of the gyrB gene from Treponema pallidum
subsp. pallidum.
FEMS Microbiol Lett. 1997 Aug 1;153(1):129-34.
PMID: 9252582; UI: 97396391


295: Pina SE, Mattingly SJ.
The role of fluoroquinolones in the promotion of alginate synthesis and
antibiotic resistance in Pseudomonas aeruginosa.
Curr Microbiol. 1997 Aug;35(2):103-8.
PMID: 9216884; UI: 97361984


296: Lim HM, Lee HJ, Jaxel C, Nadal M.
Hin-mediated inversion on positively supercoiled DNA.
J Biol Chem. 1997 Jul 18;272(29):18434-9.
PMID: 9218487; UI: 97364777


297: Lopez-Sanchez F, Ramirez-Santos J, Gomez-Eichelmann MC.
In vivo effect of DNA relaxation on the transcription of gene rpoH in
Escherichia coli.
Biochim Biophys Acta. 1997 Jul 17;1353(1):79-83.
PMID: 9256067; UI: 97398142


298: Cove ME, Tingey AP, Maxwell A.
DNA gyrase can cleave short DNA fragments in the presence of quinolone drugs.
Nucleic Acids Res. 1997 Jul 15;25(14):2716-22.
PMID: 9207016; UI: 97351138


299: Prodromou C, Roe SM, O'Brien R, Ladbury JE, Piper PW, Pearl LH.
Identification and structural characterization of the ATP/ADP-binding site in
the Hsp90 molecular chaperone.
Cell. 1997 Jul 11;90(1):65-75.
PMID: 9230303; UI: 97373820


300: Itoh R, Takahashi H, Toda K, Kuroiwa H, Kuroiwa T.
DNA gyrase involvement in chloroplast-nucleoid division in Cyanidioschyzon
merolae.
Eur J Cell Biol. 1997 Jul;73(3):252-8.
PMID: 9243186; UI: 97387123


301: de la Campa AG, Garcia E, Fenoll A, Munoz R.
Molecular bases of three characteristic phenotypes of pneumococcus:
optochin-sensitivity, coumarin-sensitivity, and quinolone-resistance.
Microb Drug Resist. 1997 Summer;3(2):177-93.
PMID: 9185146; UI: 97328619


302: Mitsuyama J, Yamada H, Maehana J, Fukuda Y, Kurose S, Minami S, Todo Y,
Watanabe Y, Narita H.
Characteristics of quinolone-induced small colony variants in Staphylococcus
aureus.
J Antimicrob Chemother. 1997 Jun;39(6):697-705.
PMID: 9222037; UI: 97365112


303: Duguet M.
When helicase and topoisomerase meet!
J Cell Sci. 1997 Jun;110 ( Pt 12):1345-50. Review.
PMID: 9217320; UI: 97360292


304: Takahashi Y, Masuda N, Otsuki M, Miki M, Nishino T.
In vitro activity of HSR-903, a new quinolone.
Antimicrob Agents Chemother. 1997 Jun;41(6):1326-30.
PMID: 9174193; UI: 97316919


305: Krah R, O'Dea MH, Gellert M.
Reverse gyrase from Methanopyrus kandleri. Reconstitution of an active
extremozyme from its two recombinant subunits.
J Biol Chem. 1997 May 23;272(21):13986-90.
PMID: 9153263; UI: 97298115


306: Cullis PM, Maxwell A, Weiner DP.
Exploiting nucleotide thiophosphates to probe mechanistic aspects of Escherichia
coli DNA gyrase.
Biochemistry. 1997 May 20;36(20):6059-68.
PMID: 9166776; UI: 97309361


307: Funatsuki K, Tanaka R, Inagaki S, Konno H, Katoh K, Nakamura H.
acrB mutation located at carboxyl-terminal region of gyrase B subunit reduces
DNA binding of DNA gyrase.
J Biol Chem. 1997 May 16;272(20):13302-8.
PMID: 9148951; UI: 97294746


308: Masse E, Phoenix P, Drolet M.
DNA topoisomerases regulate R-loop formation during transcription of the rrnB
operon in Escherichia coli.
J Biol Chem. 1997 May 9;272(19):12816-23.
PMID: 9139742; UI: 97284765


309: Yamaji K, Masubuchi M, Kawahara F, Nakamura Y, Nishio A, Matsukuma S,
Fujimori M, Nakada N, Watanabe J, Kamiyama T.
Cyclothialidine analogs, novel DNA gyrase inhibitors.
J Antibiot (Tokyo). 1997 May;50(5):402-11.
PMID: 9207910; UI: 97351628


310: Ebringer L, Polonyi J, Krajcovic J, Dobias J.
Influence of tetracyclines or cetylpyridinium bromide on activity of
fluoroquinolones in Euglena gracilis.
Arzneimittelforschung. 1997 May;47(5):683-7.
PMID: 9205787; UI: 97349907


311: Mukerji M, Mahadevan S.
Characterization of the negative elements involved in silencing the bgl operon
of Escherichia coli: possible roles for DNA gyrase, H-NS, and CRP-cAMP in
regulation.
Mol Microbiol. 1997 May;24(3):617-27.
PMID: 9179854; UI: 97323406


312: Ohtsuka Y, Mizushima T, Miki T, Sekimizu K.
Transient DNA relaxation in Escherichia coli induced by nalidixic acid.
Biol Pharm Bull. 1997 May;20(5):467-70.
PMID: 9178922; UI: 97322268


313: Rowbury RJ.
Regulatory components, including integration host factor, CysB and H-NS, that
influence pH responses in Escherichia coli.
Lett Appl Microbiol. 1997 May;24(5):319-28. Review.
PMID: 9172436; UI: 97316525


314: Kojima M.
[Mechanisms for the development of quinolone resistance].
Nippon Rinsho. 1997 May;55(5):1252-60. Review. Japanese.
PMID: 9155183; UI: 97300071


315: Hashimoto H.
[Acquisition of antibiotic-resistance in bacteria by alteration of molecular
target, or by the decreased permeability].
Nippon Rinsho. 1997 May;55(5):1167-72. Review. Japanese.
PMID: 9155170; UI: 97300058


316: Deguchi T, Saito I, Tanaka M, Sato K, Deguchi K, Yasuda M, Nakano M,
Nishino Y, Kanematsu E, Ozeki S, Kawada Y.
Fluoroquinolone treatment failure in gonorrhea. Emergence of a Neisseria
gonorrhoeae strain with enhanced resistance to fluoroquinolones.
Sex Transm Dis. 1997 May;24(5):247-50.
PMID: 9153731; UI: 97298283


317: Jovanovic G, Model P.
The RIB element in the goaG-pspF intergenic region of Escherichia coli.
J Bacteriol. 1997 May;179(10):3095-102.
PMID: 9150200; UI: 97294444


318: Bernard FX, Sable S, Cameron B, Provost J, Desnottes JF, Crouzet J, Blanche
F.
Glycosylated flavones as selective inhibitors of topoisomerase IV.
Antimicrob Agents Chemother. 1997 May;41(5):992-8.
PMID: 9145858; UI: 97291244


319: Bisognano C, Vaudaux PE, Lew DP, Ng EY, Hooper DC.
Increased expression of fibronectin-binding proteins by
fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels
of ciprofloxacin.
Antimicrob Agents Chemother. 1997 May;41(5):906-13.
PMID: 9145842; UI: 97291228


320: Tsai FT, Singh OM, Skarzynski T, Wonacott AJ, Weston S, Tucker A, Pauptit
RA, Breeze AL, Poyser JP, O'Brien R, Ladbury JE, Wigley DB.
The high-resolution crystal structure of a 24-kDa gyrase B fragment from E. coli
complexed with one of the most potent coumarin inhibitors, clorobiocin.
Proteins. 1997 May;28(1):41-52.
PMID: 9144789; UI: 97290004


321: Kuchle C, Abele-Horn M, Menninger M, Held E, Heesemann J.
[Mycoplasma hominis. A rare causative agent of acute pyelonephritis].
Dtsch Med Wochenschr. 1997 Apr 25;122(17):542-4. Review. German.
PMID: 9190301; UI: 97305130


322: Munakata N, Saitou M, Takahashi N, Hieda K, Morohoshi F.
Induction of unique tandem-base change mutations in bacterial spores exposed to
extreme dryness.
Mutat Res. 1997 Apr 24;390(1-2):189-95.
PMID: 9150768; UI: 97295116


323: Elsea SH, Westergaard M, Burden DA, Lomenick JP, Osheroff N.
Quinolones share a common interaction domain on topoisomerase II with other DNA
cleavage-enhancing antineoplastic drugs.
Biochemistry. 1997 Mar 11;36(10):2919-24.
PMID: 9062121; UI: 97215831


324: Gerloff DL, Cohen FE, Korostensky C, Turcotte M, Gonnet GH, Benner SA.
A predicted consensus structure for the N-terminal fragment of the heat shock
protein HSP90 family.
Proteins. 1997 Mar;27(3):450-8.
PMID: 9094746; UI: 97248732


325: Maxwell A.
DNA gyrase as a drug target.
Trends Microbiol. 1997 Mar;5(3):102-9. Review.
PMID: 9080608; UI: 97235489


326: Deguchi T, Fukuoka A, Yasuda M, Nakano M, Ozeki S, Kanematsu E, Nishino Y,
Ishihara S, Ban Y, Kawada Y.
Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of
topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella
pneumoniae.
Antimicrob Agents Chemother. 1997 Mar;41(3):699-701.
PMID: 9056017; UI: 97209075


327: Taylor DE, Chau AS.
Cloning and nucleotide sequence of the gyrA gene from Campylobacter fetus subsp.
fetus ATCC 27374 and characterization of ciprofloxacin-resistant laboratory and
clinical isolates.
Antimicrob Agents Chemother. 1997 Mar;41(3):665-71.
PMID: 9056011; UI: 97209069


328: Borges KM, Bergerat A, Bogert AM, DiRuggiero J, Forterre P, Robb FT.
Characterization of the reverse gyrase from the hyperthermophilic archaeon
Pyrococcus furiosus.
J Bacteriol. 1997 Mar;179(5):1721-6.
PMID: 9045834; UI: 97197538


329: Shimizu H, Yamaguchi H, Ashizawa Y, Kohno Y, Asami M, Kato J, Ikeda H.
Short-homology-independent illegitimate recombination in Escherichia coli:
distinct mechanism from short-homology-dependent illegitimate recombination.
J Mol Biol. 1997 Feb 21;266(2):297-305.
PMID: 9047364; UI: 97199388


330: Deguchi T, Yasuda M, Nakano M, Kanematsu E, Ozeki S, Ishihara S, Saito I,
Kawada Y.
Antimicrobial activity of a new fluoroquinolone, DU-6859a, against
quinolone-resistant clinical isolates of Neisseria gonorrhoeae with genetic
alterations in the GyrA subunit of DNA gyrase and the ParC subunit of
topoisomerase IV.
J Antimicrob Chemother. 1997 Feb;39(2):247-9.
PMID: 9069547; UI: 97222421


331: Pan XS, Fisher LM.
Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective
targeting of gyrase or topoisomerase IV by quinolones.
Antimicrob Agents Chemother. 1997 Feb;41(2):471-4.
PMID: 9021211; UI: 97173305


332: Bebear CM, Bove JM, Bebear C, Renaudin J.
Characterization of Mycoplasma hominis mutations involved in resistance to
fluoroquinolones.
Antimicrob Agents Chemother. 1997 Feb;41(2):269-73.
PMID: 9021178; UI: 97173272


333: Gmunder H, Kuratli K, Keck W.
In the presence of subunit A inhibitors DNA gyrase cleaves DNA fragments as
short as 20 bp at specific sites.
Nucleic Acids Res. 1997 Feb 1;25(3):604-11.
PMID: 9016602; UI: 97169261


334: Phoenix P, Raymond MA, Masse E, Drolet M.
Roles of DNA topoisomerases in the regulation of R-loop formation in vitro.
J Biol Chem. 1997 Jan 17;272(3):1473-9.
PMID: 8999816; UI: 97153095


335: Hollweg M, Kapfhammer HP, Krupinski M, Moller HJ.
[Psychopathological syndromes in treatment with gyrase inhibitors].
Nervenarzt. 1997 Jan;68(1):38-47. German.
PMID: 9132619; UI: 97206210


336: Neumann S, Quinones A.
Discoordinate gene expression of gyrA and gyrB in response to DNA gyrase
inhibition in Escherichia coli.
J Basic Microbiol. 1997;37(1):53-69.
PMID: 9090126; UI: 97245367


337: Mizushima T, Kataoka K, Ogata Y, Inoue R, Sekimizu K.
Increase in negative supercoiling of plasmid DNA in Escherichia coli exposed to
cold shock.
Mol Microbiol. 1997 Jan;23(2):381-6.
PMID: 9044271; UI: 97197182


338: Madison LL, Vivas EI, Li YM, Walsh CT, Kolter R.
The leader peptide is essential for the post-translational modification of the
DNA-gyrase inhibitor microcin B17.
Mol Microbiol. 1997 Jan;23(1):161-8.
PMID: 9004229; UI: 97157950


339: Firshein W, Kim P.
Plasmid replication and partition in Escherichia coli: is the cell membrane the
key?
Mol Microbiol. 1997 Jan;23(1):1-10. Review.
PMID: 9004215; UI: 97157936


340: Truong QC, Nguyen Van JC, Shlaes D, Gutmann L, Moreau NJ.
A novel, double mutation in DNA gyrase A of Escherichia coli conferring
resistance to quinolone antibiotics.
Antimicrob Agents Chemother. 1997 Jan;41(1):85-90.
PMID: 8980760; UI: 97135221


341: Kovalsky OI, Grossman L, Ahn B.
The topodynamics of incision of UV-irradiated covalently closed DNA by the
Escherichia coli Uvr(A)BC endonuclease.
J Biol Chem. 1996 Dec 27;271(52):33236-41.
PMID: 8969181; UI: 97125959


342: Tingey AP, Maxwell A.
Probing the role of the ATP-operated clamp in the strand-passage reaction of DNA
gyrase.
Nucleic Acids Res. 1996 Dec 15;24(24):4868-73.
PMID: 9016655; UI: 97169207


343: Mizushima T, Ohtsuka Y, Mori H, Miki T, Sekimizu K.
Increase in synthesis and stability of sigma 32 on treatment with inhibitors of
DNA gyrase in Escherichia coli.
Mol Gen Genet. 1996 Dec 13;253(3):297-302.
PMID: 9003316; UI: 97156935


344: Kampranis SC, Maxwell A.
Conversion of DNA gyrase into a conventional type II topoisomerase.
Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14416-21.
PMID: 8962066; UI: 97121400


345: Ullsperger C, Cozzarelli NR.
Contrasting enzymatic activities of topoisomerase IV and DNA gyrase from
Escherichia coli.
J Biol Chem. 1996 Dec 6;271(49):31549-55.
PMID: 8940171; UI: 97094937


346: Blanche F, Cameron B, Bernard FX, Maton L, Manse B, Ferrero L, Ratet N,
Lecoq C, Goniot A, Bisch D, Crouzet J.
Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA
topoisomerases.
Antimicrob Agents Chemother. 1996 Dec;40(12):2714-20.
PMID: 9124828; UI: 97113987


347: Gootz TD, Zaniewski R, Haskell S, Schmieder B, Tankovic J, Girard D,
Courvalin P, Polzer RJ.
Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase
and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro.
Antimicrob Agents Chemother. 1996 Dec;40(12):2691-7.
PMID: 9124824; UI: 97113983


348: Moreau NJ, Houot S, Joly-Guillou ML, Bergogne-Berezin E.
Characterisation of DNA gyrase and measurement of drug accumulation in clinical
isolates of Acinetobacter baumannii resistant to fluoroquinolones.
J Antimicrob Chemother. 1996 Dec;38(6):1079-83.
PMID: 9023657; UI: 97176084


349: Jaxel C, Bouthier de la Tour C, Duguet M, Nadal M.
Reverse gyrase gene from Sulfolobus shibatae B12: gene structure, transcription
unit and comparative sequence analysis of the two domains.
Nucleic Acids Res. 1996 Dec 1;24(23):4668-75.
PMID: 8972852; UI: 97128259


350: Ogata Y, Mizushima T, Kataoka K, Kita K, Miki T, Sekimizu K.
DnaK heat shock protein of Escherichia coli maintains the negative supercoiling
of DNA against thermal stress.
J Biol Chem. 1996 Nov 15;271(46):29407-14.
PMID: 8910606; UI: 97067204


351: Li YM, Milne JC, Madison LL, Kolter R, Walsh CT.
From peptide precursors to oxazole and thiazole-containing peptide antibiotics:
microcin B17 synthase.
Science. 1996 Nov 15;274(5290):1188-93.
PMID: 8895467; UI: 97053605


352: Maekawa T, Yanagihara K, Ohtsubo E.
A cell-free system of Tn3 transposition and transposition immunity.
Genes Cells. 1996 Nov;1(11):1007-16.
PMID: 9077463; UI: 97224215


353: Dannhardt G, Bauer A.
Pyrrolidino enaminones structural related to gyrase inhibitors: synthesis,
cyclization and pharmacological activity.
Pharmazie. 1996 Nov;51(11):805-10.
PMID: 8985975; UI: 97139003


354: Fsihi H, De Rossi E, Salazar L, Cantoni R, Labo M, Riccardi G, Takiff HE,
Eiglmeier K, Bergh S, Cole ST.
Gene arrangement and organization in a approximately 76 kb fragment encompassing
the oriC region of the chromosome of Mycobacterium leprae.
Microbiology. 1996 Nov;142 ( Pt 11):3147-61.
PMID: 8969512; UI: 97124199


355: Rose M, Entian KD.
New genes in the 170 degrees region of the Bacillus subtilis genome encode DNA
gyrase subunits, a thioredoxin, a xylanase and an amino acid transporter.
Microbiology. 1996 Nov;142 ( Pt 11):3097-101.
PMID: 8969507; UI: 97124194


356: Neumann S, Simon H, Zimmer C, Quinones A.
The antitumor agent cisplatin inhibits DNA gyrase and preferentially induces
gyrB gene expression in Escherichia coli.
Biol Chem. 1996 Nov;377(11):731-9.
PMID: 8960374; UI: 97119551


357: Tankovic J, Mahjoubi F, Courvalin P, Duval J, Leclerco R.
Development of fluoroquinolone resistance in Enterococcus faecalis and role of
mutations in the DNA gyrase gyrA gene.
Antimicrob Agents Chemother. 1996 Nov;40(11):2558-61.
PMID: 8913464; UI: 97070538


358: Xu C, Kreiswirth BN, Sreevatsan S, Musser JM, Drlica K.
Fluoroquinolone resistance associated with specific gyrase mutations in clinical
isolates of multidrug-resistant Mycobacterium tuberculosis.
J Infect Dis. 1996 Nov;174(5):1127-30.
PMID: 8896523; UI: 97051888


359: Economides AN, Everdeen D, Panayotatos N.
A shared, non-canonical DNA conformation detected at DNA/protein contact sites
and bent DNA in the absence of supercoiling or cognate protein binding.
J Biol Chem. 1996 Oct 4;271(40):24836-41.
PMID: 8798758; UI: 96394652


360: Kataoka K, Mizushima T, Ogata Y, Miki T, Sekimizu K.
Heat shock-induced DNA relaxation in vitro by DNA gyrase of Escherichia coli in
the presence of ATP.
J Biol Chem. 1996 Oct 4;271(40):24806-10.
PMID: 8798753; UI: 96394647


361: Inan S, Kalaycioglu A.
Effect of nalidixic acid on recombination and DNA repair of Escherichia coli
K-12 strains.
Indian J Exp Biol. 1996 Oct;34(10):949-53.
PMID: 9055644; UI: 97208525


362: Meulbroek JA, Oleksijew A, Tanaka SK, Alder JD.
Efficacy of ABT-719, a 2-pyridone antimicrobial, against enterococci,
Escherichia coli, and Pseudomonas aeruginosa in experimental murine
pyelonephritis.
J Antimicrob Chemother. 1996 Oct;38(4):641-53.
PMID: 8937959; UI: 97092294


363: Pato ML, Banerjee M.
The Mu strong gyrase-binding site promotes efficient synapsis of the prophage
termini.
Mol Microbiol. 1996 Oct;22(2):283-92.
PMID: 8930913; UI: 97084570


364: Pan XS, Ambler J, Mehtar S, Fisher LM.
Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in
Streptococcus pneumoniae.
Antimicrob Agents Chemother. 1996 Oct;40(10):2321-6.
PMID: 8891138; UI: 97046217


365: Munoz R, De La Campa AG.
ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary
target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming
resistance phenotype.
Antimicrob Agents Chemother. 1996 Oct;40(10):2252-7.
PMID: 8891124; UI: 97046202


366: Clerch B, Rivera E, Llagostera M.
Bacteriophage PSP3 and phi R73 activator proteins: analysis of promoter
specificities.
J Bacteriol. 1996 Oct;178(19):5568-72.
PMID: 8824598; UI: 96421981


367: Guipaud O, Labedan B, Forterre P.
A gyrB-like gene from the hyperthermophilic bacterion Thermotoga maritima.
Gene. 1996 Sep 26;174(1):121-8.
PMID: 8863738; UI: 97017137


368: Banerjee SK, Bhatt K, Rana S, Misra P, Chakraborti PK.
Involvement of an efflux system in mediating high level of fluoroquinolone
resistance in Mycobacterium smegmatis.
Biochem Biophys Res Commun. 1996 Sep 13;226(2):362-8.
PMID: 8806641; UI: 96400265


369: Conrad S, Oethinger M, Kaifel K, Klotz G, Marre R, Kern WV.
gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of
Escherichia coli.
J Antimicrob Chemother. 1996 Sep;38(3):443-55.
PMID: 8889719; UI: 97044648


370: Revel-Viravau V, Truong QC, Moreau N, Jarlier V, Sougakoff W.
Sequence analysis, purification, and study of inhibition by 4-quinolones of the
DNA gyrase from Mycobacterium smegmatis.
Antimicrob Agents Chemother. 1996 Sep;40(9):2054-61.
PMID: 8878580; UI: 97032832


371: Hiasa H, Marians KJ.
Two distinct modes of strand unlinking during theta-type DNA replication.
J Biol Chem. 1996 Aug 30;271(35):21529-35.
PMID: 8702938; UI: 96355528


372: Li Q, Chu DT, Claiborne A, Cooper CS, Lee CM, Raye K, Berst KB, Donner P,
Wang W, Hasvold L, Fung A, Ma Z, Tufano M, Flamm R, Shen LL, Baranowski J,
Nilius A, Alder J, Meulbroek J, Marsh K, Crowell D, Hui Y, Seif L, Melcher LM,
Plattner JJ, et al.
Synthesis and structure-activity relationships of 2-pyridones: a novel series of
potent DNA gyrase inhibitors as antibacterial agents.
J Med Chem. 1996 Aug 2;39(16):3070-88.
PMID: 8759628; UI: 96323331


373: Tanaka M, Otsuki M, Nishino T, Kobayashi I, Matsumoto T, Kumazawa J.
Mutation in DNA gyrase of norfloxacin-resistant clinical isolates of Neisseria
gonorrhoeae.
Genitourin Med. 1996 Aug;72(4):295-7.
PMID: 8976839; UI: 97131187


374: Gilchrist DS, Bates AD.
The structure and mechanism of DNA gyrase from divergent bacterial species.
Biochem Soc Trans. 1996 Aug;24(3):421S. No abstract available.
PMID: 8878965; UI: 97033218


375: Clarkson S, Bates AD.
Action of DNA gyrase at RIP elements in E. coli.
Biochem Soc Trans. 1996 Aug;24(3):420S. No abstract available.
PMID: 8878964; UI: 97033217


376: Qi H, Menzel R, Tse-Dinh YC.
Effect of the deletion of the sigma 32-dependent promoter (P1) of the
Escherichia coli topoisomerase I gene on thermotolerance.
Mol Microbiol. 1996 Aug;21(4):703-11.
PMID: 8878034; UI: 97032138


377: Ng EY, Trucksis M, Hooper DC.
Quinolone resistance mutations in topoisomerase IV: relationship to the flqA
locus and genetic evidence that topoisomerase IV is the primary target and DNA
gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus.
Antimicrob Agents Chemother. 1996 Aug;40(8):1881-8.
PMID: 8843298; UI: 97000156


378: Morrissey I, Hoshino K, Sato K, Yoshida A, Hayakawa I, Bures MG, Shen LL.
Mechanism of differential activities of ofloxacin enantiomers.
Antimicrob Agents Chemother. 1996 Aug;40(8):1775-84.
PMID: 8843280; UI: 97000138


379: Kocagoz T, Hackbarth CJ, Unsal I, Rosenberg EY, Nikaido H, Chambers HF.
Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of
Mycobacterium tuberculosis H37Ra.
Antimicrob Agents Chemother. 1996 Aug;40(8):1768-74.
PMID: 8843279; UI: 97000137


380: Lewis RJ, Tsai FT, Wigley DB.
Molecular mechanisms of drug inhibition of DNA gyrase.
Bioessays. 1996 Aug;18(8):661-71. Review.
PMID: 8760340; UI: 96334364


381: Gari E, Figueroa-Bossi N, Blanc-Potard AB, Spirito F, Schmid MB, Bossi L.
A class of gyrase mutants of Salmonella typhimurium show quinolone-like
lethality and require rec functions for viability.
Mol Microbiol. 1996 Jul;21(1):111-22.
PMID: 8843438; UI: 97000353


382: Schierholz JM, Rump A, Pulverer G.
Drug delivery concepts for the efficacious prevention of foreign-body
infections.
Zentralbl Bakteriol. 1996 Jul;284(2-3):390-401.
PMID: 8837400; UI: 96434433


383: Drlica K, Xu C, Wang JY, Burger RM, Malik M.
Fluoroquinolone action in mycobacteria: similarity with effects in Escherichia
coli and detection by cell lysate viscosity.
Antimicrob Agents Chemother. 1996 Jul;40(7):1594-9.
PMID: 8807046; UI: 96400670


384: Yoshida T, Yamamoto Y, Orita H, Kakiuchi M, Takahashi Y, Itakura M, Kado N,
Yasuda S, Kato H, Itoh Y.
Studies on quinolone antibacterials. V. Synthesis and antibacterial activity of
chiral 5-amino-7-(4-substituted-3-amino-1-pyrrolidinyl)-6-
fluoro-1,4-dihydro-8-methyl-4-oxoquinoline-3-carboxylic acids and derivatives.
Chem Pharm Bull (Tokyo). 1996 Jul;44(7):1376-86.
PMID: 8706143; UI: 96310655


385: Forterre P.
A hot topic: the origin of hyperthermophiles.
Cell. 1996 Jun 14;85(6):789-92. Review. No abstract available.
PMID: 8681374; UI: 96279824


386: Critchlow SE, Maxwell A.
DNA cleavage is not required for the binding of quinolone drugs to the DNA
gyrase-DNA complex.
Biochemistry. 1996 Jun 11;35(23):7387-93.
PMID: 8652515; UI: 96248334


387: Curry PT, Kropko ML, Garvin JR, Fiedler RD, Theiss JC.
In vitro induction of micronuclei and chromosome aberrations by quinolones:
possible mechanisms.
Mutat Res. 1996 Jun 10;352(1-2):143-50.
PMID: 8676903; UI: 96288535


388: Wong J, Bennett GN.
The effect of novobiocin on solvent production by Clostridium acetobutylicum.
J Ind Microbiol. 1996 Jun;16(6):354-9.
PMID: 8987493; UI: 97141149


389: Vologodskii A, Cozzarelli NR.
Effect of supercoiling on the juxtaposition and relative orientation of DNA
sites.
Biophys J. 1996 Jun;70(6):2548-56.
PMID: 8744294; UI: 96363734


390: Froshauer S, Silvia AM, Chidambaram M, Sharma B, Weinstock GM.
Sensitization of bacteria to danofloxacin by temperate prophages.
Antimicrob Agents Chemother. 1996 Jun;40(6):1561-3.
PMID: 8726041; UI: 96338389


391: Bazile-Pham-Khac S, Truong QC, Lafont JP, Gutmann L, Zhou XY, Osman M,
Moreau NJ.
Resistance to fluoroquinolones in Escherichia coli isolated from poultry.
Antimicrob Agents Chemother. 1996 Jun;40(6):1504-7.
PMID: 8726027; UI: 96338375


392: Giel M, Desnoyer M, Lopilato J.
A mutation in a new gene, bglJ, activates the bgl operon in Escherichia coli
K-12.
Genetics. 1996 Jun;143(2):627-35.
PMID: 8725214; UI: 96363900


393: Rowbury RJ, Lazim Z, Goodson M.
Regulatory aspects of alkali tolerance induction in Escherichia coli.
Lett Appl Microbiol. 1996 Jun;22(6):429-32.
PMID: 8695068; UI: 96273225


394: Althaus IW, Kezdy FJ, Peterson T, Spilman CH, Reusser F.
Novenamines as inhibitors of two independent enzymes during DNA replication in a
toluenized Escherichia coli cell system.
Biochem Pharmacol. 1996 May 17;51(10):1373-8.
PMID: 8787554; UI: 96220105


395: Chen CR, Malik M, Snyder M, Drlica K.
DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced
DNA cleavage.
J Mol Biol. 1996 May 17;258(4):627-37.
PMID: 8636997; UI: 96219177


396: Yamagishi J, Kojima T, Oyamada Y, Fujimoto K, Hattori H, Nakamura S, Inoue
M.
Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone
resistance in Staphylococcus aureus.
Antimicrob Agents Chemother. 1996 May;40(5):1157-63.
PMID: 8723458; UI: 96300529


397: Oppegaard H, Sorum H.
Cloning and nucleotide sequence of the DNA gyrase gyrA gene from the fish
pathogen Aeromonas salmonicida.
Antimicrob Agents Chemother. 1996 May;40(5):1126-33.
PMID: 8723452; UI: 96300523


398: Forterre P, Bergerat A, Lopez-Garcia P.
The unique DNA topology and DNA topoisomerases of hyperthermophilic archaea.
FEMS Microbiol Rev. 1996 May;18(2-3):237-48. Review.
PMID: 8639331; UI: 96231616


399: O'Dea MH, Tamura JK, Gellert M.
Mutations in the B subunit of Escherichia coli DNA gyrase that affect
ATP-dependent reactions.
J Biol Chem. 1996 Apr 19;271(16):9723-9.
PMID: 8621650; UI: 96199236


400: Gormley NA, Orphanides G, Meyer A, Cullis PM, Maxwell A.
The interaction of coumarin antibiotics with fragments of DNA gyrase B protein.
Biochemistry. 1996 Apr 16;35(15):5083-92.
PMID: 8664301; UI: 96267102


401: Fsihi H, Vincent V, Cole ST.
Homing events in the gyrA gene of some mycobacteria.
Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3410-5.
PMID: 8622949; UI: 96194983


402: Yamamoto S, Harayama S.
Phylogenetic analysis of Acinetobacter strains based on the nucleotide sequences
of gyrB genes and on the amino acid sequences of their products.
Int J Syst Bacteriol. 1996 Apr;46(2):506-11.
PMID: 8934907; UI: 97088999


403: Yonezawa M, Takahata M, Banzawa-Futakuchi N, Matsubara N, Watanabe Y,
Narita H, Matsunaga T, Igarashi H, Kawahara M, Onodera S.
DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of
Staphylococcus haemolyticus.
Antimicrob Agents Chemother. 1996 Apr;40(4):1065-6. No abstract available.
PMID: 8849234; UI: 96254595


404: Stieger M, Angehrn P, Wohlgensinger B, Gmunder H.
GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine,
coumermycin, and novobiocin.
Antimicrob Agents Chemother. 1996 Apr;40(4):1060-2.
PMID: 8849232; UI: 96254593


405: Deguchi T, Yasuda M, Nakano M, Ozeki S, Ezaki T, Saito I, Kawada Y.
Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the
GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with
antimicrobial susceptibility profiles.
Antimicrob Agents Chemother. 1996 Apr;40(4):1020-3.
PMID: 8849219; UI: 96254580


406: Kamenska V, Mekenyan O, Sterev A, Nedjalkova Z.
Application of the dynamic quantitative structure-activity relationship method
for modeling antibacterial activity of quinolone derivatives.
Arzneimittelforschung. 1996 Apr;46(4):423-8.
PMID: 8740092; UI: 96312777


407: van Workum M, van Dooren SJ, Oldenburg N, Molenaar D, Jensen PR, Snoep JL,
Westerhoff HV.
DNA supercoiling depends on the phosphorylation potential in Escherichia coli.
Mol Microbiol. 1996 Apr;20(2):351-60.
PMID: 8733233; UI: 96310372


408: Jurgens j, Schedletzky H, Heisig P, Seydel JK, Wiedemann B, Holzgrabe U.
Syntheses and biological activities of new N1-aryl substituted quinolone
antibacterials.
Arch Pharm (Weinheim). 1996 Apr;329(4):179-90.
PMID: 8669982; UI: 96225193


409: Kaneko T, Mizushima T, Ohtsuka Y, Kurokawa K, Kataoka K, Miki T, Sekimizu
K.
Co-induction of DNA relaxation and synthesis of DnaK and GroEL proteins in
Escherichia coli by expression of LetD (CcdB) protein, an inhibitor of DNA
gyrase encoded by the F factor.
Mol Gen Genet. 1996 Mar 20;250(5):593-600.
PMID: 8676862; UI: 96194623


410: Lewis RJ, Singh OM, Smith CV, Skarzynski T, Maxwell A, Wonacott AJ, Wigley
DB.
The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines
revealed by X-ray crystallography.
EMBO J. 1996 Mar 15;15(6):1412-20.
PMID: 8635474; UI: 96205879


411: Imamori K, Asaoka T, Matsumoto M, Maebashi K, Matsuda H, Tahara Y.
[In vitro and in vivo antibacterial activities of a new quinolone derivative,
FD501].
Jpn J Antibiot. 1996 Mar;49(3):264-72. Japanese.
PMID: 8935122; UI: 97089214


412: Naber KG.
Fleroxacin overview.
Chemotherapy. 1996 Mar;42 Suppl 1:1-9. Review.
PMID: 8861529; UI: 97014696


413: Kumagai Y, Kato JI, Hoshino K, Akasaka T, Sato K, Ikeda H.
Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene.
Antimicrob Agents Chemother. 1996 Mar;40(3):710-14.
PMID: 8851598; UI: 97004287


414: Murayama N, Shimizu H, Takiguchi S, Baba Y, Amino H, Horiuchi T, Sekimizu
K, Miki T.
Evidence for involvement of Escherichia coli genes pmbA, csrA and a previously
unrecognized gene tldD, in the control of DNA gyrase by letD (ccdB) of sex
factor F.
J Mol Biol. 1996 Mar 1;256(3):483-502.
PMID: 8604133; UI: 96177756


415: Maki S, Takiguchi S, Horiuchi T, Sekimizu K, Miki T.
Partner switching mechanisms in inactivation and rejuvenation of Escherichia
coli DNA gyrase by F plasmid proteins LetD (CcdB) and LetA (CcdA).
J Mol Biol. 1996 Mar 1;256(3):473-82.
PMID: 8604132; UI: 96177755


416: Bensaid A, Almeida A, Drlica K, Rouviere-Yaniv J.
Cross-talk between topoisomerase I and HU in Escherichia coli.
J Mol Biol. 1996 Feb 23;256(2):292-300.
PMID: 8594197; UI: 96174476


417: Malik M, Bensaid A, Rouviere-Yaniv J, Drlica K.
Histone-like protein HU and bacterial DNA topology: suppression of an HU
deficiency by gyrase mutations.
J Mol Biol. 1996 Feb 16;256(1):66-76.
PMID: 8609614; UI: 96190952


418: Hung F, Luo D, Sauve DM, Muller MT, Roberge M.
Characterization of topoisomerase II-DNA interaction and identification of a
DNA-binding domain by ultraviolet laser crosslinking.
FEBS Lett. 1996 Feb 12;380(1-2):127-32.
PMID: 8603720; UI: 96181682


419: Bates AD, O'Dea MH, Gellert M.
Energy coupling in Escherichia coli DNA gyrase: the relationship between
nucleotide binding, strand passage, and DNA supercoiling.
Biochemistry. 1996 Feb 6;35(5):1408-16.
PMID: 8634270; UI: 96223632


420: Brown SA.
Fluoroquinolones in animal health.
J Vet Pharmacol Ther. 1996 Feb;19(1):1-14. Review.
PMID: 8992019; UI: 96260858


421: Oram M, Dosanjh B, Gormley NA, Smith CV, Fisher LM, Maxwell A, Duncan K.
Mode of action of GR122222X, a novel inhibitor of bacterial DNA gyrase.
Antimicrob Agents Chemother. 1996 Feb;40(2):473-6.
PMID: 8834902; UI: 96431820


422: Jordan A, Aragall E, Gibert I, Barbe J.
Promoter identification and expression analysis of Salmonella typhimurium and
Escherichia coli nrdEF operons encoding one of two class I ribonucleotide
reductases present in both bacteria.
Mol Microbiol. 1996 Feb;19(4):777-90.
PMID: 8820648; UI: 96417857


423: Yang CF, Kim JM, Molinari E, DasSarma S.
Genetic and topological analyses of the bop promoter of Halobacterium halobium:
stimulation by DNA supercoiling and non-B-DNA structure.
J Bacteriol. 1996 Feb;178(3):840-5.
PMID: 8550521; UI: 96146536


424: Sekiguchi J, Stivers JT, Mildvan AS, Shuman S.
Mechanism of inhibition of vaccinia DNA topoisomerase by novobiocin and
coumermycin.
J Biol Chem. 1996 Jan 26;271(4):2313-22.
PMID: 8567695; UI: 96147217


425: Krah R, Kozyavkin SA, Slesarev AI, Gellert M.
A two-subunit type I DNA topoisomerase (reverse gyrase) from an extreme
hyperthermophile.
Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):106-10.
PMID: 8552584; UI: 96133886


426: Roca J, Wang JC.
The probabilities of supercoil removal and decatenation by yeast DNA
topoisomerase II.
Genes Cells. 1996 Jan;1(1):17-27.
PMID: 9078364; UI: 97233174


427: Huang WM.
Bacterial diversity based on type II DNA topoisomerase genes.
Annu Rev Genet. 1996;30:79-107. Review.
PMID: 8982450; UI: 97137073


428: Llorente B, Leclerc F, Cedergren R.
Using SAR and QSAR analysis to model the activity and structure of the
quinolone-DNA complex.
Bioorg Med Chem. 1996 Jan;4(1):61-71.
PMID: 8689241; UI: 96265081


429: Clerch B, Bravo JM, Llagostera M.
Analysis of the ciprofloxacin-induced mutations in Salmonella typhimurium.
Environ Mol Mutagen. 1996;27(2):110-5.
PMID: 8603664; UI: 96186399


430: Rowbury RJ, Hussain NH.
Exposure of Escherichia coli to acid habituation conditions sensitizes it to
alkaline stress.
Lett Appl Microbiol. 1996 Jan;22(1):57-61.
PMID: 8588889; UI: 96165772


431: Khodursky AB, Zechiedrich EL, Cozzarelli NR.
Topoisomerase IV is a target of quinolones in Escherichia coli.
Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11801-5.
PMID: 8524852; UI: 96102202


432: Piddock LJ.
Quinolone resistance and Campylobacter spp.
J Antimicrob Chemother. 1995 Dec;36(6):891-8. Review.
PMID: 8821589; UI: 96418804


433: Madhusudan K, Nagaraja V.
Mycobacterium smegmatis DNA gyrase: cloning and overexpression in Escherichia
coli.
Microbiology. 1995 Dec;141 ( Pt 12):3029-37.
PMID: 8574396; UI: 96118228


434: Tsai AC, Tseng MC, Chang SW, Hu FR.
Clinical evaluation of ciprofloxacin ophthalmic solution in the treatment of
refractory bacterial keratitis.
J Formos Med Assoc. 1995 Dec;94(12):760-4.
PMID: 8541741; UI: 96129835


435: Bayer A, Freund S, Jung G.
Post-translational heterocyclic backbone modifications in the 43-peptide
antibiotic microcin B17. Structure elucidation and NMR study of a
13C,15N-labelled gyrase inhibitor.
Eur J Biochem. 1995 Dec 1;234(2):414-26.
PMID: 8536683; UI: 96128168


436: Wu LC, Shahied SI.
Mycobacterial DNA gyrase: enzyme purification and characterization of
supercoiling activity.
Arch Biochem Biophys. 1995 Dec 1;324(1):123-9.
PMID: 7503546; UI: 96095700


437: Zechiedrich EL, Cozzarelli NR.
Roles of topoisomerase IV and DNA gyrase in DNA unlinking during replication in
Escherichia coli.
Genes Dev. 1995 Nov 15;9(22):2859-69.
PMID: 7590259; UI: 96086836


438: Hohage H, Otte B, Raffelsiefer A, Welling U, Zidek W.
[Frequent airway infections].
Schweiz Rundsch Med Prax. 1995 Nov 14;84(46):1358-63. Review. German.
PMID: 7491467; UI: 96090919


439: Wu F, Levchenko I, Filutowicz M.
A DNA segment conferring stable maintenance on R6K gamma-origin core replicons.
J Bacteriol. 1995 Nov;177(22):6338-45.
PMID: 7592407; UI: 96062214


440: Peng H, Marians KJ.
The interaction of Escherichia coli topoisomerase IV with DNA.
J Biol Chem. 1995 Oct 20;270(42):25286-90.
PMID: 7559669; UI: 96027641


441: Salama SM, Newnham E, Chang N, Taylor DE.
Genome map of Campylobacter fetus subsp. fetus ATCC 27374.
FEMS Microbiol Lett. 1995 Oct 15;132(3):239-45.
PMID: 7590179; UI: 96039596


442: Simon H, Roth M, Zimmer C.
Biochemical complementation studies in vitro of gyrase subunits from different
species.
FEBS Lett. 1995 Oct 2;373(1):88-92.
PMID: 7589441; UI: 96013893


443: Heisig P, Kratz B, Halle E, Graser Y, Altwegg M, Rabsch W, Faber JP.
Identification of DNA gyrase A mutations in ciprofloxacin-resistant isolates of
Salmonella typhimurium from men and cattle in Germany.
Microb Drug Resist. 1995 Fall;1(3):211-8.
PMID: 9158777; UI: 97302530


444: Baquero MR, Bouzon M, Varea J, Moreno F.
sbmC, a stationary-phase induced SOS Escherichia coli gene, whose product
protects cells from the DNA replication inhibitor microcin B17.
Mol Microbiol. 1995 Oct;18(2):301-11.
PMID: 8709849; UI: 96296452


445: Musser JM.
Antimicrobial agent resistance in mycobacteria: molecular genetic insights.
Clin Microbiol Rev. 1995 Oct;8(4):496-514. Review.
PMID: 8665467; UI: 96114209


446: Cambau E, Perani E, Dib C, Petinon C, Trias J, Jarlier V.
Role of mutations in DNA gyrase genes in ciprofloxacin resistance of Pseudomonas
aeruginosa susceptible or resistant to imipenem.
Antimicrob Agents Chemother. 1995 Oct;39(10):2248-52.
PMID: 8619577; UI: 96109421


447: Pato ML, Karlok M, Wall C, Higgins NP.
Characterization of Mu prophage lacking the central strong gyrase binding site:
localization of the block in replication.
J Bacteriol. 1995 Oct;177(20):5937-42.
PMID: 7592347; UI: 96011385


448: Gensberg K, Jin YF, Piddock LJ.
A novel gyrB mutation in a fluoroquinolone-resistant clinical isolate of
Salmonella typhimurium.
FEMS Microbiol Lett. 1995 Oct 1;132(1-2):57-60.
PMID: 7590165; UI: 96000947


449: Wegrzyn A, Wegrzyn G.
Transcriptional activation of ori lambda regulates lambda plasmid replication in
amino acid-starved Escherichia coli cells.
Biochem Biophys Res Commun. 1995 Sep 25;214(3):978-84.
PMID: 7575572; UI: 96024594


450: Forsyth MH, Sayed AS, Geary SJ.
Sequence and transcriptional analysis of the genes encoding the class-II
topoisomerase of Mycoplasma gallisepticum.
Gene. 1995 Sep 22;163(1):161-2.
PMID: 7557470; UI: 96001264


451: Tanaka H, Yasuzawa K, Kohno K, Goshima N, Kano Y, Saiki T, Imamoto F.
Role of HU proteins in forming and constraining supercoils of chromosomal DNA in
Escherichia coli.
Mol Gen Genet. 1995 Sep 20;248(5):518-26.
PMID: 7476850; UI: 96027922


452: Guillemin I, Cambau E, Jarlier V.
Sequences of conserved region in the A subunit of DNA gyrase from nine species
of the genus Mycobacterium: phylogenetic analysis and implication for intrinsic
susceptibility to quinolones.
Antimicrob Agents Chemother. 1995 Sep;39(9):2145-9.
PMID: 8540734; UI: 96050760


453: Yonezawa M, Takahata M, Matsubara N, Watanabe Y, Narita H.
DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of
Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1995 Sep;39(9):1970-2.
PMID: 8540700; UI: 96050726


454: Hsiung Y, Elsea SH, Osheroff N, Nitiss JL.
A mutation in yeast TOP2 homologous to a quinolone-resistant mutation in
bacteria. Mutation of the amino acid homologous to Ser83 of Escherichia coli
gyrA alters sensitivity to eukaryotic topoisomerase inhibitors.
J Biol Chem. 1995 Sep 1;270(35):20359-64.
PMID: 7657608; UI: 95386473


455: Bouayadi K, Salles B.
Influence of DNA supercoiling on cisplatin toxicity in Escherichia coli K-12.
Mutat Res. 1995 Sep;348(1):25-31.
PMID: 7565911; UI: 96017756


456: Friedman SM, Malik M, Drlica K.
DNA supercoiling in a thermotolerant mutant of Escherichia coli.
Mol Gen Genet. 1995 Aug 30;248(4):417-22.
PMID: 7565605; UI: 96004762


457: Yao Z, Nahon JL.
DNA gyrase improves DNA transformation of E.coli cells with large recombinant
plasmids.
Nucleic Acids Res. 1995 Aug 25;23(16):3353-4. No abstract available.
PMID: 7667116; UI: 95396604


458: Jackson V.
Preferential binding of histones H3 and H4 to highly positively coiled DNA.
Biochemistry. 1995 Aug 22;34(33):10607-19.
PMID: 7654715; UI: 95383328


459: Ziegelin G, Lanka E.
Bacteriophage P4 DNA replication.
FEMS Microbiol Rev. 1995 Aug;17(1-2):99-107. Review.
PMID: 7669353; UI: 95398956


460: Ali JA, Orphanides G, Maxwell A.
Nucleotide binding to the 43-kilodalton N-terminal fragment of the DNA gyrase B
protein.
Biochemistry. 1995 Aug 1;34(30):9801-8.
PMID: 7626649; UI: 95352667


461: Alangaden GJ, Manavathu EK, Vakulenko SB, Zvonok NM, Lerner SA.
Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium
tuberculosis selected in the laboratory and isolated from patients.
Antimicrob Agents Chemother. 1995 Aug;39(8):1700-3.
PMID: 7486904; UI: 96100735


462: Gupta R, Sharma P, Vyas VV.
Effect of growth environment on the stability of a recombinant shuttle plasmid,
pCPPS-31, in Escherichia coli.
J Biotechnol. 1995 Jul 15;41(1):29-37.
PMID: 7640001; UI: 95367247


463: Gomez-Eichelmann MC, Camacho-Carranza R.
[DNA supercoiling and topoisomerases in Escherichia coli].
Rev Latinoam Microbiol. 1995 Jul-Sep;37(3):291-304. Review. Spanish.
PMID: 8850348; UI: 97003009


464: Shimizu H, Yamaguchi H, Ikeda H.
Molecular analysis of lambda bio transducing phage produced by oxolinic
acid-induced illegitimate recombination in vivo.
Genetics. 1995 Jul;140(3):889-96.
PMID: 7672589; UI: 95402711


465: Harrell LJ, Andersen GL, Wilson KH.
Genetic variability of Bacillus anthracis and related species.
J Clin Microbiol. 1995 Jul;33(7):1847-50.
PMID: 7665658; UI: 95395015


466: Munoz R, Bustamante M, de la Campa AG.
Ser-127-to-Leu substitution in the DNA gyrase B subunit of Streptococcus
pneumoniae is implicated in novobiocin resistance.
J Bacteriol. 1995 Jul;177(14):4166-70.
PMID: 7608096; UI: 95332230


467: Jensen RB, Gerdes K.
Programmed cell death in bacteria: proteic plasmid stabilization systems.
Mol Microbiol. 1995 Jul;17(2):205-10. Review.
PMID: 7494469; UI: 96079270


468: Kitamura A, Hoshino K, Kimura Y, Hayakawa I, Sato K.
Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone,
to its activity against DNA gyrase mutants of Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1995 Jul;39(7):1467-71.
PMID: 7492087; UI: 96104883


469: Albertini S, Chetelat AA, Miller B, Muster W, Pujadas E, Strobel R, Gocke
E.
Genotoxicity of 17 gyrase- and four mammalian topoisomerase II-poisons in
prokaryotic and eukaryotic test systems.
Mutagenesis. 1995 Jul;10(4):343-51.
PMID: 7476271; UI: 96004007


470: Ohta T, Kobayashi M, Hirose S.
Cloning of a cDNA for DNA supercoiling factor reveals a distinctive
Ca(2+)-binding protein.
J Biol Chem. 1995 Jun 30;270(26):15571-5.
PMID: 7797553; UI: 95318140


471: Coughlin SA, Danz DW, Robinson RG, Klingbeil KM, Wentland MP, Corbett TH,
Waud WR, Zwelling LA, Altschuler E, Bales E, et al.
Mechanism of action and antitumor activity of
(S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7 H-
pyridol[1,2,3-de]-[1,4]benzothiazine-6-carboxylic acid (WIN 58161).
Biochem Pharmacol. 1995 Jun 29;50(1):111-22.
PMID: 7605336; UI: 95329091


472: Wu Y, Datta P.
Influence of DNA topology on expression of the tdc operon in Escherichia coli
K-12.
Mol Gen Genet. 1995 Jun 25;247(6):764-7.
PMID: 7616969; UI: 95342171


473: Blanc-Potard AB, Gari E, Spirito F, Figueroa-Bossi N, Bossi L.
RNA polymerase (rpoB) mutants selected for increased resistance to gyrase
inhibitors in Salmonella typhimurium.
Mol Gen Genet. 1995 Jun 25;247(6):680-92.
PMID: 7616959; UI: 95342161


474: Matsumoto K, Seki M, Masutani C, Tada S, Enomoto T, Ishimi Y.
Stimulation of DNA synthesis by mouse DNA helicase B in a DNA replication system
containing eukaryotic replication origins.
Biochemistry. 1995 Jun 20;34(24):7913-22.
PMID: 7794903; UI: 95315178


475: Zagariya AM, Sitailo LA.
The influence of antibiotics and antitumor agents on the relaxation activity of
Pisum sativum leaf chloroplast topoisomerase I.
Arch Biochem Biophys. 1995 Jun 20;320(1):177-81.
PMID: 7793978; UI: 95314316


476: Nakada N, Gmunder H, Hirata T, Arisawa M.
Characterization of the binding site for cyclothialidine on the B subunit of DNA
gyrase.
J Biol Chem. 1995 Jun 16;270(24):14286-91.
PMID: 7782285; UI: 95301507


477: Camacho-Carranza R, Membrillo-Hernandez J, Ramirez-Santos J,
Castro-Dorantes J, Chagoya de Sanchez V, Gomez-Eichelmann MC.
Topoisomerase activity during the heat shock response in Escherichia coli K-12.
J Bacteriol. 1995 Jun;177(12):3619-22.
PMID: 7768879; UI: 95286566


478: Peters HJ.
[Antibiotic treatment of complicated urinary tract infections].
Z Arztl Fortbild (Jena). 1995 Jun;89(3):279-86. Review. German.
PMID: 7668016; UI: 95397560


479: Drolet M, Phoenix P, Menzel R, Masse E, Liu LF, Crouch RJ.
Overexpression of RNase H partially complements the growth defect of an
Escherichia coli delta topA mutant: R-loop formation is a major problem in the
absence of DNA topoisomerase I.
Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3526-30.
PMID: 7536935; UI: 95241534


480: Graeff-Wohlleben H, Deppisch H, Gross R.
Global regulatory mechanisms affect virulence gene expression in Bordetella
pertussis.
Mol Gen Genet. 1995 Apr 10;247(1):86-94.
PMID: 7715607; UI: 95231520


481: Ivanisevic R, Milic M, Ajdic D, Rakonjac J, Savic DJ.
Nucleotide sequence, mutational analysis, transcriptional start site, and
product analysis of nov, the gene which affects Escherichia coli K-12 resistance
to the gyrase inhibitor novobiocin.
J Bacteriol. 1995 Apr;177(7):1766-71.
PMID: 7896699; UI: 95204342


482: Alder J, Clement J, Meulbroek J, Shipkowitz N, Mitten M, Jarvis K,
Oleksijew A, Hutch T Sr, Paige L, Flamm B, et al.
Efficacies of ABT-719 and related 2-pyridones, members of a new class of
antibacterial agents, against experimental bacterial infections.
Antimicrob Agents Chemother. 1995 Apr;39(4):971-5.
PMID: 7786005; UI: 95305560


483: Flamm RK, Vojtko C, Chu DT, Li Q, Beyer J, Hensey D, Ramer N, Clement JJ,
Tanaka SK.
In vitro evaluation of ABT-719, a novel DNA gyrase inhibitor.
Antimicrob Agents Chemother. 1995 Apr;39(4):964-70.
PMID: 7786004; UI: 95305559


484: Servis NA, Nichols S, Adams JC.
Development of a direct viable count procedure for some gram-positive bacteria.
Lett Appl Microbiol. 1995 Apr;20(4):237-9.
PMID: 7766118; UI: 95244089


485: Cecchetti V, Clementi S, Cruciani G, Fravolini A, Pagella PG, Savino A,
Tabarrini O.
6-Aminoquinolones: a new class of quinolone antibacterials?
J Med Chem. 1995 Mar 17;38(6):973-82.
PMID: 7699714; UI: 95214085


486: Lynch AS, Wang JC.
SopB protein-mediated silencing of genes linked to the sopC locus of Escherichia
coli F plasmid.
Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):1896-900.
PMID: 7534407; UI: 95199260


487: Tanaka M, Zhang YX, Ishida H, Akasaka T, Sato K, Hayakawa I.
Mechanisms of 4-quinolone resistance in quinolone-resistant and
methicillin-resistant Staphylococcus aureus isolates from Japan and China.
J Med Microbiol. 1995 Mar;42(3):214-9.
PMID: 7884804; UI: 95190917


488: Schmidt CK, Kemp P, Molineux IJ.
Streptomycin- and rifampin-resistant mutants of Escherichia coli perturb F
exclusion of bacteriophage T7 by affecting synthesis of the F plasmid protein
PifA.
J Bacteriol. 1995 Mar;177(6):1589-94.
PMID: 7883717; UI: 95189738


489: Yamamoto S, Harayama S.
PCR amplification and direct sequencing of gyrB genes with universal primers and
their application to the detection and taxonomic analysis of Pseudomonas putida
strains.
Appl Environ Microbiol. 1995 Mar;61(3):1104-9.
PMID: 7793912; UI: 95314243


490: Skamrov AV, Feoktistova ES, Bibilashvili RSh.
[Cloning and analysis of the nucleotide sequence of the segment in the
Mycoplasma gallisepticum genome containing the gene for the ATP-binding subunit
of DNA topoisomerase type II].
Mol Biol (Mosk). 1995 Mar-Apr;29(2):308-16. Russian.
PMID: 7783737; UI: 95303100


491: Loiseau PM.
Action of DNA-gyrase inhibiting derivatives of 4-oxo-1,
4-dihydro-3-pyridinecarboxylic acid against Trypanosoma brucei.
Int J Parasitol. 1995 Mar;25(3):403-5.
PMID: 7601601; UI: 95325072


492: Fan JY, Sun D, Yu H, Kerwin SM, Hurley LH.
Self-assembly of a quinobenzoxazine-Mg2+ complex on DNA: a new paradigm for the
structure of a drug-DNA complex and implications for the structure of the
quinolone bacterial gyrase-DNA complex.
J Med Chem. 1995 Feb 3;38(3):408-24.
PMID: 7853333; UI: 95156416


493: Conley DL, Cohen SN.
Isolation and characterization of plasmid mutations that enable partitioning of
pSC101 replicons lacking the partition (par) locus.
J Bacteriol. 1995 Feb;177(4):1086-9.
PMID: 7860588; UI: 95164509


494: Ohkubo S, Yamaguchi K.
Two enhancer elements for DNA replication of pSC101, par and a palindromic
binding sequence of the Rep protein.
J Bacteriol. 1995 Feb;177(3):558-65.
PMID: 7836287; UI: 95138013


495: Luttinger A.
The twisted 'life' of DNA in the cell: bacterial topoisomerases.
Mol Microbiol. 1995 Feb;15(4):601-6. Review.
PMID: 7783632; UI: 95302973


496: Sharma A, Mondragon A.
DNA topoisomerases.
Curr Opin Struct Biol. 1995 Feb;5(1):39-47. Review.
PMID: 7773745; UI: 95292060


497: Deguchi T, Yasuda M, Asano M, Tada K, Iwata H, Komeda H, Ezaki T, Saito I,
Kawada Y.
DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria
gonorrhoeae.
Antimicrob Agents Chemother. 1995 Feb;39(2):561-3.
PMID: 7726535; UI: 95243617


498: Sakemi S, Inagaki T, Kaneda K, Hirai H, Iwata E, Sakakibara T, Yamauchi Y,
Norcia M, Wondrack LM, Sutcliffe JA, et al.
CJ-12,371 and CJ-12,372, two novel DNA gyrase inhibitors.
Fermentation,isolation, structural elucidation and biological activities.
J Antibiot (Tokyo). 1995 Feb;48(2):134-42.
PMID: 7706123; UI: 95221226


499: Kaufmann SH, Hancock R.
Topoisomerase II as a target for anticancer chemotherapy.
Acta Biochim Pol. 1995;42(4):381-93. Review.
PMID: 8852329; UI: 97005018


500: Hilliard JJ, Krause HM, Bernstein JI, Fernandez JA, Nguyen V, Ohemeng KA,
Barrett JF.
A comparison of active site binding of 4-quinolones and novel flavone gyrase
inhibitors to DNA gyrase.
Adv Exp Med Biol. 1995;390:59-69.
PMID: 8718602; UI: 96342058


501: Yonezawa M, Takahata M, Banzawa N, Matsubara N, Watanabe Y, Narita H.
Analysis of the NH2-terminal 87th amino acid of Escherichia coli GyrA in
quinolone-resistance.
Microbiol Immunol. 1995;39(7):517-20.
PMID: 8569537; UI: 96025422


502: Hooper DC.
Quinolone mode of action.
Drugs. 1995;49 Suppl 2:10-5. Review.
PMID: 8549276; UI: 96092505


503: Molnar J, Batho N, Csik V, Chevalier J, Cremieux A.
Interaction between tricyclic psychopharmacons and some antibiotics.
Acta Microbiol Immunol Hung. 1995;42(3):277-85.
PMID: 8548201; UI: 96126095


504: Sanders CC, Sanders WE Jr, Thomson KS.
Fluoroquinolone resistance in staphylococci: new challenges.
Eur J Clin Microbiol Infect Dis. 1995;14 Suppl 1:S6-11. Review.
PMID: 7729471; UI: 95246791


505: Murzin AG.
A ribosomal protein module in EF-G and DNA gyrase.
Nat Struct Biol. 1995 Jan;2(1):25-6.
PMID: 7719848; UI: 95236197


506: Gmunder H, Kuratli K, Keck W.
Effect of pyrimido[1,6-a]benzimidazoles, quinolones, and Ca2+ on the DNA
gyrase-mediated cleavage reaction.
Antimicrob Agents Chemother. 1995 Jan;39(1):163-9.
PMID: 7695300; UI: 95209341


507: Wigley DB.
Structure and mechanism of DNA topoisomerases.
Annu Rev Biophys Biomol Struct. 1995;24:185-208. Review.
PMID: 7663114; UI: 95392151


508: Yonezawa M, Takahata M, Banzawa N, Matsubara N, Watanabe Y, Narita H.
Analysis of the NH2-terminal 83rd amino acid of Escherichia coli GyrA in
quinolone-resistance.
Microbiol Immunol. 1995;39(4):243-7.
PMID: 7651238; UI: 95379598


509: Ikeda H, Shimizu H, Ukita T, Kumagai M.
A novel assay for illegitimate recombination in Escherichia coli: stimulation of
lambda bio transducing phage formation by ultra-violet light and its
independence from RecA function.
Adv Biophys. 1995;31:197-208. Review.
PMID: 7625274; UI: 95351193


510: Wood DO, Waite RT.
Sequence analysis of the Rickettsia prowazekii gyrA gene.
Gene. 1994 Dec 30;151(1-2):191-6.
PMID: 7828873; UI: 95129858


511: Sano K, Miyata M.
The gyrB gene lies opposite from the replication origin on the circular
chromosome of Mycoplasma capricolum.
Gene. 1994 Dec 30;151(1-2):181-3.
PMID: 7828871; UI: 95129856


512: Hiasa H, Marians KJ.
Topoisomerase III, but not topoisomerase I, can support nascent chain elongation
during theta-type DNA replication.
J Biol Chem. 1994 Dec 23;269(51):32655-9.
PMID: 7798272; UI: 95096126


513: Gangloff S, McDonald JP, Bendixen C, Arthur L, Rothstein R.
The yeast type I topoisomerase Top3 interacts with Sgs1, a DNA helicase homolog:
a potential eukaryotic reverse gyrase.
Mol Cell Biol. 1994 Dec;14(12):8391-8.
PMID: 7969174; UI: 95059068


514: Barrett-Bee K, Pinder P, Stawpert J.
A comparison of the accumulation of novobiocin into bacteria with its
antibacterial properties.
J Antimicrob Chemother. 1994 Dec;34(6):1041-5.
PMID: 7730219; UI: 95247621


515: Schulz M, Schmoldt A.
[A compilation of therapeutic and toxic plasma drug concentrations].
Anaesthesist. 1994 Dec;43(12):835-44. Review. German.
PMID: 7717522; UI: 95233567


516: Dove SL, Dorman CJ.
The site-specific recombination system regulating expression of the type 1
fimbrial subunit gene of Escherichia coli is sensitive to changes in DNA
supercoiling.
Mol Microbiol. 1994 Dec;14(5):975-88.
PMID: 7715458; UI: 95231303


517: Saiki T, Kohno K, Goshima N, Kano Y, Imamoto F.
Construction of a gyrA-gyrB-carrying plasmid overproducing functional DNA
gyrase.
J Biochem (Tokyo). 1994 Dec;116(6):1208-11.
PMID: 7706209; UI: 95221314


518: Lecomte S, Baron MH, Chenon MT, Coupry C, Moreau NJ.
Effect of magnesium complexation by fluoroquinolones on their antibacterial
properties.
Antimicrob Agents Chemother. 1994 Dec;38(12):2810-6.
PMID: 7695267; UI: 95209307


519: Bergerat A, Gadelle D, Forterre P.
Purification of a DNA topoisomerase II from the hyperthermophilic archaeon
Sulfolobus shibatae. A thermostable enzyme with both bacterial and eucaryal
features.
J Biol Chem. 1994 Nov 4;269(44):27663-9.
PMID: 7961685; UI: 95050518


520: Hoshino K, Kitamura A, Morrissey I, Sato K, Kato J, Ikeda H.
Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with
DNA gyrase inhibition.
Antimicrob Agents Chemother. 1994 Nov;38(11):2623-7.
PMID: 7872758; UI: 95177625


521: Bernard P, Gabant P, Bahassi EM, Couturier M.
Positive-selection vectors using the F plasmid ccdB killer gene.
Gene. 1994 Oct 11;148(1):71-4.
PMID: 7926841; UI: 95011662


522: Simon H, Wittig B, Zimmer C.
Effect of netropsin, distamycin A and chromomycin A3 on the binding and cleavage
reaction of DNA gyrase.
FEBS Lett. 1994 Oct 10;353(1):79-83.
PMID: 7926028; UI: 95010770


523: Samuels DS, Mach KE, Garon CF.
Genetic transformation of the Lyme disease agent Borrelia burgdorferi with
coumarin-resistant gyrB.
J Bacteriol. 1994 Oct;176(19):6045-9.
PMID: 7928965; UI: 95014039


524: Marshall AJ, Piddock LJ.
Interaction of divalent cations, quinolones and bacteria.
J Antimicrob Chemother. 1994 Oct;34(4):465-83.
PMID: 7868402; UI: 95172896


525: Rahman M, Mauff G, Levy J, Couturier M, Pulverer G, Glasdorff N, Butzler
JP.
Detection of 4-quinolone resistance mutation in gyrA gene of Shigella
dysenteriae type 1 by PCR.
Antimicrob Agents Chemother. 1994 Oct;38(10):2488-91.
PMID: 7840594; UI: 95142603


526: Vila J, Ruiz J, Marco F, Barcelo A, Goni P, Giralt E, Jimenez de Anta T.
Association between double mutation in gyrA gene of ciprofloxacin-resistant
clinical isolates of Escherichia coli and MICs.
Antimicrob Agents Chemother. 1994 Oct;38(10):2477-9.
PMID: 7840592; UI: 95142600


527: Oppegaard H, Sorum H.
gyrA mutations in quinolone-resistant isolates of the fish pathogen Aeromonas
salmonicida.
Antimicrob Agents Chemother. 1994 Oct;38(10):2460-4.
PMID: 7840589; UI: 95142596


528: Straney R, Krah R, Menzel R.
Mutations in the -10 TATAAT sequence of the gyrA promoter affect both promoter
strength and sensitivity to DNA supercoiling.
J Bacteriol. 1994 Oct;176(19):5999-6006.
PMID: 7523360; UI: 95014033


529: Willmott CJ, Critchlow SE, Eperon IC, Maxwell A.
The complex of DNA gyrase and quinolone drugs with DNA forms a barrier to
transcription by RNA polymerase.
J Mol Biol. 1994 Sep 30;242(4):351-63.
PMID: 7932695; UI: 95018203


530: Assairi LM.
DNA unknotting activity (DNA topoisomerase II) isolated from a thermophilic
archaebacterium Sulfolobus is inhibited by novobiocin. Partial purification,
identification of the two subunits and characteristics of the enzyme.
Biochim Biophys Acta. 1994 Sep 13;1219(1):107-14.
PMID: 8086447; UI: 94368837


531: Salmon MA, Van Melderen L, Bernard P, Couturier M.
The antidote and autoregulatory functions of the F plasmid CcdA protein: a
genetic and biochemical survey.
Mol Gen Genet. 1994 Sep 1;244(5):530-8.
PMID: 8078480; UI: 94359479


532: Ogata Y, Mizushima T, Kataoka K, Miki T, Sekimizu K.
Identification of DNA topoisomerases involved in immediate and transient DNA
relaxation induced by heat shock in Escherichia coli.
Mol Gen Genet. 1994 Sep 1;244(5):451-5.
PMID: 8078472; UI: 94359470


533: Kowalczykowski SC, Dixon DA, Eggleston AK, Lauder SD, Rehrauer WM.
Biochemistry of homologous recombination in Escherichia coli.
Microbiol Rev. 1994 Sep;58(3):401-65. Review.
PMID: 7968921; UI: 95058623


534: Thornton M, Armitage M, Maxwell A, Dosanjh B, Howells AJ, Norris V, Sigee
DC.
Immunogold localization of GyrA and GyrB proteins in Escherichia coli.
Microbiology. 1994 Sep;140 ( Pt 9):2371-82.
PMID: 7952188; UI: 95039898


535: Korten V, Huang WM, Murray BE.
Analysis by PCR and direct DNA sequencing of gyrA mutations associated with
fluoroquinolone resistance in Enterococcus faecalis.
Antimicrob Agents Chemother. 1994 Sep;38(9):2091-4.
PMID: 7811024; UI: 95110073


536: Ito H, Yoshida H, Bogaki-Shonai M, Niga T, Hattori H, Nakamura S.
Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of
Staphylococcus aureus.
Antimicrob Agents Chemother. 1994 Sep;38(9):2014-23.
PMID: 7811012; UI: 95110061


537: Revel V, Cambau E, Jarlier V, Sougakoff W.
Characterization of mutations in Mycobacterium smegmatis involved in resistance
to fluoroquinolones.
Antimicrob Agents Chemother. 1994 Sep;38(9):1991-6.
PMID: 7811008; UI: 95110057


538: Volff JN, Vandewiele D, Decaris B.
Stimulation of genetic instability and associated large genomic rearrangements
in Streptomyces ambofaciens by three fluoroquinolones.
Antimicrob Agents Chemother. 1994 Sep;38(9):1984-90.
PMID: 7811007; UI: 95110056


539: Nakada N, Gmunder H, Hirata T, Arisawa M.
Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase
inhibitor.
Antimicrob Agents Chemother. 1994 Sep;38(9):1966-73.
PMID: 7811004; UI: 95110053


540: Kureishi A, Diver JM, Beckthold B, Schollaardt T, Bryan LE.
Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene
from strain PAO1 and quinolone-resistant clinical isolates.
Antimicrob Agents Chemother. 1994 Sep;38(9):1944-52.
PMID: 7811002; UI: 95110050


541: Yang X, Daniell H, McFadden B.
In vitro replication of cyanobacterial plasmids from Synechocystis PCC 6803.
Plasmid. 1994 Sep;32(2):195-207.
PMID: 7531350; UI: 95148721


542: Lewis RJ, Singh OM, Smith CV, Maxwell A, Skarzynski T, Wonacott AJ, Wigley
DB.
Crystallization of inhibitor complexes of an N-terminal 24 kDa fragment of the
DNA gyrase B protein.
J Mol Biol. 1994 Aug 5;241(1):128-30.
PMID: 8051702; UI: 94328322


543: Ferrero L, Cameron B, Manse B, Lagneaux D, Crouzet J, Famechon A, Blanche
F.
Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a
primary target of fluoroquinolones.
Mol Microbiol. 1994 Aug;13(4):641-53.
PMID: 7997176; UI: 95089700


544: Tanaka M, Fukuda H, Hirai K, Hosaka M, Matsumoto T, Kumazawa J.
Reduced uptake and accumulation of norfloxacin in resistant strains of Neisseria
gonorrhoeae isolated in Japan.
Genitourin Med. 1994 Aug;70(4):253-5.
PMID: 7959709; UI: 95048309


545: Fleckenstein E, Uphoff CC, Drexler HG.
Effective treatment of mycoplasma contamination in cell lines with enrofloxacin
(Baytril).
Leukemia. 1994 Aug;8(8):1424-34.
PMID: 7520103; UI: 94335338


546: Pato ML.
Central location of the Mu strong gyrase binding site is obligatory for optimal
rates of replicative transposition.
Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7056-60.
PMID: 8041745; UI: 94316636


547: Ito T, Kojima K, Koizumi K, Nagano H, Nishino T.
Inhibitory activity on DNA gyrase and intracellular accumulation of quinolones:
structure-activity relationship of Q-35 analogs.
Biol Pharm Bull. 1994 Jul;17(7):927-30.
PMID: 8000379; UI: 95093426


548: Madhusudan K, Ramesh V, Nagaraja V.
Molecular cloning of gyrA and gyrB genes of Mycobacterium tuberculosis: analysis
of nucleotide sequence.
Biochem Mol Biol Int. 1994 Jul;33(4):651-60.
PMID: 7981652; UI: 95072534


549: Yoshida T, Muratani T, Iyobe S, Mitsuhashi S.
Mechanisms of high-level resistance to quinolones in urinary tract isolates of
Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1994 Jul;38(7):1466-9.
PMID: 7979273; UI: 95070001


550: Ye F, Renaudin J, Bove JM, Laigret F.
Cloning and sequencing of the replication origin (oriC) of the Spiroplasma citri
chromosome and construction of autonomously replicating artificial plasmids.
Curr Microbiol. 1994 Jul;29(1):23-9.
PMID: 7764984; UI: 94290261


551: Blandamer MJ, Briggs B, Cullis PM, Jackson AP, Maxwell A, Reece RJ.
Domain structure of Escherichia coli DNA gyrase as revealed by differential
scanning calorimetry.
Biochemistry. 1994 Jun 21;33(24):7510-6.
PMID: 8011616; UI: 94281178


552: Diaz Orejas R, Ziegelin G, Lurz R, Lanka E.
Phage P4 DNA replication in vitro.
Nucleic Acids Res. 1994 Jun 11;22(11):2065-70.
PMID: 8029013; UI: 94301789


553: Kruklitis R, Nakai H.
Participation of the bacteriophage Mu A protein and host factors in the
initiation of Mu DNA synthesis in vitro.
J Biol Chem. 1994 Jun 10;269(23):16469-77.
PMID: 8206956; UI: 94266846


554: Hiasa H, Marians KJ.
Topoisomerase IV can support oriC DNA replication in vitro.
J Biol Chem. 1994 Jun 10;269(23):16371-5.
PMID: 8206945; UI: 94266833


555: Kohno K, Yasuzawa K, Hirose M, Kano Y, Goshima N, Tanaka H, Imamoto F.
Autoregulation of transcription of the hupA gene in Escherichia coli: evidence
for steric hindrance of the functional promoter domains induced by HU.
J Biochem (Tokyo). 1994 Jun;115(6):1113-8.
PMID: 7982891; UI: 95073973


556: von Rosenstiel N, Adam D.
Quinolone antibacterials. An update of their pharmacology and therapeutic use.
Drugs. 1994 Jun;47(6):872-901. Review.
PMID: 7521829; UI: 94364232


557: Marguet E, Forterre P.
DNA stability at temperatures typical for hyperthermophiles.
Nucleic Acids Res. 1994 May 11;22(9):1681-6.
PMID: 8202372; UI: 94261438


558: Orphanides G, Maxwell A.
Evidence for a conformational change in the DNA gyrase-DNA complex from hydroxyl
radical footprinting.
Nucleic Acids Res. 1994 May 11;22(9):1567-75.
PMID: 8202356; UI: 94261420


559: Yorgey P, Lee J, Kordel J, Vivas E, Warner P, Jebaratnam D, Kolter R.
Posttranslational modifications in microcin B17 define an additional class of
DNA gyrase inhibitor.
Proc Natl Acad Sci U S A. 1994 May 10;91(10):4519-23.
PMID: 8183941; UI: 94240167


560: Khac SB, Moreau NJ.
Interactions between fluoroquinolones, Mg2+, DNA and DNA gyrase, studied by
phase partitioning in an aqueous two-phase system and by affinity
chromatography.
J Chromatogr A. 1994 May 6;668(1):241-7.
PMID: 7516247; UI: 94272641


561: Samuels DS, Marconi RT, Huang WM, Garon CF.
gyrB mutations in coumermycin A1-resistant Borrelia burgdorferi.
J Bacteriol. 1994 May;176(10):3072-5.
PMID: 8188609; UI: 94245637


562: Gilbert EJ, Maxwell A.
The 24 kDa N-terminal sub-domain of the DNA gyrase B protein binds coumarin
drugs.
Mol Microbiol. 1994 May;12(3):365-73.
PMID: 8065258; UI: 94344026


563: Hoffler D.
[Quinolones. Gyrase inhibitors].
Internist (Berl). 1994 May;35(5):484-9. Review. German. No abstract available.
PMID: 8021119; UI: 94292355


564: Katayama T, Kornberg A.
Hyperactive initiation of chromosomal replication in vivo and in vitro by a
mutant initiator protein, DnaAcos, of Escherichia coli.
J Biol Chem. 1994 Apr 29;269(17):12698-703.
PMID: 8175680; UI: 94230343


565: Kozyavkin SA, Krah R, Gellert M, Stetter KO, Lake JA, Slesarev AI.
A reverse gyrase with an unusual structure. A type I DNA topoisomerase from the
hyperthermophile Methanopyrus kandleri is a two-subunit protein.
J Biol Chem. 1994 Apr 15;269(15):11081-9.
PMID: 8157633; UI: 94209275


566: Tobe T, Yoshikawa M, Sasakawa C.
Deregulation of temperature-dependent transcription of the invasion regulatory
gene, virB, in Shigella by rho mutation.
Mol Microbiol. 1994 Apr;12(2):267-76.
PMID: 8057851; UI: 94335646


567: Rohde JR, Fox JM, Minnich SA.
Thermoregulation in Yersinia enterocolitica is coincident with changes in DNA
supercoiling.
Mol Microbiol. 1994 Apr;12(2):187-99.
PMID: 8057844; UI: 94335639


568: Bachellier S, Saurin W, Perrin D, Hofnung M, Gilson E.
Structural and functional diversity among bacterial interspersed mosaic elements
(BIMEs).
Mol Microbiol. 1994 Apr;12(1):61-70.
PMID: 8057840; UI: 94335633


569: Takiff HE, Salazar L, Guerrero C, Philipp W, Huang WM, Kreiswirth B, Cole
ST, Jacobs WR Jr, Telenti A.
Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB
genes and detection of quinolone resistance mutations.
Antimicrob Agents Chemother. 1994 Apr;38(4):773-80.
PMID: 8031045; UI: 94304125


570: Blanc-Potard AB, Bossi L.
Phenotypic suppression of DNA gyrase deficiencies by a deletion lowering the
gene dosage of a major tRNA in Salmonella typhimurium.
J Bacteriol. 1994 Apr;176(8):2216-26.
PMID: 7512550; UI: 94209220


571: Pedre X, Weise F, Chai S, Luder G, Alonso JC.
Analysis of cis and trans acting elements required for the initiation of DNA
replication in the Bacillus subtilis bacteriophage SPP1.
J Mol Biol. 1994 Mar 11;236(5):1324-40.
PMID: 8126723; UI: 94172631


572: Ishimi Y, Matsumoto K.
Loading of a DNA helicase on the DNA unwinding element in the yeast replication
origin: mechanism of DNA replication in a model system.
Biochemistry. 1994 Mar 8;33(9):2733-40.
PMID: 8117739; UI: 94162294


573: Storl K, Storl J, Roth M, Zimmer C.
DNA topoisomerases from Streptomyces noursei: influence of coumarins and
quinolones on the enzymic activity.
Biochim Biophys Acta. 1994 Mar 2;1199(2):143-8.
PMID: 8123663; UI: 94169164


574: Charbonnier F, Forterre P.
Comparison of plasmid DNA topology among mesophilic and thermophilic eubacteria
and archaebacteria.
J Bacteriol. 1994 Mar;176(5):1251-9.
PMID: 8113163; UI: 94156826


575: Park SH, Lee CG, Namkung R, Kim CG, Park SD.
Active DNA topoisomerase II with minimum molecular mass from regenerating rat
liver.
Biochem Mol Biol Int. 1994 Mar;32(4):641-50.
PMID: 8038715; UI: 94313013


576: Young GM, Postle K.
Repression of tonB transcription during anaerobic growth requires Fur binding at
the promoter and a second factor binding upstream.
Mol Microbiol. 1994 Mar;11(5):943-54.
PMID: 8022270; UI: 94293768


577: Grau R, Gardiol D, Glikin GC, de Mendoza D.
DNA supercoiling and thermal regulation of unsaturated fatty acid synthesis in
Bacillus subtilis.
Mol Microbiol. 1994 Mar;11(5):933-41.
PMID: 8022269; UI: 94293767


578: Celia H, Hoermann L, Schultz P, Lebeau L, Mallouh V, Wigley DB, Wang JC,
Mioskowski C, Oudet P.
Three-dimensional model of Escherichia coli gyrase B subunit crystallized in
two-dimensions on novobiocin-linked phospholipid films.
J Mol Biol. 1994 Feb 18;236(2):618-28.
PMID: 8107146; UI: 94149764


579: Nadal M, Couderc E, Duguet M, Jaxel C.
Purification and characterization of reverse gyrase from Sulfolobus shibatae.
Its proteolytic product appears as an ATP-independent topoisomerase.
J Biol Chem. 1994 Feb 18;269(7):5255-63.
PMID: 8106509; UI: 94148991


580: Slesarev AI, Lake JA, Stetter KO, Gellert M, Kozyavkin SA.
Purification and characterization of DNA topoisomerase V. An enzyme from the
hyperthermophilic prokaryote Methanopyrus kandleri that resembles eukaryotic
topoisomerase I.
J Biol Chem. 1994 Feb 4;269(5):3295-303.
PMID: 8106368; UI: 94148821


581: Wiseman LR, Balfour JA.
Ciprofloxacin. A review of its pharmacological profile and therapeutic use in
the elderly.
Drugs Aging. 1994 Feb;4(2):145-73. Review.
PMID: 8186542; UI: 94243119


582: Fouet A, Sirard JC, Mock M.
Bacillus anthracis pXO1 virulence plasmid encodes a type 1 DNA topoisomerase.
Mol Microbiol. 1994 Feb;11(3):471-9.
PMID: 8152371; UI: 94203050


583: Cambau E, Sougakoff W, Jarlier V.
Amplification and nucleotide sequence of the quinolone resistance-determining
region in the gyrA gene of mycobacteria.
FEMS Microbiol Lett. 1994 Feb 1;116(1):49-54.
PMID: 8132154; UI: 94178711


584: Zuerner RL, Stanton TB.
Physical and genetic map of the Serpulina hyodysenteriae B78T chromosome.
J Bacteriol. 1994 Feb;176(4):1087-92.
PMID: 8106320; UI: 94148767


585: Kern WV, Markus A, Andriof E.
Bacteremia due to fluoroquinolone-resistant Escherichia coli in two
immunocompromised patients.
Eur J Clin Microbiol Infect Dis. 1994 Feb;13(2):161-5.
PMID: 8013490; UI: 94283418


586: Hiasa H, DiGate RJ, Marians KJ.
Decatenating activity of Escherichia coli DNA gyrase and topoisomerases I and
III during oriC and pBR322 DNA replication in vitro.
J Biol Chem. 1994 Jan 21;269(3):2093-9.
PMID: 8294462; UI: 94124564


587: Drolet M, Bi X, Liu LF.
Hypernegative supercoiling of the DNA template during transcription elongation
in vitro.
J Biol Chem. 1994 Jan 21;269(3):2068-74.
PMID: 8294458; UI: 94124560


588: Lee MP, Hsieh TS.
Linker insertion mutagenesis of Drosophila topoisomerase II. Probing the
structure of eukaryotic topoisomerase II.
J Mol Biol. 1994 Jan 14;235(2):436-47.
PMID: 8289273; UI: 94118300


589: Howard BM, Pinney RJ, Smith JT.
Antagonism between bactericidal activities of 4-quinolones and coumarins gives
insight into 4-quinolone killing mechanisms.
Microbios. 1994;77(311):121-31.
PMID: 8152392; UI: 94203078


590: Gootz TD, McGuirk PR, Moynihan MS, Haskell SL.
Placement of alkyl substituents on the C-7 piperazine ring of fluoroquinolones:
dramatic differential effects on mammalian topoisomerase II and DNA gyrase.
Antimicrob Agents Chemother. 1994 Jan;38(1):130-3.
PMID: 8141566; UI: 94190038


591: Kamiyama T, Shimma N, Ohtsuka T, Nakayama N, Itezono Y, Nakada N, Watanabe
J, Yokose K.
Cyclothialidine, a novel DNA gyrase inhibitor. II. Isolation, characterization
and structure elucidation.
J Antibiot (Tokyo). 1994 Jan;47(1):37-45.
PMID: 8119860; UI: 94164862


592: Watanabe J, Nakada N, Sawairi S, Shimada H, Ohshima S, Kamiyama T, Arisawa
M.
Cyclothialidine, a novel DNA gyrase inhibitor. I. Screening, taxonomy,
fermentation and biological activity.
J Antibiot (Tokyo). 1994 Jan;47(1):32-6.
PMID: 8119859; UI: 94164861


593: Wiedemann B, Heisig P.
Mechanisms of quinolone resistance.
Infection. 1994;22 Suppl 2:S73-9. Review.
PMID: 7927834; UI: 95012777


594: Ball P.
Bacterial resistance to fluoroquinolones: lessons to be learned.
Infection. 1994;22 Suppl 2:S140-7. Review.
PMID: 7927833; UI: 95012776


595: Ghelardini P, La Valle R, Paolozzi L.
The Mu gem operon: its role in gene expression, recombination and cell cycle.
Genetica. 1994;94(2-3):151-6. Review.
PMID: 7896136; UI: 95203723


596: Chu DT, Hallas R, Tanaka SK, Alder J, Balli D, Plattner JJ.
Synthesis and antitumour activities of tetracyclic quinolone antineoplastic
agents.
Drugs Exp Clin Res. 1994;20(5):177-83.
PMID: 7875053; UI: 95180134


597: Menzel R, Gellert M.
The biochemistry and biology of DNA gyrase.
Adv Pharmacol. 1994;29A:39-69. Review. No abstract available.
PMID: 7826864; UI: 95127470


598: Shen LL.
Molecular mechanisms of DNA gyrase inhibition by quinolone antibacterials.
Adv Pharmacol. 1994;29A:285-304. Review. No abstract available.
PMID: 7826863; UI: 95127469


599: Drlica K, Kreiswirth B.
4-quinolones and the physiology of DNA gyrase.
Adv Pharmacol. 1994;29A:263-83. Review. No abstract available.
PMID: 7826862; UI: 95127468


600: Bernard P, Kezdy KE, Van Melderen L, Steyaert J, Wyns L, Pato ML, Higgins
PN, Couturier M.
The F plasmid CcdB protein induces efficient ATP-dependent DNA cleavage by
gyrase.
J Mol Biol. 1993 Dec 5;234(3):534-41.
PMID: 8254658; UI: 94076333


601: Martorell C, Calpena AC, Escribano E, Poblet JM, Freixas J.
Influence of the chromatographic capacity factor (log k') as an index of
lipophilicity in the antibacterial activity of a series of 6-fluoroquinolones.
Relationship between physico-chemical and structural properties and their
hydrophobicity.
J Chromatogr A. 1993 Dec 3;655(2):177-84.
PMID: 8111471; UI: 94154849


602: Jackson AP, Maxwell A.
Identifying the catalytic residue of the ATPase reaction of DNA gyrase.
Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11232-6.
PMID: 8248233; UI: 94068578


603: Nakada N, Shimada H, Hirata T, Aoki Y, Kamiyama T, Watanabe J, Arisawa M.
Biological characterization of cyclothialidine, a new DNA gyrase inhibitor.
Antimicrob Agents Chemother. 1993 Dec;37(12):2656-61.
PMID: 8109932; UI: 94153043


604: Soussy CJ, Wolfson JS, Ng EY, Hooper DC.
Limitations of plasmid complementation test for determination of quinolone
resistance due to changes in the gyrase A protein and identification of
conditional quinolone resistance locus.
Antimicrob Agents Chemother. 1993 Dec;37(12):2588-92.
PMID: 8109921; UI: 94153031


605: Chu S, Gustafson CE, Feutrier J, Cavaignac S, Trust TJ.
Transcriptional analysis of the Aeromonas salmonicida S-layer protein gene vapA.
J Bacteriol. 1993 Dec;175(24):7968-75.
PMID: 7504668; UI: 94075236


606: Peng H, Marians KJ.
Escherichia coli topoisomerase IV. Purification, characterization, subunit
structure, and subunit interactions.
J Biol Chem. 1993 Nov 15;268(32):24481-90.
PMID: 8227000; UI: 94043292


607: Ullrich KJ, Rumrich G, David C, Fritzsch G.
Bisubstrates: substances that interact with both, renal contraluminal organic
anion and organic cation transport systems. II. Zwitterionic substrates:
dipeptides, cephalosporins, quinolone-carboxylate gyrase inhibitors and
phosphamide thiazine carboxylates; nonionizable substrates: steroid hormones and
cyclophosphamides.
Pflugers Arch. 1993 Nov;425(3-4):300-12.
PMID: 8309791; UI: 94143148


608: Horiuchi S, Inagaki Y, Yamamoto N, Okamura N, Imagawa Y, Nakaya R.
Reduced susceptibilities of Shigella sonnei strains isolated from patients with
dysentery to fluoroquinolones.
Antimicrob Agents Chemother. 1993 Nov;37(11):2486-9.
PMID: 8285640; UI: 94113661


609: Volff JN, Vandewiele D, Simonet JM, Decaris B.
Stimulation of genetic instability in Streptomyces ambofaciens ATCC 23877 by
antibiotics that interact with DNA gyrase.
J Gen Microbiol. 1993 Nov;139 ( Pt 11):2551-8.
PMID: 8277240; UI: 94103729


610: Osburne MS, Maiese WM, Greenstein M.
An assay for the detection of bacterial DNA gyrase inhibitors.
J Antibiot (Tokyo). 1993 Nov;46(11):1764-6.
PMID: 8270502; UI: 94095515


611: Rizzo MF, Shapiro L, Gober J.
Asymmetric expression of the gyrase B gene from the replication-competent
chromosome in the Caulobacter crescentus predivisional cell.
J Bacteriol. 1993 Nov;175(21):6970-81.
PMID: 8226640; UI: 94042862


612: Goetschi E, Angehrn P, Gmuender H, Hebeisen P, Link H, Masciadri R, Nielsen
J.
Cyclothialidine and its congeners: a new class of DNA gyrase inhibitors.
Pharmacol Ther. 1993 Nov;60(2):367-80. Review.
PMID: 8022866; UI: 94294486


613: Miller WG, Simons RW.
Chromosomal supercoiling in Escherichia coli.
Mol Microbiol. 1993 Nov;10(3):675-84.
PMID: 7968544; UI: 95058210


614: Atarashi S, Imamura M, Kimura Y, Yoshida A, Hayakawa I.
Fluorocyclopropyl quinolones. 1. Synthesis and structure-activity relationships
of 1-(2-fluorocyclopropyl)-3-pyridonecarboxylic acid antibacterial agents.
J Med Chem. 1993 Oct 29;36(22):3444-8.
PMID: 8230135; UI: 94046983


615: Palm P, Schleper C, Arnold-Ammer I, Holz I, Meier T, Lottspeich F, Zillig
W.
The DNA-dependent RNA-polymerase of Thermotoga maritima; characterisation of the
enzyme and the DNA-sequence of the genes for the large subunits.
Nucleic Acids Res. 1993 Oct 25;21(21):4904-8.
PMID: 8177738; UI: 94232816


616: Jinbo Y, Taguchi M, Inoue Y, Kondo H, Miyasaka T, Tsujishita H, Sakamoto F,
Tsukamoto G.
Synthesis and antibacterial activity of a new series of tetracyclic pyridone
carboxylic acids.
J Med Chem. 1993 Oct 15;36(21):3148-53.
PMID: 8230101; UI: 94046945


617: Alarcon T, Pita J, Lopez-Brea M, Piddock LJ.
High-level quinolone resistance amongst clinical isolates of Escherichia coli
and Klebsiella pneumoniae from Spain.
J Antimicrob Chemother. 1993 Oct;32(4):605-9.
PMID: 8288502; UI: 94117320


618: Barrett JF, Bernstein JI, Krause HM, Hilliard JJ, Ohemeng KA.
Testing potential gyrase inhibitors of bacterial DNA gyrase: a comparison of the
supercoiling inhibition assay and "cleavable complex" assay.
Anal Biochem. 1993 Oct;214(1):313-7.
PMID: 8250240; UI: 94071087


619: del Solar G, Kramer G, Ballester S, Espinosa M.
Replication of the promiscuous plasmid pLS1: a region encompassing the minus
origin of replication is associated with stable plasmid inheritance.
Mol Gen Genet. 1993 Oct;241(1-2):97-105.
PMID: 8232217; UI: 94049694


620: Marincs F, White DW.
Nopaline causes a conformational change in the NocR regulatory protein-nocR
promoter complex of Agrobacterium tumefaciens Ti plasmid pTiT37.
Mol Gen Genet. 1993 Oct;241(1-2):65-72.
PMID: 8232213; UI: 94049690


621: Cortassa S, Aon MA.
Altered topoisomerase activities may be involved in the regulation of DNA
supercoiling in aerobic-anaerobic transitions in Escherichia coli.
Mol Cell Biochem. 1993 Sep 22;126(2):115-24.
PMID: 8302289; UI: 94134069


622: Wentland MP, Lesher GY, Reuman M, Gruett MD, Singh B, Aldous SC, Dorff PH,
Rake JB, Coughlin SA.
Mammalian topoisomerase II inhibitory activity of 1-cyclopropyl-6,8-
difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarb oxylic
acid and related derivatives.
J Med Chem. 1993 Sep 17;36(19):2801-9.
PMID: 8410993; UI: 94016314


623: Peng H, Marians KJ.
Decatenation activity of topoisomerase IV during oriC and pBR322 DNA replication
in vitro.
Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8571-5.
PMID: 8104339; UI: 93391396


624: Jinbo Y, Kondo H, Inoue Y, Taguchi M, Tsujishita H, Kotera Y, Sakamoto F,
Tsukamoto G.
Synthesis and antibacterial activity of a new series of tetracyclic pyridone
carboxylic acids.
J Med Chem. 1993 Sep 3;36(18):2621-6.
PMID: 8410974; UI: 94016293


625: Denis A, Moreau NJ.
Mechanisms of quinolone resistance in clinical isolates: accumulation of
sparfloxacin and of fluoroquinolones of various hydrophobicity, and analysis of
membrane composition.
J Antimicrob Chemother. 1993 Sep;32(3):379-92.
PMID: 8262860; UI: 94086423


626: Klopman G, Wang S, Jacobs MR, Ellner JJ.
Anti-Mycobacterium avium activity of quinolones: structure-activity relationship
studies.
Antimicrob Agents Chemother. 1993 Sep;37(9):1807-15.
PMID: 8239588; UI: 94058167


627: Palumbo M, Gatto B, Zagotto G, Palu G.
On the mechanism of action of quinolone drugs.
Trends Microbiol. 1993 Sep;1(6):232-5.
PMID: 8137121; UI: 94184808


628: Carmona M, Balsalobre C, Munoa F, Mourino M, Jubete Y, De la Cruz F, Juarez
A.
Escherichia coli hha mutants, DNA supercoiling and expression of the haemolysin
genes from the recombinant plasmid pANN202-312.
Mol Microbiol. 1993 Sep;9(5):1011-8.
PMID: 7934907; UI: 95020622


629: Kataoka T, Wachi M, Nakamura J, Gayama S, Yamasaki M, Nagai K.
Fully methylated oriC with negative superhelicity forms an oriC-membrane complex
before initiation of chromosome replication.
Biochem Biophys Res Commun. 1993 Aug 16;194(3):1420-6.
PMID: 8394707; UI: 93356822


630: Scarlato V, Arico B, Rappuoli R.
DNA topology affects transcriptional regulation of the pertussis toxin gene of
Bordetella pertussis in Escherichia coli and in vitro.
J Bacteriol. 1993 Aug;175(15):4764-71.
PMID: 8393006; UI: 93328681


631: Yorgey P, Davagnino J, Kolter R.
The maturation pathway of microcin B17, a peptide inhibitor of DNA gyrase.
Mol Microbiol. 1993 Aug;9(4):897-905.
PMID: 8231817; UI: 94049128


632: Maxwell A.
The interaction between coumarin drugs and DNA gyrase.
Mol Microbiol. 1993 Aug;9(4):681-6. Review.
PMID: 8231802; UI: 94049109


633: Neubert U, Schaller M, Januschke E, Stolz W, Schmieger H.
Bacteriophages induced by ciprofloxacin in a Borrelia burgdorferi skin isolate.
Zentralbl Bakteriol. 1993 Aug;279(3):307-15.
PMID: 8219501; UI: 94033913


634: Laborde E, Kiely JS, Culbertson TP, Lesheski LE.
Quinolone antibacterials: synthesis and biological activity of carbon isosteres
of the 1-piperazinyl and 3-amino-1-pyrrolidinyl side chains.
J Med Chem. 1993 Jul 9;36(14):1964-70.
PMID: 8393112; UI: 93329709


635: Yoshinari T, Mano E, Arakawa H, Kurama M, Iguchi T, Nakagawa S, Tanaka N,
Okura A.
Stereo (C7)-dependent topoisomerase II inhibition and tumor growth suppression
by a new quinolone, BO-2367.
Jpn J Cancer Res. 1993 Jul;84(7):800-6.
PMID: 8396568; UI: 93380865


636: Ebringer L, Polonyi J, Krajcovic J.
Influence of ofloxacin on chloroplasts and mitochondria in Euglena gracilis.
Arzneimittelforschung. 1993 Jul;43(7):777-81.
PMID: 8369012; UI: 93378635


637: Peng M, Lemke PA, Singh NK.
A nucleotide sequence involved in replicative transformation of a filamentous
fungus.
Curr Genet. 1993 Jul-Aug;24(1-2):114-21.
PMID: 8358817; UI: 93365019


638: Burckhardt G, Luck G, Storl K, Zimmer C, Lown JW.
Binding to DNA of selected lexitropsins and effects on prokaryotic topoisomerase
activity.
Biochim Biophys Acta. 1993 Jun 25;1173(3):266-72.
PMID: 8391323; UI: 93305719


639: Ishimi Y, Matsumoto K.
Model system for DNA replication of a plasmid DNA containing the autonomously
replicating sequence from Saccharomyces cerevisiae.
Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5399-403.
PMID: 8390661; UI: 93296145


640: Cambau E, Bordon F, Collatz E, Gutmann L.
Novel gyrA point mutation in a strain of Escherichia coli resistant to
fluoroquinolones but not to nalidixic acid.
Antimicrob Agents Chemother. 1993 Jun;37(6):1247-52.
PMID: 8392306; UI: 93319253


641: Brockbank SM, Barth PT.
Cloning, sequencing, and expression of the DNA gyrase genes from Staphylococcus
aureus.
J Bacteriol. 1993 Jun;175(11):3269-77.
PMID: 8388872; UI: 93273692


642: Niu J, Wang Y, Dixon R, Bowden S, Qiao M, Einck L, Locarnini S.
The use of ampligen alone and in combination with ganciclovir and coumermycin A1
for the treatment of ducks congenitally-infected with duck hepatitis B virus.
Antiviral Res. 1993 Jun;21(2):155-71.
PMID: 7687840; UI: 93332403


643: Confalonieri F, Elie C, Nadal M, de La Tour C, Forterre P, Duguet M.
Reverse gyrase: a helicase-like domain and a type I topoisomerase in the same
polypeptide.
Proc Natl Acad Sci U S A. 1993 May 15;90(10):4753-7.
PMID: 8389456; UI: 93281657


644: Thiara AS, Cundliffe E.
Expression and analysis of two gyrB genes from the novobiocin producer,
Streptomyces sphaeroides.
Mol Microbiol. 1993 May;8(3):495-506.
PMID: 8392138; UI: 93316846


645: Domagala JM, Hagen SE, Joannides T, Kiely JS, Laborde E, Schroeder MC,
Sesnie JA, Shapiro MA, Suto MJ, Vanderroest S.
Quinolone antibacterials containing the new 7-[3-(1-aminoethyl)-1- pyrrolidinyl]
side chain: the effects of the 1-aminoethyl moiety and its stereochemical
configurations on potency and in vivo efficacy.
J Med Chem. 1993 Apr 2;36(7):871-82.
PMID: 8385225; UI: 93217958


646: Yoshida H, Nakamura M, Bogaki M, Ito H, Kojima T, Hattori H, Nakamura S.
Mechanism of action of quinolones against Escherichia coli DNA gyrase.
Antimicrob Agents Chemother. 1993 Apr;37(4):839-45.
PMID: 8388200; UI: 93263659


647: Yoshida T, Mitsuhashi S.
Antibacterial activity of NM394, the active form of prodrug NM441, a new
quinolone.
Antimicrob Agents Chemother. 1993 Apr;37(4):793-800.
PMID: 8388199; UI: 93263652


648: Heisig P, Schedletzky H, Falkenstein-Paul H.
Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical
isolate of Escherichia coli.
Antimicrob Agents Chemother. 1993 Apr;37(4):696-701.
PMID: 8388197; UI: 93263635


649: Li C, Louise CJ, Shi W, Adler J.
Adverse conditions which cause lack of flagella in Escherichia coli.
J Bacteriol. 1993 Apr;175(8):2229-35.
PMID: 8385664; UI: 93224442


650: Mizushima T, Natori S, Sekimizu K.
Relaxation of supercoiled DNA associated with induction of heat shock proteins
in Escherichia coli.
Mol Gen Genet. 1993 Apr;238(1-2):1-5.
PMID: 8097554; UI: 93241142


651: Sorgel F, Kinzig M.
Pharmacokinetics of gyrase inhibitors, Part 2: Renal and hepatic elimination
pathways and drug interactions.
Am J Med. 1993 Mar 22;94(3A):56S-69S. Review.
PMID: 8383921; UI: 93198926


652: Sorgel F, Kinzig M.
Pharmacokinetics of gyrase inhibitors, Part 1: Basic chemistry and
gastrointestinal disposition.
Am J Med. 1993 Mar 22;94(3A):44S-55S. Review.
PMID: 8383920; UI: 93198925


653: Ali JA, Jackson AP, Howells AJ, Maxwell A.
The 43-kilodalton N-terminal fragment of the DNA gyrase B protein hydrolyzes ATP
and binds coumarin drugs.
Biochemistry. 1993 Mar 16;32(10):2717-24.
PMID: 8383523; UI: 93192216


654: Waterman SR, Hackett J, Manning PA.
Characterization of the replication region of the small cryptic plasmid of
Campylobacter hyointestinalis.
Gene. 1993 Mar 15;125(1):11-7.
PMID: 8449408; UI: 93194072


655: Raina R, Bageshwar UK, Das HK.
The Azotobacter vinelandii nifL-like gene: nucleotide sequence analysis and
regulation of expression.
Mol Gen Genet. 1993 Mar;237(3):400-6.
PMID: 8483455; UI: 93247554


656: McCullough JE, Muller MT, Howells AJ, Maxwell A, O'Sullivan J, Summerill
RS, Parker WL, Wells JS, Bonner DP, Fernandes PB.
Clerocidin, a terpenoid antibiotic, inhibits bacterial DNA gyrase.
J Antibiot (Tokyo). 1993 Mar;46(3):526-30. No abstract available.
PMID: 8386713; UI: 93239596


657: Georgopapadakou NH, Bertasso A.
Mechanisms of action of cephalosporin 3'-quinolone esters, carbamates, and
tertiary amines in Escherichia coli.
Antimicrob Agents Chemother. 1993 Mar;37(3):559-65.
PMID: 8384817; UI: 93213130


658: Wang Y, Huang WM, Taylor DE.
Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and
characterization of quinolone resistance mutations.
Antimicrob Agents Chemother. 1993 Mar;37(3):457-63.
PMID: 8384814; UI: 93213116


659: Stim KP, Bennett GN.
Nucleotide sequence of the adi gene, which encodes the biodegradative
acid-induced arginine decarboxylase of Escherichia coli.
J Bacteriol. 1993 Mar;175(5):1221-34.
PMID: 8383109; UI: 93186686


660: Storl K, Storl J, Zimmer C, Lown JW.
Minor-groove binders are inhibitors of the catalytic activity of DNA gyrases.
FEBS Lett. 1993 Feb 8;317(1-2):157-62.
PMID: 8381366; UI: 93154509


661: Lawrence JW, Darkin-Rattray S, Xie F, Neims AH, Rowe TC.
4-Quinolones cause a selective loss of mitochondrial DNA from mouse L1210
leukemia cells.
J Cell Biochem. 1993 Feb;51(2):165-74.
PMID: 8440750; UI: 93179506


662: Bassini C, Bismara C, Carlesso R, Feriani A, Gaviraghi G, Marchioro C,
Perboni A, Shaw RE, Tamburini B, Tarzia G, et al.
Synthesis and antimicrobial activity of DNA-gyrase inhibiting derivatives of
4-oxo-1,4-dihydro-3-pyridinecarboxylic acid.
Farmaco. 1993 Feb;48(2):159-89.
PMID: 8388214; UI: 93263969


663: Baillie LW, Power EG, Phillips I.
Chlorhexidine hypersensitivity of ciprofloxacin-resistant variants of
Pseudomonas aeruginosa PAO.
J Antimicrob Chemother. 1993 Feb;31(2):219-25.
PMID: 8385092; UI: 93216557


664: Petracca K, Riond JL, Graser T, Wanner M.
Pharmacokinetics of the gyrase inhibitor marbofloxacin: influence of pregnancy
and lactation in sows.
Zentralbl Veterinarmed A. 1993 Feb;40(1):73-9.
PMID: 8383902; UI: 93198448


665: Mukherjee A, Sen S, Agarwal K.
Ciprofloxacin: mammalian DNA topoisomerase type II poison in vivo.
Mutat Res. 1993 Feb;301(2):87-92.
PMID: 7678175; UI: 93116780


666: Chan VT, Ng SW, Eder JP, Schnipper LE.
Molecular cloning and identification of a point mutation in the topoisomerase II
cDNA from an etoposide-resistant Chinese hamster ovary cell line.
J Biol Chem. 1993 Jan 25;268(3):2160-5.
PMID: 8380592; UI: 93131977


667: Herrera G, Aleixandra V, Urios A, Blanco M.
Quinolone action in Escherichia coli cells carrying gyrA and gyrB mutations.
FEMS Microbiol Lett. 1993 Jan 15;106(2):187-91.
PMID: 8384139; UI: 93202440


668: Kreutzberger A, Balbach S.
[2-Guanidino-4(3H)-quinazolinones with chemotherapeutic activities].
Pharmazie. 1993 Jan;48(1):17-20. German.
PMID: 8384724; UI: 93212001


669: Samuels DS, Garon CF.
Coumermycin A1 inhibits growth and induces relaxation of supercoiled plasmids in
Borrelia burgdorferi, the Lyme disease agent.
Antimicrob Agents Chemother. 1993 Jan;37(1):46-50.
PMID: 8381639; UI: 93159143


670: Willmott CJ, Maxwell A.
A single point mutation in the DNA gyrase A protein greatly reduces binding of
fluoroquinolones to the gyrase-DNA complex.
Antimicrob Agents Chemother. 1993 Jan;37(1):126-7.
PMID: 8381633; UI: 93159130


671: Ephrati-Elizur E.
A mutation in a new gene of Escherichia coli, psu, requires secondary mutations
for survival: psu mutants express a pleiotropic suppressor phenotype.
J Bacteriol. 1993 Jan;175(1):207-13.
PMID: 8380152; UI: 93106957


672: Petracca K, Wanner M.
[The effect of pregnancy and lactation in sows on the pharmacokinetics of the
gyrase inhibitor marbofloxacin].
Schweiz Arch Tierheilkd. 1993;135(10):298-304. German.
PMID: 8235542; UI: 94053650


673: Hooper DC.
Quinolone mode of action--new aspects.
Drugs. 1993;45 Suppl 3:8-14. Review.
PMID: 7689456; UI: 93365410


674: Cambau E, Gutmann L.
Mechanisms of resistance to quinolones.
Drugs. 1993;45 Suppl 3:15-23. Review.
PMID: 7689446; UI: 93365400


675: Kato J, Suzuki H, Ikeda H.
Purification and characterization of DNA topoisomerase IV in Escherichia coli.
J Biol Chem. 1992 Dec 25;267(36):25676-84.
PMID: 1334483; UI: 93100274


676: Wu HY, Lau K, Liu LF.
Interlocking of plasmid DNAs due to Lac repressor-operator interaction.
J Mol Biol. 1992 Dec 20;228(4):1104-14.
PMID: 1335514; UI: 93116055


677: Suto MJ, Domagala JM, Roland GE, Mailloux GB, Cohen MA.
Fluoroquinolones: relationships between structural variations, mammalian cell
cytotoxicity, and antimicrobial activity.
J Med Chem. 1992 Dec 11;35(25):4745-50.
PMID: 1469702; UI: 93108424


678: Tabassum R, Sandman KM, Reeve JN.
HMt, a histone-related protein from Methanobacterium thermoautotrophicum delta
H.
J Bacteriol. 1992 Dec;174(24):7890-5.
PMID: 1459937; UI: 93094115


679: Huang PL, Chen HC, Kung HF, Huang PL, Huang P, Huang HI, Lee-Huang S.
Anti-HIV plant proteins catalyze topological changes of DNA into inactive forms.
Biofactors. 1992 Dec;4(1):37-41.
PMID: 1337969; UI: 93183329


680: Bazile S, Moreau N, Bouzard D, Essiz M.
Relationships among antibacterial activity, inhibition of DNA gyrase, and
intracellular accumulation of 11 fluoroquinolones.
Antimicrob Agents Chemother. 1992 Dec;36(12):2622-7.
PMID: 1336340; UI: 93128866


681: Schrum LW, Hassan HM.
Transcriptional regulation of Mn-superoxide dismutase gene (sodA) of Escherichia
coli is stimulated by DNA gyrase inhibitors.
Arch Biochem Biophys. 1992 Nov 15;299(1):185-92.
PMID: 1332615; UI: 93073953


682: Cook DN, Ma D, Pon NG, Hearst JE.
Dynamics of DNA supercoiling by transcription in Escherichia coli.
Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10603-7.
PMID: 1332053; UI: 93066292


683: Oram M, Kuroda R, Fisher LM.
Escherichia coli DNA gyrase: genetic analysis of gyrA and gyrB mutations
responsible for thermosensitive enzyme activity.
FEBS Lett. 1992 Nov 2;312(1):61-5.
PMID: 1330681; UI: 93050164


684: Fernandez-Beros ME, Tse-Dinh YC.
Conditional growth of Escherichia coli caused by expression of vaccinia virus
DNA topoisomerase I.
J Bacteriol. 1992 Nov;174(21):7059-62.
PMID: 1328167; UI: 93015773


685: Csiszar K, Molnar J.
Mechanism of action of tricyclic drugs on Escherichia coli and Yersinia
enterocolitica plasmid maintenance and replication.
Anticancer Res. 1992 Nov-Dec;12(6B):2267-72.
PMID: 1295474; UI: 93199267


686: Adams DE, Shekhtman EM, Zechiedrich EL, Schmid MB, Cozzarelli NR.
The role of topoisomerase IV in partitioning bacterial replicons and the
structure of catenated intermediates in DNA replication.
Cell. 1992 Oct 16;71(2):277-88.
PMID: 1330320; UI: 93046628


687: Cullis PM, Maxwell A, Weiner DP.
Energy coupling in DNA gyrase: a thermodynamic limit to the extent of DNA
supercoiling.
Biochemistry. 1992 Oct 13;31(40):9642-6.
PMID: 1327123; UI: 93003119


688: Dri AM, Moreau PL, Rouviere-Yaniv J.
Role of the histone-like proteins OsmZ and HU in homologous recombination.
Gene. 1992 Oct 12;120(1):11-6.
PMID: 1327969; UI: 93013008


689: Markiewicz P, Malone C, Chase JW, Rothman-Denes LB.
Escherichia coli single-stranded DNA-binding protein is a supercoiled
template-dependent transcriptional activator of N4 virion RNA polymerase.
Genes Dev. 1992 Oct;6(10):2010-9.
PMID: 1383090; UI: 93012955


690: Gauthier MJ, Labedan B, Breittmayer VA.
Influence of DNA supercoiling on the loss of culturability of Escherichia coli
cells incubated in seawater.
Mol Ecol. 1992 Oct;1(3):183-90.
PMID: 1344994; UI: 94236285


691: Debbia EA.
Filamentation promotes F'lac loss in Escherichia coli K12.
J Gen Microbiol. 1992 Oct;138 ( Pt 10):2083-91.
PMID: 1336031; UI: 93123966


692: Charbonnier F, Erauso G, Barbeyron T, Prieur D, Forterre P.
Evidence that a plasmid from a hyperthermophilic archaebacterium is relaxed at
physiological temperatures.
J Bacteriol. 1992 Oct;174(19):6103-8.
PMID: 1328151; UI: 93015648


693: Guan L, Blumenthal RM, Burnham JC.
Analysis of macromolecular biosynthesis to define the quinolone-induced
postantibiotic effect in Escherichia coli.
Antimicrob Agents Chemother. 1992 Oct;36(10):2118-24.
PMID: 1280055; UI: 93073751


694: O'Brien K, Deno G, Ostrovsky de Spicer P, Gardner JF, Maloy SR.
Integration host factor facilitates repression of the put operon in Salmonella
typhimurium.
Gene. 1992 Sep 1;118(1):13-9.
PMID: 1511875; UI: 92380479


695: O'Byrne CP, Ni Bhriain N, Dorman CJ.
The DNA supercoiling-sensitive expression of the Salmonella typhimurium his
operon requires the his attenuator and is modulated by anaerobiosis and by
osmolarity.
Mol Microbiol. 1992 Sep;6(17):2467-76.
PMID: 1406284; UI: 93023876


696: Kato M, Furuno A.
Unusual structure of plasmid DNA formed in transformants of Escherichia coli.
Res Microbiol. 1992 Sep;143(7):665-9.
PMID: 1336880; UI: 93141813


697: Lebeau L, Olland S, Oudet P, Mioskowski C.
Rational design and synthesis of phospholipids for the two-dimensional
crystallization of DNA gyrase, a key element in chromosome organization.
Chem Phys Lipids. 1992 Sep;62(2):93-103.
PMID: 1330339; UI: 93046901


698: Jones PG, Krah R, Tafuri SR, Wolffe AP.
DNA gyrase, CS7.4, and the cold shock response in Escherichia coli.
J Bacteriol. 1992 Sep;174(18):5798-802.
PMID: 1325964; UI: 92394881


699: Bernard P, Couturier M.
Cell killing by the F plasmid CcdB protein involves poisoning of
DNA-topoisomerase II complexes.
J Mol Biol. 1992 Aug 5;226(3):735-45.
PMID: 1324324; UI: 92373759


700: Adams DE, Bliska JB, Cozzarelli NR.
Cre-lox recombination in Escherichia coli cells. Mechanistic differences from
the in vitro reaction.
J Mol Biol. 1992 Aug 5;226(3):661-73.
PMID: 1324323; UI: 92373753


701: Hinnebusch J, Barbour AG.
Linear- and circular-plasmid copy numbers in Borrelia burgdorferi.
J Bacteriol. 1992 Aug;174(16):5251-7.
PMID: 1644750; UI: 92355497


702: Parsot C, Mekalanos JJ.
Structural analysis of the acfA and acfD genes of Vibrio cholerae: effects of
DNA topology and transcriptional activators on expression.
J Bacteriol. 1992 Aug;174(16):5211-8.
PMID: 1644747; UI: 92355492


703: Tempel K, Ignatius A.
Effect of gyrase inhibitors on some eukaryotic short-term test systems. DNase I
in vitro nucleic acid synthesis and DNA repair in primary cultures of chicken
embryo and rat cells.
Arzneimittelforschung. 1992 Aug;42(8):1031-6.
PMID: 1384518; UI: 93038987


704: Osburne MS, Zavodny SM, Greenstein M, Maiese WM.
Phenotypes conferred by the Bacillus subtilis recM13 mutation and the din23
fusion.
Mutat Res. 1992 Aug;274(2):79-84.
PMID: 1378209; UI: 92326842


705: Swartzman E, Meighen EA.
Vibrio harveyi RNA polymerase: purification and resolution from gyrase A.
Biochem Cell Biol. 1992 Aug;70(8):698-702.
PMID: 1335732; UI: 93119593


706: Gasser SM, Walter R, Dang Q, Cardenas ME.
Topoisomerase II: its functions and phosphorylation.
Antonie Van Leeuwenhoek. 1992 Aug;62(1-2):15-24. Review.
PMID: 1332607; UI: 93073815


707: Ito T, Otsuki M, Nishino T.
In vitro antibacterial activity of Q-35, a new fluoroquinolone.
Antimicrob Agents Chemother. 1992 Aug;36(8):1708-14.
PMID: 1329626; UI: 93037294


708: Toone WM, Rudd KE, Friesen JD.
Mutations causing aminotriazole resistance and temperature sensitivity reside in
gyrB, which encodes the B subunit of DNA gyrase.
J Bacteriol. 1992 Aug;174(16):5479-81.
PMID: 1322887; UI: 92355530


709: Dobbs ST, Cullis PM, Maxwell A.
The cleavage of DNA at phosphorothioate internucleotidic linkages by DNA gyrase.
Nucleic Acids Res. 1992 Jul 25;20(14):3567-73.
PMID: 1322526; UI: 92350654


710: Patil MA, Katoch VM, Venkatesan K, Sharma VD, Shivannavar CT, Kanaujia GV,
Agrawal BM.
Correlation between inhibitory effect of quinolones and mycolic acid metabolism
in mycobacteria.
Indian J Lepr. 1992 Jul-Sep;64(3):331-40.
PMID: 1431322; UI: 93056790


711: Maddix DS, Warner L.
Do we need an intravenous fluoroquinolone?
West J Med. 1992 Jul;157(1):55-9. Review.
PMID: 1413744; UI: 93033421


712: Maki S, Takiguchi S, Miki T, Horiuchi T.
Modulation of DNA supercoiling activity of Escherichia coli DNA gyrase by F
plasmid proteins. Antagonistic actions of LetA (CcdA) and LetD (CcdB) proteins.
J Biol Chem. 1992 Jun 15;267(17):12244-51.
PMID: 1318314; UI: 92291110


713: Rakonjac J, Milic M, Ajdic-Predic D, Santos D, Ivanisevic R, Savic DJ.
nov: a new genetic locus that affects the response of Escherichia coli K-12 to
novobiocin.
Mol Microbiol. 1992 Jun;6(11):1547-53.
PMID: 1625583; UI: 92326639


714: Ishii S, Murakami T, Shishido K.
A pSC101-par sequence-mediated study on the intracellular state of supercoiling
of the pBR322 genome in Escherichia coli DNA topoisomerase I deletion mutant.
FEMS Microbiol Lett. 1992 Jun 1;72(2):115-20.
PMID: 1324199; UI: 92371730


715: Jacquet MA, Reiss C.
In vivo control of promoter and terminator efficiencies at a distance.
Mol Microbiol. 1992 Jun;6(12):1681-91.
PMID: 1323024; UI: 92356832


716: Contreras A, Maxwell A.
gyrB mutations which confer coumarin resistance also affect DNA supercoiling and
ATP hydrolysis by Escherichia coli DNA gyrase.
Mol Microbiol. 1992 Jun;6(12):1617-24.
PMID: 1323022; UI: 92356825


717: Oram M, Fisher LM.
An Escherichia coli DNA topoisomerase I mutant has a compensatory mutation that
alters two residues between functional domains of the DNA gyrase A protein.
J Bacteriol. 1992 Jun;174(12):4175-8.
PMID: 1317847; UI: 92283777


718: Kranz RG, Beckman DL, Foster-Hartnett D.
DNA gyrase activities from Rhodobacter capsulatus: analysis of target(s) of
coumarins and cloning of the gyrB locus.
FEMS Microbiol Lett. 1992 May 15;72(1):25-32.
PMID: 1319375; UI: 92307401


719: Miki T, Park JA, Nagao K, Murayama N, Horiuchi T.
Control of segregation of chromosomal DNA by sex factor F in Escherichia coli.
Mutants of DNA gyrase subunit A suppress letD (ccdB) product growth inhibition.
J Mol Biol. 1992 May 5;225(1):39-52.
PMID: 1316444; UI: 92260536


720: Tamura JK, Bates AD, Gellert M.
Slow interaction of 5'-adenylyl-beta,gamma-imidodiphosphate with Escherichia
coli DNA gyrase. Evidence for cooperativity in nucleotide binding.
J Biol Chem. 1992 May 5;267(13):9214-22.
PMID: 1315750; UI: 92250521


721: DeMarini DM, Lawrence BK.
Prophage induction by DNA topoisomerase II poisons and reactive-oxygen species:
role of DNA breaks.
Mutat Res. 1992 May;267(1):1-17.
PMID: 1373845; UI: 92236685


722: Babinchak TJ, Fass RJ.
In vitro activity of DNA gyrase inhibitors, singly and in combination, against
Mycobacterium avium complex.
Diagn Microbiol Infect Dis. 1992 May-Jun;15(4):367-70.
PMID: 1319302; UI: 92306541


723: Fisher LM, Austin CA, Hopewell R, Margerrison EE, Oram M, Patel S, Plummer
K, Sng JH, Sreedharan S.
DNA supercoiling and relaxation by ATP-dependent DNA topoisomerases.
Philos Trans R Soc Lond B Biol Sci. 1992 Apr 29;336(1276):83-91. Review.
PMID: 1351300; UI: 92294241


724: Uphoff CC, Gignac SM, Drexler HG.
Mycoplasma contamination in human leukemia cell lines. II. Elimination with
various antibiotics.
J Immunol Methods. 1992 Apr 27;149(1):55-62.
PMID: 1316409; UI: 92259985


725: Hubschwerlen C, Pflieger P, Specklin JL, Gubernator K, Gmunder H, Angehrn
P, Kompis I.
Pyrimido[1,6-a]benzimidazoles: a new class of DNA gyrase inhibitors.
J Med Chem. 1992 Apr 17;35(8):1385-92.
PMID: 1315393; UI: 92243437


726: Fu KP, Lafredo SC, Foleno B, Isaacson DM, Barrett JF, Tobia AJ, Rosenthale
ME.
In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an
optically active ofloxacin.
Antimicrob Agents Chemother. 1992 Apr;36(4):860-6.
PMID: 1503449; UI: 92368190


727: Izu R, Gardeazabal J, Gonzalez M, Landa N, Raton JA, Diaz-Perez JL.
Enoxacin-induced photosensitivity: study of two cases.
Photodermatol Photoimmunol Photomed. 1992 Apr;9(2):86-8.
PMID: 1489723; UI: 93144166


728: Segreti J, Gootz TD, Goodman LJ, Parkhurst GW, Quinn JP, Martin BA,
Trenholme GM.
High-level quinolone resistance in clinical isolates of Campylobacter jejuni.
J Infect Dis. 1992 Apr;165(4):667-70.
PMID: 1313069; UI: 92202727


729: Sheehan BJ, Foster TJ, Dorman CJ, Park S, Stewart GS.
Osmotic and growth-phase dependent regulation of the eta gene of Staphylococcus
aureus: a role for DNA supercoiling.
Mol Gen Genet. 1992 Mar;232(1):49-57.
PMID: 1552902; UI: 92204134


730: Margerrison EE, Hopewell R, Fisher LM.
Nucleotide sequence of the Staphylococcus aureus gyrB-gyrA locus encoding the
DNA gyrase A and B proteins.
J Bacteriol. 1992 Mar;174(5):1596-603.
PMID: 1311298; UI: 92165734


731: Scheel O, Sandvik T, Hoel T, Aasen S.
[Tularemia in Norway. A clinical and epidemiological review].
Tidsskr Nor Laegeforen. 1992 Feb 20;112(5):635-7. Review. Norwegian.
PMID: 1557730; UI: 92213709


732: Lee MS, Wang JC, Beran M.
Two independent amsacrine-resistant human myeloid leukemia cell lines share an
identical point mutation in the 170 kDa form of human topoisomerase II.
J Mol Biol. 1992 Feb 20;223(4):837-43.
PMID: 1311390; UI: 92167262


733: Sanders CC.
Review of preclinical studies with ofloxacin.
Clin Infect Dis. 1992 Feb;14(2):526-38. Review.
PMID: 1554842; UI: 92208137


734: Drlica K.
Control of bacterial DNA supercoiling.
Mol Microbiol. 1992 Feb;6(4):425-33. Review.
PMID: 1313943; UI: 92219986


735: Sander J.
[Fluoroquinolones--a new and important group of antimicrobial agents].
Tidsskr Nor Laegeforen. 1992 Jan 30;112(3):346-9. Review. Norwegian.
PMID: 1553674; UI: 92205660


736: Rohner P, Peebo M, Lew DP, Auckenthaler R, Pechere JC.
Comparative in-vitro activity of new quinolones against clinical isolates and
resistant mutants.
J Antimicrob Chemother. 1992 Jan;29(1):41-8.
PMID: 1737723; UI: 92147511


737: DeMarini DM, Abu-Shakra A, Gupta R, Hendee LJ, Levine JG.
Molecular analysis of mutations induced by the intercalating agent ellipticine
at the hisD3052 allele of Salmonella typhimurium TA98.
Environ Mol Mutagen. 1992;20(1):12-8.
PMID: 1639078; UI: 92347353


738: Fiaccadori F.
[Fluoroquinolones: a new era in antibiotic therapy]?
Ann Ital Med Int. 1992 Jan-Mar;7(1):46-50. Review. Italian.
PMID: 1524947; UI: 92399121


739: Boheim K.
[Diagnosis and therapy of infectious otitis externa. An overview for the non-ENT
physician].
Wien Med Wochenschr. 1992;142(20-21):481-4. Review. German.
PMID: 1488848; UI: 93142396


740: Xu DK, Ding AZ, Yuan YS, Diao Y.
[Determination of ofloxacin in human plasma and studies of its pharmacokinetics
using HPLC method].
Yao Hsueh Hsueh Pao. 1992;27(6):462-6. Chinese.
PMID: 1442075; UI: 93071094


741: Baxa CA, Chiang L, Howe MM.
DNA sequence characterization of the G gene region of bacteriophage Mu.
DNA Seq. 1992;2(5):329-33.
PMID: 1385991; UI: 92338399


742: Chu DT, Hallas R, Clement JJ, Alder J, McDonald E, Plattner JJ.
Synthesis and antitumour activities of quinolone antineoplastic agents.
Drugs Exp Clin Res. 1992;18(7):275-82.
PMID: 1338309; UI: 93201959


743: Sato K, Hoshino K, Mitsuhashi S.
Mode of action of new quinolones: the inhibitory activity on DNA gyrase.
Prog Drug Res. 1992;38:121-32. Review. No abstract available.
PMID: 1319080; UI: 92302575


744: Batista S, Castro S, Aguilar OM, Martinez-Drets G.
Induction of C4-dicarboxylate transport genes by external stimuli in Rhizobium
meliloti.
Can J Microbiol. 1992 Jan;38(1):51-5.
PMID: 1316220; UI: 92257418


745: Tapsall JW, Shultz TR, Phillips EA.
Characteristics of Neisseria gonorrhoeae isolated in Australia showing decreased
sensitivity to quinolone antibiotics.
Pathology. 1992 Jan;24(1):27-31.
PMID: 1315946; UI: 92253247


746: Smith CM, Arany Z, Orrego C, Eisenstadt E.
Mutations in topA interfere with the inducible expression of DNA damage response
loci in Salmonella typhimurium.
Environ Mol Mutagen. 1992;19(3):185-94.
PMID: 1315267; UI: 92241265


747: Power EG, Munoz Bellido JL, Phillips I.
Detection of ciprofloxacin resistance in gram-negative bacteria due to
alterations in gyrA.
J Antimicrob Chemother. 1992 Jan;29(1):9-17.
PMID: 1310671; UI: 92147521


748: Cundliffe E.
Self-protection mechanisms in antibiotic producers.
Ciba Found Symp. 1992;171:199-208; discussion 208-14. Review.
PMID: 1302178; UI: 93251933


749: Molnar J, Foldeak S, Nakamura MJ, Rausch H, Domonkos K, Szabo M.
Antiplasmid activity: loss of bacterial resistance to antibiotics.
APMIS Suppl. 1992;30:24-31. Review.
PMID: 1295542; UI: 93199839


750: Furuno A, Kato M.
Topological alteration of plasmid DNA during cell growth of Escherichia coli.
Nucleic Acids Symp Ser. 1992;(27):157-8.
PMID: 1289801; UI: 93173626


751: Appelbaum PC.
Mechanisms and frequency of resistance to temafloxacin.
Am J Med. 1991 Dec 30;91(6A):27S-30S.
PMID: 1662892; UI: 92117029


752: Jiang H, Zacharias W, Amirhaeri S.
Potassium permanganate as an in situ probe for B-Z and Z-Z junctions.
Nucleic Acids Res. 1991 Dec 25;19(24):6943-8.
PMID: 1662368; UI: 92107685


753: Hofstetter A.
[Current chemotherapy in urogenital infections. 4: Gyrase inhibitors].
Fortschr Med. 1991 Dec 20;109(36):739. German. No abstract available.
PMID: 1663912; UI: 92137809


754: Mukhopadhyay G, Ghosh A.
Purification and properties of DNA gyrase from Vibrio cholerae.
Biochem J. 1991 Dec 15;280 ( Pt 3):797-800.
PMID: 1662488; UI: 92109684


755: Walker RC, Wright AJ.
The fluoroquinolones.
Mayo Clin Proc. 1991 Dec;66(12):1249-59. Review.
PMID: 1749294; UI: 92085738


756: Ishii H, Sato K, Hoshino K, Sato M, Yamaguchi A, Sawai T, Osada Y.
Active efflux of ofloxacin by a highly quinolone-resistant strain of Proteus
vulgaris.
J Antimicrob Chemother. 1991 Dec;28(6):827-36.
PMID: 1667782; UI: 92276121


757: Nakanishi N, Yoshida S, Wakebe H, Inoue M, Yamaguchi T, Mitsuhashi S.
Mechanisms of clinical resistance to fluoroquinolones in Staphylococcus aureus.
Antimicrob Agents Chemother. 1991 Dec;35(12):2562-7.
PMID: 1667255; UI: 92238683


758: Ozaki M, Matsuda M, Tomii Y, Kimura K, Kazuno K, Kitano M, Kise M, Shibata
K, Otsuki M, Nishino T.
In vitro antibacterial activity of a new quinolone, NM394.
Antimicrob Agents Chemother. 1991 Dec;35(12):2490-5.
PMID: 1667251; UI: 92238670


759: Lewin CS, Howard BM, Smith JT.
4-Quinolone interactions with gyrase subunit B inhibitors.
J Med Microbiol. 1991 Dec;35(6):358-62.
PMID: 1661337; UI: 92092247


760: Li MX, Yeung HW, Pan LP, Chan SI.
Trichosanthin, a potent HIV-1 inhibitor, can cleave supercoiled DNA in vitro.
Nucleic Acids Res. 1991 Nov 25;19(22):6309-12.
PMID: 1659689; UI: 92066485


761: Todd PA, Faulds D.
Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and
therapeutic use.
Drugs. 1991 Nov;42(5):825-76. Review.
PMID: 1723377; UI: 92137072


762: Singh M, John JF.
Isomeric DNA ladder formation of a plasmid encoding tobramycin resistance from
Escherichia coli.
J Antimicrob Chemother. 1991 Nov;28(5):627-37.
PMID: 1685732; UI: 92138455


763: Okuda J, Okamoto S, Takahata M, Nishino T.
Inhibitory effects of ciprofloxacin and sparfloxacin on DNA gyrase purified from
fluoroquinolone-resistant strains of methicillin-resistant Staphylococcus
aureus.
Antimicrob Agents Chemother. 1991 Nov;35(11):2288-93.
PMID: 1666495; UI: 92206834


764: Kumagai M, Ikeda H.
Molecular analysis of the recombination junctions of lambda bio transducing
phages.
Mol Gen Genet. 1991 Nov;230(1-2):60-4.
PMID: 1660569; UI: 92079920


765: Zhang MQ, Haemers A.
Quinolone antimicrobial agents: structure-activity relationships.
Pharmazie. 1991 Oct;46(10):687-700. Review.
PMID: 1803382; UI: 92204950


766: Sreedharan S, Peterson LR, Fisher LM.
Ciprofloxacin resistance in coagulase-positive and -negative staphylococci: role
of mutations at serine 84 in the DNA gyrase A protein of Staphylococcus aureus
and Staphylococcus epidermidis.
Antimicrob Agents Chemother. 1991 Oct;35(10):2151-4.
PMID: 1662027; UI: 92102204


767: del Castillo I, Vizan JL, Rodriguez-Sainz MC, Moreno F.
An unusual mechanism for resistance to the antibiotic coumermycin A1.
Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8860-4.
PMID: 1656457; UI: 92020950


768: Andrea JE, Adachi K, Morgan AR.
Fluorometric assays for DNA topoisomerases and topoisomerase-targeted drugs:
quantitation of catalytic activity and DNA cleavage.
Mol Pharmacol. 1991 Oct;40(4):495-501.
PMID: 1656189; UI: 92017675


769: Trucksis M, Wolfson JS, Hooper DC.
A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus.
J Bacteriol. 1991 Sep;173(18):5854-60.
PMID: 1653224; UI: 91358379


770: Hammond GG, Cassidy PJ, Overbye KM.
Novobiocin-dependent topA deletion mutants of Escherichia coli.
J Bacteriol. 1991 Sep;173(17):5564-7.
PMID: 1653212; UI: 91358338


771: Ishii S, Murakami T, Shishido K.
Gyrase inhibitors increase the content of knotted DNA species of plasmid pBR322
in Escherichia coli.
J Bacteriol. 1991 Sep;173(17):5551-3.
PMID: 1653211; UI: 91358335


772: Beaucage SL, Miller CA, Cohen SN.
Gyrase-dependent stabilization of pSC101 plasmid inheritance by
transcriptionally active promoters.
EMBO J. 1991 Sep;10(9):2583-8.
PMID: 1651231; UI: 91330882


773: MacAllister TW, Kelley WL, Miron A, Stenzel TT, Bastia D.
Replication of plasmid R6K origin gamma in vitro. Dependence on dual initiator
proteins and inhibition by transcription.
J Biol Chem. 1991 Aug 25;266(24):16056-62.
PMID: 1651932; UI: 91340755


774: Lei Y, Sato K, Nakae T.
Ofloxacin-resistant Pseudomonas aeruginosa mutants with elevated drug extrusion
across the inner membrane.
Biochem Biophys Res Commun. 1991 Aug 15;178(3):1043-8.
PMID: 1651710; UI: 91337037


775: Rakonjac J, Milic M, Savic DJ.
cysB and cysE mutants of Escherichia coli K12 show increased resistance to
novobiocin.
Mol Gen Genet. 1991 Aug;228(1-2):307-11.
PMID: 1886615; UI: 91360081


776: Zhvingila DIu, Bashkirov VI.
[The role of DNA-gyrase from Bacillus subtilis during intermolecular irregular
recombination].
Mol Gen Mikrobiol Virusol. 1991 Aug;(8):23-5. Russian.
PMID: 1664491; UI: 92149610


777: Yoshida H, Bogaki M, Nakamura M, Yamanaka LM, Nakamura S.
Quinolone resistance-determining region in the DNA gyrase gyrB gene of
Escherichia coli.
Antimicrob Agents Chemother. 1991 Aug;35(8):1647-50.
PMID: 1656869; UI: 92027669


778: Diver JM, Schollaardt T, Rabin HR, Thorson C, Bryan LE.
Persistence mechanisms in Pseudomonas aeruginosa from cystic fibrosis patients
undergoing ciprofloxacin therapy.
Antimicrob Agents Chemother. 1991 Aug;35(8):1538-46.
PMID: 1656866; UI: 92027650


779: Thomas W, Spell RM, Ming ME, Holm C.
Genetic analysis of the gyrase A-like domain of DNA topoisomerase II of
Saccharomyces cerevisiae.
Genetics. 1991 Aug;128(4):703-16.
PMID: 1655564; UI: 92009138


780: Slesarev AI, Zaitzev DA, Kopylov VM, Stetter KO, Kozyavkin SA.
DNA topoisomerase III from extremely thermophilic archaebacteria.
ATP-independent type I topoisomerase from Desulfurococcus amylolyticus drives
extensive unwinding of closed circular DNA at high temperature.
J Biol Chem. 1991 Jul 5;266(19):12321-8.
PMID: 1648092; UI: 91286250


781: Luttinger AL, Springer AL, Schmid MB.
A cluster of genes that affects nucleoid segregation in Salmonella typhimurium.
New Biol. 1991 Jul;3(7):687-97.
PMID: 1751451; UI: 92089025


782: Tanaka M, Sato K, Kimura Y, Hayakawa I, Osada Y, Nishino T.
Inhibition by quinolones of DNA gyrase from Staphylococcus aureus.
Antimicrob Agents Chemother. 1991 Jul;35(7):1489-91.
PMID: 1656864; UI: 92027636


783: Wigley DB, Davies GJ, Dodson EJ, Maxwell A, Dodson G.
Crystal structure of an N-terminal fragment of the DNA gyrase B protein.
Nature. 1991 Jun 20;351(6328):624-9.
PMID: 1646964; UI: 91270367


784: Hsieh LS, Burger RM, Drlica K.
Bacterial DNA supercoiling and [ATP]/[ADP]. Changes associated with a transition
to anaerobic growth.
J Mol Biol. 1991 Jun 5;219(3):443-50.
PMID: 1646892; UI: 91269321


785: Holmes ML, Nuttall SD, Dyall-Smith ML.
Construction and use of halobacterial shuttle vectors and further studies on
Haloferax DNA gyrase.
J Bacteriol. 1991 Jun;173(12):3807-13.
PMID: 1711028; UI: 91267947


786: Nakanishi N, Yoshida S, Wakebe H, Inoue M, Mitsuhashi S.
Mechanisms of clinical resistance to fluoroquinolones in Enterococcus faecalis.
Antimicrob Agents Chemother. 1991 Jun;35(6):1053-9.
PMID: 1656852; UI: 92027550


787: Bouthier de la Tour C, Portemer C, Huber R, Forterre P, Duguet M.
Reverse gyrase in thermophilic eubacteria.
J Bacteriol. 1991 Jun;173(12):3921-3.
PMID: 1646792; UI: 91267964


788: Hsieh LS, Rouviere-Yaniv J, Drlica K.
Bacterial DNA supercoiling and [ATP]/[ADP] ratio: changes associated with salt
shock.
J Bacteriol. 1991 Jun;173(12):3914-7.
PMID: 1646791; UI: 91267962


789: Stein DC.
Transformation of Neisseria gonorrhoeae: physical requirements of the
transforming DNA.
Can J Microbiol. 1991 May;37(5):345-9.
PMID: 1908744; UI: 91347161


790: Gocke E.
Mechanism of quinolone mutagenicity in bacteria.
Mutat Res. 1991 May;248(1):135-43.
PMID: 1851537; UI: 91232537


791: Kaatz GW, Seo SM, Ruble CA.
Mechanisms of fluoroquinolone resistance in Staphylococcus aureus.
J Infect Dis. 1991 May;163(5):1080-6.
PMID: 1850442; UI: 91210569


792: Ruberti I, Crescenzi F, Paolozzi L, Ghelardini P.
A class of gyrB mutants, substantially unaffected in DNA topology, suppresses
the Escherichia coli K12 ftsZ84 mutation.
Mol Microbiol. 1991 May;5(5):1065-72.
PMID: 1720186; UI: 92065801


793: Fabbri S, Broggini M, Pagella P, D'Incalci M.
The inhibition of supercoiling activity of DNA gyrase from Micrococcus luteus
caused by rufloxacin (MF 934) and MF 961.
J Antimicrob Chemother. 1991 May;27(5):687-9. No abstract available.
PMID: 1653205; UI: 91358174


794: Masecar BL, Robillard NJ.
Spontaneous quinolone resistance in Serratia marcescens due to a mutation in
gyrA.
Antimicrob Agents Chemother. 1991 May;35(5):898-902.
PMID: 1649573; UI: 91307268


795: Gootz TD, Martin BA.
Characterization of high-level quinolone resistance in Campylobacter jejuni.
Antimicrob Agents Chemother. 1991 May;35(5):840-5.
PMID: 1649570; UI: 91307259


796: Reece RJ, Maxwell A.
The C-terminal domain of the Escherichia coli DNA gyrase A subunit is a
DNA-binding protein.
Nucleic Acids Res. 1991 Apr 11;19(7):1399-405.
PMID: 1851291; UI: 91227126


797: Bryan LE, Bedard J.
Impermeability to quinolones in gram-positive and gram-negative bacteria.
Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):232-9. Review.
PMID: 1864283; UI: 91323333


798: Lilley DM, Higgins CF.
Local DNA topology and gene expression: the case of the leu-500 promoter.
Mol Microbiol. 1991 Apr;5(4):779-83. Review.
PMID: 1857204; UI: 91312113


799: Figueroa N, Wills N, Bossi L.
Common sequence determinants of the response of a prokaryotic promoter to DNA
bending and supercoiling.
EMBO J. 1991 Apr;10(4):941-9.
PMID: 1849077; UI: 91184141


800: Urios A, Herrera G, Aleixandre V, Blanco M.
Influence of recA mutations on gyrA dependent quinolone resistance.
Biochimie. 1991 Apr;73(4):519-21.
PMID: 1655054; UI: 92002342


801: Hooper DC, Wolfson JS.
Mode of action of the new quinolones: new data.
Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):223-31. Review.
PMID: 1650698; UI: 91323332


802: Scherzinger E, Haring V, Lurz R, Otto S.
Plasmid RSF1010 DNA replication in vitro promoted by purified RSF1010 RepA, RepB
and RepC proteins.
Nucleic Acids Res. 1991 Mar 25;19(6):1203-11.
PMID: 1851552; UI: 91232899


803: Moniot-Ville N, Guibert J, Moreau N, Acar JF, Collatz E, Gutmann L.
Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli
highly resistant to fluoroquinolones but susceptible to nalidixic acid.
Antimicrob Agents Chemother. 1991 Mar;35(3):519-23.
PMID: 2039202; UI: 91247782


804: Domagala JM, Bridges AJ, Culbertson TP, Gambino L, Hagen SE, Karrick G,
Porter K, Sanchez JP, Sesnie JA, Spense FG, et al.
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the
overwhelming influence of the remote N1-substituent in determining the
structure-activity relationship.
J Med Chem. 1991 Mar;34(3):1142-54.
PMID: 1848296; UI: 91162550


805: Michea-Hamzehpour M, Lucain C, Pechere JC.
Resistance to pefloxacin in Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1991 Mar;35(3):512-8.
PMID: 1645509; UI: 91247781


806: Bredberg A, Brant M, Jaszyk M.
Ciprofloxacin-induced inhibition of topoisomerase II in human lymphoblastoid
cells.
Antimicrob Agents Chemother. 1991 Mar;35(3):448-50.
PMID: 1645508; UI: 91247770


807: Reece RJ, Maxwell A.
Probing the limits of the DNA breakage-reunion domain of the Escherichia coli
DNA gyrase A protein.
J Biol Chem. 1991 Feb 25;266(6):3540-6.
PMID: 1847377; UI: 91139640


808: Jaworski A, Higgins NP, Wells RD, Zacharias W.
Topoisomerase mutants and physiological conditions control supercoiling and
Z-DNA formation in vivo.
J Biol Chem. 1991 Feb 5;266(4):2576-81.
PMID: 1846630; UI: 91115887


809: Petzinger E.
[Gyrase inhibitors, a new class of therapeutic drugs].
Tierarztl Prax. 1991 Feb;19(1):14-20. Review. German.
PMID: 2048102; UI: 91263041


810: Malkhosyan SR, Panchenko YuA, Rekesh AN.
A physiological role for DNA supercoiling in the anaerobic regulation of colicin
gene expression.
Mol Gen Genet. 1991 Feb;225(2):342-5.
PMID: 2005875; UI: 91172136


811: Kiely JS, Hutt MP, Culbertson TP, Bucsh RA, Worth DF, Lesheski LE,
Gogliotti RD, Sesnie JC, Solomon M, Mich TF.
Quinolone antibacterials: preparation and activity of bridged bicyclic analogues
of the C7-piperazine.
J Med Chem. 1991 Feb;34(2):656-63.
PMID: 1995890; UI: 91140594


812: McFall E, Nikam SS, Palchaudhuri S.
Effects of structural changes in the dsdA-dsdC intergenic region on D-serine
deaminase synthesis.
J Bacteriol. 1991 Feb;173(3):1161-7.
PMID: 1899415; UI: 91123189


813: Oram M, Fisher LM.
4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical
isolates identified by using the polymerase chain reaction.
Antimicrob Agents Chemother. 1991 Feb;35(2):387-9.
PMID: 1850972; UI: 91221620


814: Hallett P, Maxwell A.
Novel quinolone resistance mutations of the Escherichia coli DNA gyrase A
protein: enzymatic analysis of the mutant proteins.
Antimicrob Agents Chemother. 1991 Feb;35(2):335-40.
PMID: 1850970; UI: 91221607


815: Hoshino K, Sato K, Akahane K, Yoshida A, Hayakawa I, Sato M, Une T, Osada
Y.
Significance of the methyl group on the oxazine ring of ofloxacin derivatives in
the inhibition of bacterial and mammalian type II topoisomerases.
Antimicrob Agents Chemother. 1991 Feb;35(2):309-12.
PMID: 1850968; UI: 91221603


816: Vizan JL, Hernandez-Chico C, del Castillo I, Moreno F.
The peptide antibiotic microcin B17 induces double-strand cleavage of DNA
mediated by E. coli DNA gyrase.
EMBO J. 1991 Feb;10(2):467-76.
PMID: 1846808; UI: 91122055


817: Ghelardini P, Lauri P, Ruberti I, Orlando V, Paolozzi L.
Synchronous division induced in Escherichia coli K12 by phage Mu: analysis of
DNA topology and gene expression during the cell cycle.
Res Microbiol. 1991 Feb-Apr;142(2-3):259-67.
PMID: 1656496; UI: 92021788


818: von Freiesleben U, Rasmussen KV.
DNA replication in Escherichia coli gyrB(Ts) mutants analysed by flow cytometry.
Res Microbiol. 1991 Feb-Apr;142(2-3):223-7.
PMID: 1656495; UI: 92021783


819: Gilson E, Saurin W, Perrin D, Bachellier S, Hofnung M.
The BIME family of bacterial highly repetitive sequences.
Res Microbiol. 1991 Feb-Apr;142(2-3):217-22.
PMID: 1656494; UI: 92021782


820: Jackson AP, Maxwell A, Wigley DB.
Preliminary crystallographic analysis of the ATP-hydrolysing domain of the
Escherichia coli DNA gyrase B protein.
J Mol Biol. 1991 Jan 5;217(1):15-7.
PMID: 1846427; UI: 91108810


821: Kincade JM, deHaseth PL.
Bacteriophage lambda promoters pL and pR: sequence determinants of in vivo
activity and of sensitivity to the DNA gyrase inhibitor, coumermycin.
Gene. 1991 Jan 2;97(1):7-12.
PMID: 1847348; UI: 91138989


822: Goldstein EJ.
Prevention of bacterial resistance in urinary tract infections.
Eur Urol. 1991;19 Suppl 1:28-32. Review.
PMID: 2022230; UI: 91216172


823: Doco-Lecompte T.
[Biochemical, pharmacokinetic and bacteriologic properties of ofloxacin].
Acta Leprol. 1991;7(4):315-9. Review. French.
PMID: 1950439; UI: 92057563


824: Aleixandre V, Herrera G, Urios A, Blanco M.
Effects of ciprofloxacin on plasmid DNA supercoiling of Escherichia coli
topoisomerase I and gyrase mutants.
Antimicrob Agents Chemother. 1991 Jan;35(1):20-3.
PMID: 1849710; UI: 91197081


825: Holmes ML, Dyall-Smith ML.
Mutations in DNA gyrase result in novobiocin resistance in halophilic
archaebacteria.
J Bacteriol. 1991 Jan;173(2):642-8.
PMID: 1846146; UI: 91100352


826: Link A, Tempel K.
Inhibition of O6-alkylguanine-DNA alkyltransferase and DNase I activities in
vitro by some alkylating substances and antineoplastic agents.
J Cancer Res Clin Oncol. 1991;117(6):549-55.
PMID: 1720784; UI: 92078258


827: Lewin CS, Howard BM, Smith JT.
Protein- and RNA-synthesis independent bactericidal activity of ciprofloxacin
that involves the A subunit of DNA gyrase.
J Med Microbiol. 1991 Jan;34(1):19-22.
PMID: 1703579; UI: 91116609


828: Ramirez RM, Villarejo M.
Osmotic signal transduction to proU is independent of DNA supercoiling in
Escherichia coli.
J Bacteriol. 1991 Jan;173(2):879-85.
PMID: 1670937; UI: 91100380


829: Bashkirov VI, Zvingila DJ.
Sequence specificity of Bacillus subtilis DNA gyrase in vivo.
Genetica. 1991;85(1):3-12.
PMID: 1663896; UI: 92137724


830: Reece RJ, Maxwell A.
DNA gyrase: structure and function.
Crit Rev Biochem Mol Biol. 1991;26(3-4):335-75. Review.
PMID: 1657531; UI: 92036488


831: Bashkirov VI, Zhvingila DIu.
[Nucleotide sequences cleavable by Bacillus subtilis DNA gyrase in vivo].
Dokl Akad Nauk SSSR. 1991;316(5):1257-61. Russian. No abstract available.
PMID: 1653129; UI: 91356939


832: Condemine G, Smith CL.
Transcription regulates oxolinic acid-induced DNA gyrase cleavage at specific
sites on the E. coli chromosome.
Nucleic Acids Res. 1990 Dec 25;18(24):7389-96.
PMID: 2175434; UI: 91081328


833: Tamura JK, Gellert M.
Characterization of the ATP binding site on Escherichia coli DNA gyrase.
Affinity labeling of Lys-103 and Lys-110 of the B subunit by pyridoxal
5'-diphospho-5'-adenosine.
J Biol Chem. 1990 Dec 5;265(34):21342-9.
PMID: 2174443; UI: 91065955


834: Vance-Bryan K, Guay DR, Rotschafer JC.
Clinical pharmacokinetics of ciprofloxacin.
Clin Pharmacokinet. 1990 Dec;19(6):434-61. Review.
PMID: 2292168; UI: 91152963


835: Sreedharan S, Oram M, Jensen B, Peterson LR, Fisher LM.
DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus
aureus: close similarity with quinolone resistance mutations in Escherichia
coli.
J Bacteriol. 1990 Dec;172(12):7260-2.
PMID: 2174869; UI: 91072282


836: Bouthier de la Tour C, Portemer C, Nadal M, Stetter KO, Forterre P, Duguet
M.
Reverse gyrase, a hallmark of the hyperthermophilic archaebacteria.
J Bacteriol. 1990 Dec;172(12):6803-8.
PMID: 2174859; UI: 91072227


837: Drlica K.
Bacterial topoisomerases and the control of DNA supercoiling.
Trends Genet. 1990 Dec;6(12):433-7. Review.
PMID: 1965069; UI: 91205604


838: Crumplin GC.
Mechanisms of resistance to the 4-quinolone antibacterial agents.
J Antimicrob Chemother. 1990 Dec;26 Suppl F:131-44. Review.
PMID: 1963425; UI: 91154047


839: Huff AC, Kreuzer KN.
Evidence for a common mechanism of action for antitumor and antibacterial agents
that inhibit type II DNA topoisomerases.
J Biol Chem. 1990 Nov 25;265(33):20496-505.
PMID: 2173709; UI: 91056100


840: Pato ML, Howe MM, Higgins NP.
A DNA gyrase-binding site at the center of the bacteriophage Mu genome is
required for efficient replicative transposition.
Proc Natl Acad Sci U S A. 1990 Nov;87(22):8716-20.
PMID: 2174162; UI: 91062351


841: Reece RJ, Dauter Z, Wilson KS, Maxwell A, Wigley DB.
Preliminary crystallographic analysis of the breakage-reunion domain of the
Escherichia coli DNA gyrase A protein.
J Mol Biol. 1990 Oct 20;215(4):493-5.
PMID: 2172550; UI: 91039312


842: Kato J, Nishimura Y, Imamura R, Niki H, Hiraga S, Suzuki H.
New topoisomerase essential for chromosome segregation in E. coli.
Cell. 1990 Oct 19;63(2):393-404.
PMID: 2170028; UI: 91004247


843: Furet YX, Pechere JC.
Usual and unusual antibacterial effects of quinolones.
J Antimicrob Chemother. 1990 Oct;26 Suppl B:7-15. Review.
PMID: 2175306; UI: 91079106


844: Acar JF, Francoual S.
The clinical problems of bacterial resistance to the new quinolones.
J Antimicrob Chemother. 1990 Oct;26 Suppl B:207-13.
PMID: 2175305; UI: 91079098


845: Moreau NJ, Robaux H, Baron L, Tabary X.
Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and
II.
Antimicrob Agents Chemother. 1990 Oct;34(10):1955-60.
PMID: 1963290; UI: 91151056


846: Wolfson JS, Hooper DC, McHugh GL, Bozza MA, Swartz MN.
Mutants of Escherichia coli K-12 exhibiting reduced killing by both quinolone
and beta-lactam antimicrobial agents.
Antimicrob Agents Chemother. 1990 Oct;34(10):1938-43.
PMID: 1963289; UI: 91151053


847: Robillard NJ.
Broad-host-range gyrase A gene probe.
Antimicrob Agents Chemother. 1990 Oct;34(10):1889-94.
PMID: 1963286; UI: 91151045


848: Grosset J.
[Norfloxacin: a broad-spectrum quinolone for superficial eye infections].
Pathol Biol (Paris). 1990 Sep;38(7):735-41. French.
PMID: 2235090; UI: 91044565


849: Hallett P, Grimshaw AJ, Wigley DB, Maxwell A.
Cloning of the DNA gyrase genes under tac promoter control: overproduction of
the gyrase A and B proteins.
Gene. 1990 Sep 1;93(1):139-42.
PMID: 2172086; UI: 91033005


850: Tauchnitz C.
[Effective microbiologic spectrum of gyrase inhibitors--indications and
contraindications].
Z Gesamte Inn Med. 1990 Sep 1;45(17):509-12. Review. German.
PMID: 1963246; UI: 91150270


851: Jenkins JR, Pocklington MJ, Orr E.
The F1 ATP synthetase beta-subunit: a major yeast novobiocin binding protein.
J Cell Sci. 1990 Aug;96 ( Pt 4):675-82.
PMID: 2178164; UI: 91131709


852: Koo HS, Wu HY, Liu LF.
Effects of transcription and translation on gyrase-mediated DNA cleavage in
Escherichia coli.
J Biol Chem. 1990 Jul 25;265(21):12300-5.
PMID: 2165057; UI: 90324212


853: Carty M, Menzel R.
Inhibition of DNA gyrase activity in an in vitro transcription-translation
system stimulates gyrA expression in a DNA concentration dependent manner.
Evidence for the involvement of factors which may be titrated.
J Mol Biol. 1990 Jul 20;214(2):397-406.
PMID: 2166166; UI: 90339484


854: Kozyavkin SA, Slesarev AI, Malkhosyan SR, Panyutin IG.
DNA linking potential generated by gyrase.
Eur J Biochem. 1990 Jul 20;191(1):105-13.
PMID: 2165903; UI: 90336618


855: Lebeau L, Regnier E, Schultz P, Wang JC, Mioskowski C, Oudet P.
Two-dimensional crystallization of DNA gyrase B subunit on specifically designed
lipid monolayers.
FEBS Lett. 1990 Jul 2;267(1):38-42.
PMID: 2163898; UI: 90306403


856: Colman SD, Hu PC, Bott KF.
Mycoplasma pneumoniae DNA gyrase genes.
Mol Microbiol. 1990 Jul;4(7):1129-34.
PMID: 2172693; UI: 91041721


857: Osburne MS, Maiese WM, Greenstein M.
In vitro inhibition of bacterial DNA gyrase by cinodine, a
glycocinnamoylspermidine antibiotic.
Antimicrob Agents Chemother. 1990 Jul;34(7):1450-2.
PMID: 2167040; UI: 90351143


858: Kotera Y, Inoue M, Mitsuhashi S.
Activity of KB-5246 against outer membrane mutants of Escherichia coli and
Salmonella typhimurium.
Antimicrob Agents Chemother. 1990 Jul;34(7):1323-5.
PMID: 2167038; UI: 90351117


859: Kondo H, Taguchi M, Inoue Y, Sakamoto F, Tsukamoto G.
Synthesis and antibacterial activity of thiazolo-, oxazolo-, and
imidazolo[3,2-a][1,8]naphthyridinecarboxylic acids.
J Med Chem. 1990 Jul;33(7):2012-5.
PMID: 2163456; UI: 90300501


860: Yang CF, DasSarma S.
Transcriptional induction of purple membrane and gas vesicle synthesis in the
archaebacterium Halobacterium halobium is blocked by a DNA gyrase inhibitor.
J Bacteriol. 1990 Jul;172(7):4118-21.
PMID: 2163398; UI: 90299845


861: Yoshida H, Nakamura M, Bogaki M, Nakamura S.
Proportion of DNA gyrase mutants among quinolone-resistant strains of
Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1990 Jun;34(6):1273-5.
PMID: 2168149; UI: 90365483


862: Yoshida H, Bogaki M, Nakamura M, Nakamura S.
Quinolone resistance-determining region in the DNA gyrase gyrA gene of
Escherichia coli.
Antimicrob Agents Chemother. 1990 Jun;34(6):1271-2.
PMID: 2168148; UI: 90365482


863: Piddock LJ, Hall MC, Wise R.
Mechanism of action of lomefloxacin.
Antimicrob Agents Chemother. 1990 Jun;34(6):1088-93.
PMID: 2168142; UI: 90365446


864: Cullmann W.
[Causes of quinolone resistance in gram-negative bacteria].
Immun Infekt. 1990 Jun;18(3):80-8. Review. German.
PMID: 2165997; UI: 90337532


865: Shah PM.
[Should the use of gyrase inhibitors be limited to hospitals]?
Immun Infekt. 1990 Jun;18(3):69-70. German. No abstract available.
PMID: 2165996; UI: 90337530


866: Hopewell R, Oram M, Briesewitz R, Fisher LM.
DNA cloning and organization of the Staphylococcus aureus gyrA and gyrB genes:
close homology among gyrase proteins and implications for 4-quinolone action and
resistance.
J Bacteriol. 1990 Jun;172(6):3481-4.
PMID: 2160946; UI: 90264350


867: Galan JE, Curtiss R 3d.
Expression of Salmonella typhimurium genes required for invasion is regulated by
changes in DNA supercoiling.
Infect Immun. 1990 Jun;58(6):1879-85.
PMID: 2160435; UI: 90256273


868: Chamberland S, Malouin F, Rabin HR, Schollaardt T, Parr TR Jr, Bryan LE.
Persistence of Pseudomonas aeruginosa during ciprofloxacin therapy of a cystic
fibrosis patient: transient resistance to quinolones and protein F-deficiency.
J Antimicrob Chemother. 1990 Jun;25(6):995-1010.
PMID: 2115039; UI: 90316921


869: Kovalsky OI, Kozyavkin SA, Slesarev AI.
Archaebacterial reverse gyrase cleavage-site specificity is similar to that of
eubacterial DNA topoisomerases I.
Nucleic Acids Res. 1990 May 11;18(9):2801-5.
PMID: 2160070; UI: 90251458


870: DeVault JD, Kimbara K, Chakrabarty AM.
Pulmonary dehydration and infection in cystic fibrosis: evidence that ethanol
activates alginate gene expression and induction of mucoidy in Pseudomonas
aeruginosa.
Mol Microbiol. 1990 May;4(5):737-45.
PMID: 2167423; UI: 90355834


871: Thomas A, Tocher J, Edwards DI.
Electrochemical characteristics of five quinolone drugs and their effect on DNA
damage and repair in Escherichia coli.
J Antimicrob Chemother. 1990 May;25(5):733-44.
PMID: 2165050; UI: 90324139


872: Wickner SH.
Three Escherichia coli heat shock proteins are required for P1 plasmid DNA
replication: formation of an active complex between E. coli DnaJ protein and the
P1 initiator protein.
Proc Natl Acad Sci U S A. 1990 Apr;87(7):2690-4.
PMID: 2181445; UI: 90207262


873: Llanes C, Michel-Briand Y, Thouverez M, Bailly C, Grimont F.
Stability of conjugative and non-conjugative R-plasmids from Serratia marcescens
to gyrase inhibitors.
Microbiologica. 1990 Apr;13(2):157-9.
PMID: 2161994; UI: 90279550


874: Urios A, Herrera G, Aleixandre V, Blanco M.
Expression of the recA gene is reduced in Escherichia coli topoisomerase I
mutants.
Mutat Res. 1990 Apr;243(4):267-72.
PMID: 2157980; UI: 90220717


875: Shyamala V, Schneider E, Ames GF.
Tandem chromosomal duplications: role of REP sequences in the recombination
event at the join-point.
EMBO J. 1990 Mar;9(3):939-46.
PMID: 2178927; UI: 90183995


876: Suciu D.
Inhibition of DNA synthesis and cytotoxic effects of some DNA topoisomerase II
and gyrase inhibitors in Chinese hamster V79 cells.
Mutat Res. 1990 Mar;243(3):213-8.
PMID: 2155387; UI: 90174210


877: Ogura T, Niki H, Mori H, Morita M, Hasegawa M, Ichinose C, Hiraga S.
Identification and characterization of gyrB mutants of Escherichia coli that are
defective in partitioning of mini-F plasmids.
J Bacteriol. 1990 Mar;172(3):1562-8.
PMID: 2155204; UI: 90170875


878: Hallett P, Mehlert A, Maxwell A.
Escherichia coli cells resistant to the DNA gyrase inhibitor, ciprofloxacin,
overproduce a 60 kD protein homologous to GroEL.
Mol Microbiol. 1990 Mar;4(3):345-53.
PMID: 1972534; UI: 90286912


879: Harder S, Shah PM, Staib AH.
[Gyrase inhibitors. Central nervous side effects and inhibition of
methylxanthine elimination].
Dtsch Med Wochenschr. 1990 Feb 16;115(7):270-3. Review. German. No abstract
available.
PMID: 2406120; UI: 90151471


880: Bottomley PJ, Maggard SP.
Determination of viability within serotypes of a soil population of Rhizobium
leguminosarum bv. trifolii.
Appl Environ Microbiol. 1990 Feb;56(2):533-40.
PMID: 2407187; UI: 90165406


881: Miura-Masuda A, Ikeda H.
The DNA gyrase of Escherichia coli participates in the formation of a
spontaneous deletion by recA-independent recombination in vivo.
Mol Gen Genet. 1990 Feb;220(3):345-52.
PMID: 2160049; UI: 90251242


882: Masecar BL, Celesk RA, Robillard NJ.
Analysis of acquired ciprofloxacin resistance in a clinical strain of
Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1990 Feb;34(2):281-6.
PMID: 2158277; UI: 90225762


883: Slesarev AI, Kozyavkin SA.
DNA substrate specificity of reverse gyrase from extremely thermophilic
archaebacteria.
J Biomol Struct Dyn. 1990 Feb;7(4):935-42.
PMID: 2155623; UI: 90180274


884: Gupta R.
Tests for the genotoxicity of m-AMSA, etoposide, teniposide and ellipticine in
Neurospora crassa.
Mutat Res. 1990 Feb;240(2):47-58.
PMID: 2137196; UI: 90136678


885: Holmes ML, Dyall-Smith ML.
A plasmid vector with a selectable marker for halophilic archaebacteria.
J Bacteriol. 1990 Feb;172(2):756-61.
PMID: 2105303; UI: 90130312


886: Dimri GP, Das HK.
Cloning and sequence analysis of gyrA gene of Klebsiella pneumoniae.
Nucleic Acids Res. 1990 Jan 11;18(1):151-6.
PMID: 2155395; UI: 90174909


887: Krueger S, Zaccai G, Wlodawer A, Langowski J, O'Dea M, Maxwell A, Gellert
M.
Neutron and light-scattering studies of DNA gyrase and its complex with DNA.
J Mol Biol. 1990 Jan 5;211(1):211-20.
PMID: 2153834; UI: 90133951


888: Nakanishi N, Inoue M, Inoue K, Yamaguchi T, Mitsuhashi S.
In vitro activity of temafloxacin hydrochloride (TA-167 or A-62254), a new
fluorinated 4-quinolone.
Chemotherapy. 1990;36(5):345-55.
PMID: 2209168; UI: 91005434


889: Radl S.
Structure-activity relationships in DNA gyrase inhibitors.
Pharmacol Ther. 1990;48(1):1-17. Review.
PMID: 2177203; UI: 91110723


890: Fujimoto T, Mitsuhashi S.
In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin.
Chemotherapy. 1990;36(4):268-76.
PMID: 2174762; UI: 91071001


891: Zimmer C, Storl K, Storl J.
Microbial DNA topoisomerases and their inhibition by antibiotics.
J Basic Microbiol. 1990;30(3):209-24. Review.
PMID: 2164580; UI: 90317774


892: Baquero F.
Resistance to quinolones in gram-negative microorganisms: mechanisms and
prevention.
Eur Urol. 1990;17 Suppl 1:3-12. Review.
PMID: 2162298; UI: 90284516


893: Polonyi J, Ebringer L, Krajcovic J, Kapeller K.
Injured mitochondria in cells of Euglena gracilis after DNA gyrase inhibitors
treatment.
Z Mikrosk Anat Forsch. 1990;104(1):61-78.
PMID: 2161591; UI: 90273753


894: Hiraga S, Ogura T, Niki H, Ichinose C, Mori H.
Positioning of replicated chromosomes in Escherichia coli.
J Bacteriol. 1990 Jan;172(1):31-9.
PMID: 2152907; UI: 90094234


895: Portoles M, Igual A, Jauch A, Nos-Barbera S.
In vitro toxicity of lomefloxacin in rabbit corneal epithelial cell cultures.
Lens Eye Toxic Res. 1990;7(3-4):469-80.
PMID: 2100173; UI: 91299688


896: Westerhoff HV, van Workum M.
Control of DNA structure and gene expression.
Biomed Biochim Acta. 1990;49(8-9):839-53.
PMID: 1964556; UI: 91190131


897: Lutz H, Lenarz T, Gotz R.
Ototoxicity of gyrase antagonist ciprofloxacin?
Adv Otorhinolaryngol. 1990;45:175-80. No abstract available.
PMID: 1964023; UI: 91173966


898: Hooper DC, Wolfson JS.
Bacterial resistance to the quinolone antimicrobial agents.
Am J Med. 1989 Dec 29;87(6C):17S-23S. Review.
PMID: 2690616; UI: 90102513


899: Neu HC.
Chemical evolution of the fluoroquinolone antimicrobial agents.
Am J Med. 1989 Dec 29;87(6C):2S-9S.
PMID: 2557762; UI: 90102514


900: Lee MP, Sander M, Hsieh T.
Nuclease protection by Drosophila DNA topoisomerase II. Enzyme/DNA contacts at
the strong topoisomerase II cleavage sites.
J Biol Chem. 1989 Dec 25;264(36):21779-87.
PMID: 2557338; UI: 90094354


901: Wolfson JS.
Quinolone antimicrobial agents: adverse effects and bacterial resistance.
Eur J Clin Microbiol Infect Dis. 1989 Dec;8(12):1080-92. Review.
PMID: 2559848; UI: 90151698


902: Franco RJ, Drlica K.
Gyrase inhibitors can increase gyrA expression and DNA supercoiling.
J Bacteriol. 1989 Dec;171(12):6573-9.
PMID: 2556367; UI: 90078100


903: Fisher LM, Lawrence JM, Josty IC, Hopewell R, Margerrison EE, Cullen ME.
Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action
and resistance.
Am J Med. 1989 Nov 30;87(5A):2S-8S.
PMID: 2574005; UI: 90072175


904: Reece RJ, Maxwell A.
Tryptic fragments of the Escherichia coli DNA gyrase A protein.
J Biol Chem. 1989 Nov 25;264(33):19648-53.
PMID: 2555327; UI: 90062062


905: Sumantran VN, Tranguch AJ, Datta P.
Increased expression of biodegradative threonine dehydratase of Escherichia coli
by DNA gyrase inhibitors.
FEMS Microbiol Lett. 1989 Nov;53(1-2):37-40.
PMID: 2558950; UI: 90128192


906: Kojima T, Inoue M, Mitsuhashi S.
In vitro activity of AT-4140 against clinical bacterial isolates.
Antimicrob Agents Chemother. 1989 Nov;33(11):1980-8.
PMID: 2558617; UI: 90120562


907: Krajcovic J, Ebringer L, Polonyi J.
Quinolones and coumarins eliminate chloroplasts from Euglena gracilis.
Antimicrob Agents Chemother. 1989 Nov;33(11):1883-9.
PMID: 2558612; UI: 90120545


908: Watanabe M, Inoue M, Mitsuhashi S.
In vitro activity of amifloxacin against outer membrane mutants of the family
Enterobacteriaceae and frequency of spontaneous resistance.
Antimicrob Agents Chemother. 1989 Nov;33(11):1837-40.
PMID: 2558611; UI: 90120536


909: Hoffmann M.
[Local treatment of Pseudomonas aeruginosa infection of the external ear canal
with the gyrase inhibitor Tarivid].
Laryngorhinootologie. 1989 Nov;68(11):643. German. No abstract available.
PMID: 2513817; UI: 90104442


910: Wolfson JS, Hooper DC.
Fluoroquinolone antimicrobial agents.
Clin Microbiol Rev. 1989 Oct;2(4):378-424. Review.
PMID: 2680058; UI: 90030169


911: Aleixandre V, Urios A, Herrera G, Blanco M.
New Escherichia coli gyrA and gyrB mutations which have a graded effect on DNA
supercoiling.
Mol Gen Genet. 1989 Oct;219(1-2):306-12.
PMID: 2559316; UI: 90136521


912: Hoshino K, Sato K, Une T, Osada Y.
Inhibitory effects of quinolones on DNA gyrase of Escherichia coli and
topoisomerase II of fetal calf thymus.
Antimicrob Agents Chemother. 1989 Oct;33(10):1816-8.
PMID: 2556080; UI: 90072997


913: Barrett JF, Gootz TD, McGuirk PR, Farrell CA, Sokolowski SA.
Use of in vitro topoisomerase II assays for studying quinolone antibacterial
agents.
Antimicrob Agents Chemother. 1989 Oct;33(10):1697-703.
PMID: 2556075; UI: 90072975


914: Jaxel C, Nadal M, Mirambeau G, Forterre P, Takahashi M, Duguet M.
Reverse gyrase binding to DNA alters the double helix structure and produces
single-strand cleavage in the absence of ATP.
EMBO J. 1989 Oct;8(10):3135-9.
PMID: 2555155; UI: 90059901


915: Parada CA, Marians KJ.
Transcriptional activation of pBR322 DNA can lead to duplex DNA unwinding
catalyzed by the Escherichia coli preprimosome.
J Biol Chem. 1989 Sep 5;264(25):15120-9.
PMID: 2475495; UI: 89359328


916: Cook DN, Armstrong GA, Hearst JE.
Induction of anaerobic gene expression in Rhodobacter capsulatus is not
accompanied by a local change in chromosomal supercoiling as measured by a novel
assay.
J Bacteriol. 1989 Sep;171(9):4836-43.
PMID: 2768190; UI: 89359117


917: Akaboshi E, Howard-Flanders P.
Proteins induced by DNA-damaging agents in cultured Drosophila cells.
Mutat Res. 1989 Sep;227(1):1-6.
PMID: 2570350; UI: 89364965


918: Thiara AS, Cundliffe E.
Interplay of novobiocin-resistant and -sensitive DNA gyrase activities in
self-protection of the novobiocin producer, Streptomyces sphaeroides.
Gene. 1989 Sep 1;81(1):65-72.
PMID: 2553539; UI: 90034187


919: Graeme-Cook KA, May G, Bremer E, Higgins CF.
Osmotic regulation of porin expression: a role for DNA supercoiling.
Mol Microbiol. 1989 Sep;3(9):1287-94.
PMID: 2552265; UI: 90014189


920: Arnold GF, Phillips TA, Tessman I.
Levels of DNA topoisomerases, single-stranded-DNA-binding protein, and DNA
polymerase I in rho+ and rho-15 strains of Escherichia coli.
J Bacteriol. 1989 Sep;171(9):5183-6.
PMID: 2549016; UI: 89359167


921: Menzel R.
A microtiter plate-based system for the semiautomated growth and assay of
bacterial cells for beta-galactosidase activity.
Anal Biochem. 1989 Aug 15;181(1):40-50.
PMID: 2510548; UI: 90054316


922: McEachern F, Fisher LM.
Regulation of DNA supercoiling in Escherichia coli: genetic basis of a
compensatory mutation in DNA gyrase.
FEBS Lett. 1989 Aug 14;253(1-2):67-70.
PMID: 2547660; UI: 89338760


923: White JH, Gallo R, Bauer WR.
Dependence of the linking deficiency of supercoiled minichromosomes upon
nucleosome distortion.
Nucleic Acids Res. 1989 Jul 25;17(14):5827-35.
PMID: 2762154; UI: 89345171


924: Landini P, Pagani L, Debiaggi M, Cereda PM, Romero E.
Modification of norfloxacin inhibition of DNA gyrase induced by a 28 KDal DNA
binding protein.
Microbiologica. 1989 Jul;12(3):247-55.
PMID: 2550742; UI: 89384237


925: Wolfson JS, Hooper DC.
Bacterial resistance to quinolones: mechanisms and clinical importance.
Rev Infect Dis. 1989 Jul-Aug;11 Suppl 5:S960-8. Review.
PMID: 2549610; UI: 89368572


926: Hooper DC, Wolfson JS.
Mode of action of the quinolone antimicrobial agents: review of recent
information.
Rev Infect Dis. 1989 Jul-Aug;11 Suppl 5:S902-11. Review.
PMID: 2549608; UI: 89368569


927: Sorgel F.
Metabolism of gyrase inhibitors.
Rev Infect Dis. 1989 Jul-Aug;11 Suppl 5:S1119-29. Review.
PMID: 2549606; UI: 89368550


928: Ratet P, Pawlowski K, Schell J, de Bruijn FJ.
The Azorhizobium caulinodans nitrogen-fixation regulatory gene, nifA, is
controlled by the cellular nitrogen and oxygen status.
Mol Microbiol. 1989 Jun;3(6):825-38.
PMID: 2664425; UI: 89313312


929: Bates AD, Maxwell A.
DNA gyrase can supercoil DNA circles as small as 174 base pairs.
EMBO J. 1989 Jun;8(6):1861-6.
PMID: 2548859; UI: 89356663


930: Lucain C, Regamey P, Bellido F, Pechere JC.
Resistance emerging after pefloxacin therapy of experimental Enterobacter
cloacae peritonitis.
Antimicrob Agents Chemother. 1989 Jun;33(6):937-43.
PMID: 2548441; UI: 89350142


931: Cullen ME, Wyke AW, Kuroda R, Fisher LM.
Cloning and characterization of a DNA gyrase A gene from Escherichia coli that
confers clinical resistance to 4-quinolones.
Antimicrob Agents Chemother. 1989 Jun;33(6):886-94.
PMID: 2548439; UI: 89350134


932: Schildger BJ, Zschock M, Gobel T.
[O-serovar distribution and antibiotic sensitivity of Pseudomonas aeruginosa
strains from birds and reptiles].
Zentralbl Veterinarmed [B]. 1989 Jun;36(4):292-6. German.
PMID: 2503958; UI: 89348619


933: Reddy KJ, Masamoto K, Sherman DM, Sherman LA.
DNA sequence and regulation of the gene (cbpA) encoding the 42-kilodalton
cytoplasmic membrane carotenoprotein of the cyanobacterium Synechococcus sp.
strain PCC 7942.
J Bacteriol. 1989 Jun;171(6):3486-93.
PMID: 2498292; UI: 89255122


934: Norton VG, Imai BS, Yau P, Bradbury EM.
Histone acetylation reduces nucleosome core particle linking number change.
Cell. 1989 May 5;57(3):449-57.
PMID: 2541913; UI: 89249307


935: Sioud M, Forterre P.
Ciprofloxacin and etoposide (VP16) produce a similar pattern of DNA cleavage in
a plasmid of an archaebacterium.
Biochemistry. 1989 May 2;28(9):3638-41.
PMID: 2751986; UI: 89323064


936: Shen LL, Mitscher LA, Sharma PN, O'Donnell TJ, Chu DW, Cooper CS, Rosen T,
Pernet AG.
Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative
drug--DNA binding model.
Biochemistry. 1989 May 2;28(9):3886-94.
PMID: 2546585; UI: 89323096


937: Shen LL, Baranowski J, Pernet AG.
Mechanism of inhibition of DNA gyrase by quinolone antibacterials: specificity
and cooperativity of drug binding to DNA.
Biochemistry. 1989 May 2;28(9):3879-85.
PMID: 2546584; UI: 89323095


938: Rosen T, Fernandes PB, Marovich MA, Shen L, Mao J, Pernet AG.
Aromatic dienoyl tetramic acids. Novel antibacterial agents with activity
against anaerobes and staphylococci.
J Med Chem. 1989 May;32(5):1062-9.
PMID: 2709374; UI: 89216812


939: Wolfson JS, Hooper DC, Shih DJ, McHugh GL, Swartz MN.
Isolation and characterization of an Escherichia coli strain exhibiting partial
tolerance to quinolones.
Antimicrob Agents Chemother. 1989 May;33(5):705-9.
PMID: 2665642; UI: 89321454


940: Novak PD, Maier RJ.
Hydrogenase synthesis in Bradyrhizobium japonicum Hupc mutants is altered in
sensitivity to DNA gyrase inhibitors.
Appl Environ Microbiol. 1989 May;55(5):1157-64.
PMID: 2547335; UI: 89334341


941: Fujimaki K, Fujii T, Aoyama H, Sato K, Inoue Y, Inoue M, Mitsuhashi S.
Quinolone resistance in clinical isolates of Serratia marcescens.
Antimicrob Agents Chemother. 1989 May;33(5):785-7.
PMID: 2546493; UI: 89321472


942: Zylicz M, Ang D, Liberek K, Georgopoulos C.
Initiation of lambda DNA replication with purified host- and
bacteriophage-encoded proteins: the role of the dnaK, dnaJ and grpE heat shock
proteins.
EMBO J. 1989 May;8(5):1601-8.
PMID: 2527744; UI: 89356630


943: Adler D, Maier H.
Gyrase inhibitor ciprofloxacin in human parotid saliva.
J Clin Chem Clin Biochem. 1989 Apr;27(4):232-3.
PMID: 2738528; UI: 89292975


944: Lodge JK, Kazic T, Berg DE.
Formation of supercoiling domains in plasmid pBR322.
J Bacteriol. 1989 Apr;171(4):2181-7.
PMID: 2649489; UI: 89197793


945: Dorman CJ, Lynch AS, Bhriain NN, Higgins CF.
DNA supercoiling in Escherichia coli: topA mutations can be suppressed by DNA
amplifications involving the tolC locus.
Mol Microbiol. 1989 Apr;3(4):531-40.
PMID: 2548062; UI: 89343639


946: Hooper DC, Wolfson JS, Tung C, Souza KS, Swartz MN.
Effects of inhibition of the B subunit of DNA gyrase on conjugation in
Escherichia coli.
J Bacteriol. 1989 Apr;171(4):2235-7.
PMID: 2539364; UI: 89197803


947: Biek DP, Cohen SN.
Involvement of integration host factor (IHF) in maintenance of plasmid pSC101 in
Escherichia coli: mutations in the topA gene allow pSC101 replication in the
absence of IHF.
J Bacteriol. 1989 Apr;171(4):2066-74.
PMID: 2539359; UI: 89197776


948: Shapiro TA, Klein VA, Englund PT.
Drug-promoted cleavage of kinetoplast DNA minicircles. Evidence for type II
topoisomerase activity in trypanosome mitochondria.
J Biol Chem. 1989 Mar 5;264(7):4173-8.
PMID: 2537308; UI: 89139492


949: Ghelardini P, Liebart JC, Paolozzi L, Pedrini AM.
Suppression of the thermosensitive DNA ligase mutations in Escherichia coli K12
through modulation of gene expression induced by phage Mu.
Mol Gen Genet. 1989 Mar;216(1):31-6.
PMID: 2543906; UI: 89281487


950: Tomono M, Shiozaki M, Ikeda H.
Formation of lambda transducing phage in vitro: involvement of DNA gyrase.
J Biochem (Tokyo). 1989 Mar;105(3):423-8.
PMID: 2543660; UI: 89278067


951: Higgins NP, Collier DA, Kilpatrick MW, Krause HM.
Supercoiling and integration host factor change the DNA conformation and alter
the flow of convergent transcription in phage Mu.
J Biol Chem. 1989 Feb 15;264(5):3035-42.
PMID: 2644278; UI: 89123412


952: Shen LL, Kohlbrenner WE, Weigl D, Baranowski J.
Mechanism of quinolone inhibition of DNA gyrase. Appearance of unique
norfloxacin binding sites in enzyme-DNA complexes.
J Biol Chem. 1989 Feb 15;264(5):2973-8.
PMID: 2536729; UI: 89123402


953: Mensa-Wilmot K, Seaby R, Alfano C, Wold MC, Gomes B, McMacken R.
Reconstitution of a nine-protein system that initiates bacteriophage lambda DNA
replication.
J Biol Chem. 1989 Feb 15;264(5):2853-61.
PMID: 2536726; UI: 89123385


954: Bryan LE, Bedard J, Wong S, Chamberland S.
Quinolone antimicrobial agents: mechanism of action and resistance development.
Clin Invest Med. 1989 Feb;12(1):14-9. Review.
PMID: 2537696; UI: 89151961


955: Wyckoff E, Natalie D, Nolan JM, Lee M, Hsieh T.
Structure of the Drosophila DNA topoisomerase II gene. Nucleotide sequence and
homology among topoisomerases II.
J Mol Biol. 1989 Jan 5;205(1):1-13.
PMID: 2538621; UI: 89178626


956: Sorgel F, Naber KG, Metz R, Morgenroth A.
[Enoxacin--comparative pharmacokinetics and tissue penetration].
Infection. 1989;17 Suppl 1:S14-8. Review. German.
PMID: 2680989; UI: 90035494


957: Underner M, Grignon B, Roblot F, Meurice JC, Patte F.
[Fluoroquinolones: pharmacology, antibacterial spectrum and indications in
pneumology].
Rev Pneumol Clin. 1989;45(1):14-22. Review. French.
PMID: 2662344; UI: 89298012


958: Kolchanov NA, Kel' AE, Solov'ev VV.
[Statistical evidence for the correlation of DNA deletions in prokaryotic
genomes with direct repeats].
Mol Biol (Mosk). 1989 Jan-Feb;23(1):175-83. Russian.
PMID: 2661991; UI: 89295413


959: Kerschmann RL, Wolfson JS, McHugh GL, Dickersin GR, Hooper DC, Swartz MN.
Novobiocin-induced ultrastructural changes and antagonism of DNA synthesis in
Trypanosoma cruzi amastigotes growing in cell-free medium.
J Protozool. 1989 Jan-Feb;36(1):14-20.
PMID: 2651651; UI: 89216639


960: Drlica K, Coughlin S.
Inhibitors of DNA gyrase.
Pharmacol Ther. 1989;44(1):107-21. Review. No abstract available.
PMID: 2562411; UI: 92052489


961: Llanes C, Michel-Briand Y, Couturier M, Thouverez M, Bailly C.
[Antibiotic resistance plasmids from Serratia marcescens and their elimination
by DNA-gyrase inhibitors].
C R Seances Soc Biol Fil. 1989;183(3):240-6. French.
PMID: 2557972; UI: 90106255


962: Forterre P, Elie C, Sioud M, Hamal A.
Studies on DNA polymerases and topoisomerases in archaebacteria.
Can J Microbiol. 1989 Jan;35(1):228-33.
PMID: 2541877; UI: 89248687


963: Neu HC.
Clinical utility of DNA gyrase inhibitors.
Pharmacol Ther. 1989;41(1-2):207-21. Review.
PMID: 2540495; UI: 89221147


964: Holden HE, Barett JF, Huntington CM, Muehlbauer PA, Wahrenburg MG.
Genetic profile of a nalidixic acid analog: a model for the mechanism of sister
chromatid exchange induction.
Environ Mol Mutagen. 1989;13(3):238-52.
PMID: 2539998; UI: 89210834


965: Nadal M, Jaxel C, Portemer C, Forterre P, Mirambeau G, Duguet M.
Reverse gyrase of Sulfolobus: purification to homogeneity and characterization.
Biochemistry. 1988 Dec 27;27(26):9102-8.
PMID: 2853975; UI: 89207497


966: Kaneko M, Horikoshi J.
Nalidixic acid and oxolinic acid reversibly suppress
3-methylcholanthrene-induced cell transformation of BALB/3T3 mouse cells.
Int J Cancer. 1988 Dec 15;42(6):913-6.
PMID: 3192335; UI: 89053535


967: Parham C, Cunningham E, McGinnis E.
Differential effects of DNA gyrase inhibitors on the genetic transformation of
Neisseria gonorrhoeae.
Antimicrob Agents Chemother. 1988 Dec;32(12):1788-92.
PMID: 2854452; UI: 89227095


968: Figueroa N, Bossi L.
Transcription induces gyration of the DNA template in Escherichia coli.
Proc Natl Acad Sci U S A. 1988 Dec;85(24):9416-20.
PMID: 2849103; UI: 89071709


969: Yang Y, Ames GF.
DNA gyrase binds to the family of prokaryotic repetitive extragenic palindromic
sequences.
Proc Natl Acad Sci U S A. 1988 Dec;85(23):8850-4.
PMID: 2848243; UI: 89057836


970: Dixon RA, Henderson NC, Austin S.
DNA supercoiling and aerobic regulation of transcription from the Klebsiella
pneumoniae nifLA promoter.
Nucleic Acids Res. 1988 Nov 11;16(21):9933-46.
PMID: 3057450; UI: 89057524


971: Pinkney M, Diaz R, Lanka E, Thomas CM.
Replication of mini RK2 plasmid in extracts of Escherichia coli requires
plasmid-encoded protein TrfA and host-encoded proteins DnaA, B, G DNA gyrase and
DNA polymerase III.
J Mol Biol. 1988 Oct 20;203(4):927-38.
PMID: 2850370; UI: 89094869


972: Aoyama H, Inoue M, Mitsuhashi S.
In-vitro and in-vivo antibacterial activity of fleroxacin, a new fluorinated
quinolone.
J Antimicrob Chemother. 1988 Oct;22 Suppl D:99-114.
PMID: 2849604; UI: 89079595


973: Sekiguchi JA, Kmiec EB.
Studies on DNA topoisomerase activity during in vitro chromatin assembly.
Mol Cell Biochem. 1988 Oct;83(2):195-205.
PMID: 2849054; UI: 89070562


974: DiGate RJ, Marians KJ.
Identification of a potent decatenating enzyme from Escherichia coli.
J Biol Chem. 1988 Sep 15;263(26):13366-73.
PMID: 2843517; UI: 88330843


975: Piddock LJ, Wise R.
The selection and frequency of streptococci with decreased susceptibility to
ofloxacin compared with other quinolones.
J Antimicrob Chemother. 1988 Sep;22 Suppl C:45-51.
PMID: 3182461; UI: 89033455


976: Barabanshchikov BI, Malkov SV, Belov IS, Khabibullina GN.
[Reduced frequency of homologous recombination in Bacillus subtilis mutants
resistant to novobiocin].
Mol Gen Mikrobiol Virusol. 1988 Sep;(9):39-43. Russian.
PMID: 3145419; UI: 89097023


977: Kaatz GW, Seo SM.
Mechanism of ciprofloxacin resistance in Pseudomonas aeruginosa.
J Infect Dis. 1988 Sep;158(3):537-41.
PMID: 3137271; UI: 88315845


978: Kumaresan KR, Jayaraman R.
SOS independent survival against mitomycin C induced lethality in a
rifampicin-nalidixic acid-resistant mutant of Escherichia coli.
Mutat Res. 1988 Sep;194(2):109-20.
PMID: 3045531; UI: 88318763


979: Arnold GF, Tessman I.
Regulation of DNA superhelicity by rpoB mutations that suppress defective
Rho-mediated transcription termination in Escherichia coli.
J Bacteriol. 1988 Sep;170(9):4266-71.
PMID: 3045090; UI: 88314928


980: Saing KM, Orii H, Tanaka Y, Yanagisawa K, Miura A, Ikeda H.
Formation of deletion in Escherichia coli between direct repeats located in the
long inverted repeats of a cellular slime mold plasmid: participation of DNA
gyrase.
Mol Gen Genet. 1988 Sep;214(1):1-5.
PMID: 2852300; UI: 89143446


981: Wentland MP, Perni RB, Dorff PH, Rake JB.
Synthesis and bacterial DNA gyrase inhibitory properties of a
spirocyclopropylquinolone derivative.
J Med Chem. 1988 Sep;31(9):1694-7.
PMID: 2842501; UI: 88316899


982: Lindberg GK, Rist JK, Kunkel TA, Sugino A, Rothman-Denes LB.
Purification and characterization of bacteriophage N4-induced DNA polymerase.
J Biol Chem. 1988 Aug 15;263(23):11319-26.
PMID: 3403528; UI: 88298782


983: Horwitz MS, Loeb LA.
An E. coli promoter that regulates transcription by DNA superhelix-induced
cruciform extrusion.
Science. 1988 Aug 5;241(4866):703-5.
PMID: 2456617; UI: 88290698


984: Chow RT, Dougherty TJ, Fraimow HS, Bellin EY, Miller MH.
Association between early inhibition of DNA synthesis and the MICs and MBCs of
carboxyquinolone antimicrobial agents for wild-type and mutant [gyrA nfxB(ompF)
acrA] Escherichia coli K-12.
Antimicrob Agents Chemother. 1988 Aug;32(8):1113-8.
PMID: 3056251; UI: 89049050


985: Paton JH, Reeves DS.
Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.
Drugs. 1988 Aug;36(2):193-228. Review.
PMID: 3053126; UI: 89030358


986: Takahata M, Nishino T.
DNA gyrase of Staphylococcus aureus and inhibitory effect of quinolones on its
activity.
Antimicrob Agents Chemother. 1988 Aug;32(8):1192-5.
PMID: 2847648; UI: 89049064


987: Divo AA, Sartorelli AC, Patton CL, Bia FJ.
Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro.
Antimicrob Agents Chemother. 1988 Aug;32(8):1182-6.
PMID: 2847647; UI: 89049062


988: Van der Auwera P, Matsumoto T, Husson M.
Intraphagocytic penetration of antibiotics.
J Antimicrob Chemother. 1988 Aug;22(2):185-92.
PMID: 2846489; UI: 89033370


989: Rosen T, Chu DT, Lico IM, Fernandes PB, Marsh K, Shen L, Cepa VG, Pernet
AG.
Design, synthesis, and properties of
(4S)-7-(4-amino-2-substituted-pyrrolidin-1-yl)quinolone-3-carboxylic acids.
J Med Chem. 1988 Aug;31(8):1598-611.
PMID: 2840501; UI: 88286638


990: Leon P, Alvarez G, Diaz de Leon F, Gomez-Eichelmann MC.
Effect of DNA supercoiling and catabolite repression on the expression of the
tetA genes in Escherichia coli.
Can J Microbiol. 1988 Jul;34(7):839-42.
PMID: 3058275; UI: 89063068


991: Walton L, Elwell LP.
In vitro cleavable-complex assay to monitor antimicrobial potency of quinolones.
Antimicrob Agents Chemother. 1988 Jul;32(7):1086-9.
PMID: 2847641; UI: 89049033


992: Thiara AS, Cundliffe E.
Cloning and characterization of a DNA gyrase B gene from Streptomyces
sphaeroides that confers resistance to novobiocin.
EMBO J. 1988 Jul;7(7):2255-9.
PMID: 2843361; UI: 88329013


993: Wahle E, Kornberg A.
The partition locus of plasmid pSC101 is a specific binding site for DNA gyrase.
EMBO J. 1988 Jun;7(6):1889-95.
PMID: 2844527; UI: 89005082


994: Aoyama H, Fujimaki K, Sato K, Fujii T, Inoue M, Hirai K, Mitsuhashi S.
Clinical isolate of Citrobacter freundii highly resistant to new quinolones.
Antimicrob Agents Chemother. 1988 Jun;32(6):922-4.
PMID: 2843087; UI: 88325340


995: Fujimaki K, Noumi T, Saikawa I, Inoue M, Mitsuhashi S.
In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.
Antimicrob Agents Chemother. 1988 Jun;32(6):827-33.
PMID: 2843082; UI: 88325323


996: Zhu YS, Hearst JE.
Transcription of oxygen-regulated photosynthetic genes requires DNA gyrase in
Rhodobacter capsulatus.
Proc Natl Acad Sci U S A. 1988 Jun;85(12):4209-13.
PMID: 2837760; UI: 88247991


997: Dorman CJ, Barr GC, Bhriain NN, Higgins CF.
DNA supercoiling and the anaerobic and growth phase regulation of tonB gene
expression.
J Bacteriol. 1988 Jun;170(6):2816-26.
PMID: 2836373; UI: 88227869


998: Rose KM.
DNA topoisomerases as targets for chemotherapy.
FASEB J. 1988 Jun;2(9):2474-8. Review.
PMID: 2836254; UI: 88225865


999: Sekimizu K, Bramhill D, Kornberg A.
Sequential early stages in the in vitro initiation of replication at the origin
of the Escherichia coli chromosome.
J Biol Chem. 1988 May 25;263(15):7124-30.
PMID: 2835363; UI: 88213386


1000: Wu HY, Shyy SH, Wang JC, Liu LF.
Transcription generates positively and negatively supercoiled domains in the
template.
Cell. 1988 May 6;53(3):433-40.
PMID: 2835168; UI: 88210468


1001: Franco RJ, Drlica K.
DNA gyrase on the bacterial chromosome. Oxolinic acid-induced DNA cleavage in
the dnaA-gyrB region.
J Mol Biol. 1988 May 5;201(1):229-33.
PMID: 2843645; UI: 88332954


1002: Sanders CC.
Ciprofloxacin: in vitro activity, mechanism of action, and resistance.
Rev Infect Dis. 1988 May-Jun;10(3):516-27. Review.
PMID: 3293157; UI: 88277590


1003: Ferrazzi E, Peracchi M, Biasolo MA, Faggionato O, Stefanelli S, Palu G.
Antiviral activity of gyrase inhibitors norfloxacin, coumermycin A1 and
nalidixic acid.
Biochem Pharmacol. 1988 May 1;37(9):1885-6. No abstract available.
PMID: 2837249; UI: 88240592


1004: Landini P, Pagani L, Cereda PM, Debiaggi M, Romero E.
Norfloxacin resistance in Providencia stuartii: modifications in DNA-gyrase and
permeability.
Biochem Pharmacol. 1988 May 1;37(9):1855-6. No abstract available.
PMID: 2837244; UI: 88240577


1005: Domagala JM, Heifetz CL, Hutt MP, Mich TF, Nichols JB, Solomon M, Worth
DF.
1-Substituted 7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-
difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids. New quantitative
structure-activity relationships at N1 for the quinolone antibacterials.
J Med Chem. 1988 May;31(5):991-1001.
PMID: 2834557; UI: 88200229


1006: Slesarev AI.
Positive supercoiling catalysed in vitro by ATP-dependent topoisomerase from
Desulfurococcus amylolyticus.
Eur J Biochem. 1988 Apr 15;173(2):395-9.
PMID: 2834207; UI: 88196127


1007: Campoli-Richards DM, Monk JP, Price A, Benfield P, Todd PA, Ward A.
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic
properties and therapeutic use.
Drugs. 1988 Apr;35(4):373-447. Review.
PMID: 3292209; UI: 88271203


1008: Portolani M, Pietrosemoli P, Cermelli C, Mannini-Palenzona A, Grossi MP,
Paolini L, Barbanti-Brodano G.
Suppression of BK virus replication and cytopathic effect by inhibitors of
prokaryotic DNA gyrase.
Antiviral Res. 1988 Apr;9(3):205-18.
PMID: 2840850; UI: 88292935


1009: Robillard NJ, Scarpa AL.
Genetic and physiological characterization of ciprofloxacin resistance in
Pseudomonas aeruginosa PAO.
Antimicrob Agents Chemother. 1988 Apr;32(4):535-9.
PMID: 2837141; UI: 88239588


1010: Granston AE, Alessi DM, Eades LJ, Friedman DI.
A point mutation in the Nul gene of bacteriophage lambda facilitates phage
growth in Escherichia coli with himA and gyrB mutations.
Mol Gen Genet. 1988 Apr;212(1):149-56.
PMID: 2836702; UI: 88232425


1011: Bae YS, Kawasaki I, Ikeda H, Liu LF.
Illegitimate recombination mediated by calf thymus DNA topoisomerase II in
vitro.
Proc Natl Acad Sci U S A. 1988 Apr;85(7):2076-80.
PMID: 2832845; UI: 88176889


1012: Tornaletti S, Pedrini AM.
Studies on the interaction of 4-quinolones with DNA by DNA unwinding
experiments.
Biochim Biophys Acta. 1988 Mar 31;949(3):279-87.
PMID: 2831987; UI: 88163727


1013: Zivanovic Y, Goulet I, Revet B, Le Bret M, Prunell A.
Chromatin reconstitution on small DNA rings. II. DNA supercoiling on the
nucleosome.
J Mol Biol. 1988 Mar 20;200(2):267-90.
PMID: 2836595; UI: 88230451


1014: Kullich W, Brugger P, Klein G.
[Assessment of the genotoxic risk caused by the gyrase inhibitor ofloxacin using
sister chromatid exchange rate analysis].
Wien Med Wochenschr. 1988 Mar 15;138(5):107-9. German.
PMID: 2838977; UI: 88266035


1015: Hirschl AM, Georgopoulos A, Stanek G, Breyer S, Rotter ML.
Efficacy of coumermycin, ofloxacin and vancomycin against methicillin-resistant
Staphylococcus aureus in vitro and in experimental infections of mice.
Zentralbl Bakteriol Mikrobiol Hyg [A]. 1988 Mar;267(4):541-8.
PMID: 3164157; UI: 88249759


1016: Althaus IW, Dolak L, Reusser F.
Coumarins as inhibitors of bacterial DNA gyrase.
J Antibiot (Tokyo). 1988 Mar;41(3):373-6.
PMID: 2835349; UI: 88213160


1017: Albright LM, Kassavetis GA, Geiduschek EP.
Bacteriophage T4 late transcription from plasmid templates is enhanced by
negative supercoiling.
J Bacteriol. 1988 Mar;170(3):1279-89.
PMID: 2830234; UI: 88139190


1018: Sioud M, Baldacci G, de Recondo AM, Forterre P.
Novobiocin induces positive supercoiling of small plasmids from halophilic
archaebacteria in vivo.
Nucleic Acids Res. 1988 Feb 25;16(4):1379-91.
PMID: 3347494; UI: 88157702


1019: Neuman M.
Clinical pharmacokinetics of the newer antibacterial 4-quinolones.
Clin Pharmacokinet. 1988 Feb;14(2):96-121. Review.
PMID: 3282749; UI: 88195235


1020: Wolfson JS, Hooper DC.
Norfloxacin: a new targeted fluoroquinolone antimicrobial agent.
Ann Intern Med. 1988 Feb;108(2):238-51. Review.
PMID: 3277508; UI: 88132128


1021: Courtright JB, Turowski DA, Sonstein SA.
Alteration of bacterial DNA structure, gene expression, and plasmid encoded
antibiotic resistance following exposure to enoxacin.
J Antimicrob Chemother. 1988 Feb;21 Suppl B:1-18.
PMID: 2834313; UI: 88197870


1022: Axley MJ, Stadtman TC.
Anaerobic induction of Escherichia coli formate dehydrogenase
(hydrogenase-linked) is enhanced by gyrase inactivation.
Proc Natl Acad Sci U S A. 1988 Feb;85(4):1023-7.
PMID: 2829213; UI: 88124967


1023: Sioud M, Possot O, Elie C, Sibold L, Forterre P.
Coumarin and quinolone action in archaebacteria: evidence for the presence of a
DNA gyrase-like enzyme.
J Bacteriol. 1988 Feb;170(2):946-53.
PMID: 2828337; UI: 88115204


1024: Mitsuhashi S.
Comparative antibacterial activity of new quinolone-carboxylic acid derivatives.
Rev Infect Dis. 1988 Jan-Feb;10 Suppl 1:S27-31.
PMID: 3347811; UI: 88159022


1025: Drew RH, Gallis HA.
Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical
application.
Pharmacotherapy. 1988;8(1):35-46. Review.
PMID: 3287354; UI: 88234110


1026: Neu HC.
Bacterial resistance to fluoroquinolones.
Rev Infect Dis. 1988 Jan-Feb;10 Suppl 1:S57-63. Review.
PMID: 3279500; UI: 88159023


1027: Christ W, Lehnert T, Ulbrich B.
Specific toxicologic aspects of the quinolones.
Rev Infect Dis. 1988 Jan-Feb;10 Suppl 1:S141-6. Review.
PMID: 3279489; UI: 88159011


1028: Verho M, Korn A, Badian M, Malerczyk V, Waldhausl W.
Dose linearity testing of intravenous ofloxacin, a novel gyrase inhibitor.
Chemotherapy. 1988;34(3):170-7.
PMID: 3166420; UI: 88328526


1029: DeMarini DM, Lawrence BK.
Mutagenicity of topoisomerase-active agents in bacteriophage T4.
Teratog Carcinog Mutagen. 1988;8(5):293-301.
PMID: 2905838; UI: 89114646


1030: Page WJ, Patrick J.
The DNA gyrase inhibitors, nalidixic acid and oxolinic acid, prevent
iron-mediated repression of catechol siderophore synthesis in Azotobacter
vinelandii.
Biol Met. 1988;1(1):57-61.
PMID: 2856355; UI: 91001359


1031: Domagala JM, Hagen SE, Hutt MP, Sanchez JP, Sesnie J, Trehan AK.
5-Amino-7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6,8-difluoro-1,4-
dihydro-4-oxo-3-quinolinecarboxylic acid (PD 124,816). Synthesis and biological
evaluation of a new class of quinolone antibacterials.
Drugs Exp Clin Res. 1988;14(7):453-60.
PMID: 2853667; UI: 89196204


1032: Chu DT, Fernandes PB, Claiborne AK, Shen L, Pernet AG.
Structure-activity relationships in quinolone antibacterials: design, synthesis
and biological activities of novel isothiazoloquinolones.
Drugs Exp Clin Res. 1988;14(6):379-83.
PMID: 2850902; UI: 89106889


1033: Popov N.
[Molecular pharmacologic aspects of the effect of antimicrobial drugs: gyrase
inhibitors and anaerobic chemotherapeutic drugs].
Z Arztl Fortbild (Jena). 1988;82(3):107-14. Review. German. No abstract
available.
PMID: 2838978; UI: 88266060


1034: LeBel M.
Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial
spectrum, pharmacokinetics, clinical trials, and adverse reactions.
Pharmacotherapy. 1988;8(1):3-33. Review.
PMID: 2836821; UI: 88234109


1035: Aoyama H, Sato K, Fujii T, Fujimaki K, Inoue M, Mitsuhashi S.
Purification of Citrobacter freundii DNA gyrase and inhibition by quinolones.
Antimicrob Agents Chemother. 1988 Jan;32(1):104-9.
PMID: 2831810; UI: 88162203


1036: Hooper DC, Wolfson JS.
Mode of action of the quinolone antimicrobial agents.
Rev Infect Dis. 1988 Jan-Feb;10 Suppl 1:S14-21. Review.
PMID: 2831608; UI: 88159010


1037: Osburne MS, Zavodny SM, Peterson GA.
Drug-induced relaxation of supercoiled plasmid DNA in Bacillus subtilis and
induction of the SOS response.
J Bacteriol. 1988 Jan;170(1):442-5.
PMID: 2826401; UI: 88086909


1038: Westerhoff HV, O'Dea MH, Maxwell A, Gellert M.
DNA supercoiling by DNA gyrase. A static head analysis.
Cell Biophys. 1988 Jan-Jun;12:157-81.
PMID: 2453279; UI: 88223321


1039: Wobbe CR, Dean FB, Murakami Y, Borowiec JA, Bullock P, Hurwitz J.
In vitro replication of DNA containing either the SV40 or the polyoma origin.
Philos Trans R Soc Lond B Biol Sci. 1987 Dec 15;317(1187):439-53.
PMID: 2894681; UI: 88158245


1040: Mouton RP.
Resistance to quinolones.
Pharm Weekbl Sci. 1987 Dec 11;9 Suppl:S11-5.
PMID: 3125517; UI: 88143935


1041: Tabary X, Moreau N, Dureuil C, Le Goffic F.
Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin,
and clorobiocin on Escherichia coli topoisomerase I.
Antimicrob Agents Chemother. 1987 Dec;31(12):1925-8.
PMID: 2830840; UI: 88148997


1042: Kropp R, Eckert G.
[Interaction of gyrase inhibitor with theophylline].
Prax Klin Pneumol. 1987 Dec;41(12):1018-21. German. No abstract available.
PMID: 2830610; UI: 88144273


1043: Mitscher LA, Sharma PN, Chu DT, Shen LL, Pernet AG.
Chiral DNA gyrase inhibitors. 2. Asymmetric synthesis and biological activity of
the enantiomers of
9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-
pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid (ofloxacin).
J Med Chem. 1987 Dec;30(12):2283-6.
PMID: 2824776; UI: 88062590


1044: Hussain K, Elliott EJ, Salmond GP.
The parD- mutant of Escherichia coli also carries a gyrAam mutation. The
complete sequence of gyrA.
Mol Microbiol. 1987 Nov;1(3):259-73.
PMID: 2834621; UI: 88201664


1045: Wolfson JS, Hooper DC, Ng EY, Souza KS, McHugh GL, Swartz MN.
Antagonism of wild-type and resistant Escherichia coli and its DNA gyrase by the
tricyclic 4-quinolone analogs ofloxacin and S-25930 stereoisomers.
Antimicrob Agents Chemother. 1987 Nov;31(11):1861-3.
PMID: 2829717; UI: 88132746


1046: Klopman G, Macina OT, Levinson ME, Rosenkranz HS.
Computer automated structure evaluation of quinolone antibacterial agents.
Antimicrob Agents Chemother. 1987 Nov;31(11):1831-40.
PMID: 2829716; UI: 88132738


1047: Staib AH, Harder S, Papenburg A, Stille W.
[Gyrase inhibitors modify metabolising processes in the liver].
Dtsch Med Wochenschr. 1987 Oct 30;112(44):1720-1. German. No abstract available.
PMID: 2822371; UI: 88029086


1048: Swanberg SL, Wang JC.
Cloning and sequencing of the Escherichia coli gyrA gene coding for the A
subunit of DNA gyrase.
J Mol Biol. 1987 Oct 20;197(4):729-36.
PMID: 2828631; UI: 88118900


1049: Duschak VG, Goldemberg SH.
Effects of DNA gyrase inhibitors in a polyamine-auxotrophic strain of
Escherichia coli.
Biochim Biophys Acta. 1987 Oct 9;910(1):21-6.
PMID: 2820496; UI: 88000698


1050: Aoyama H, Sato K, Kato T, Hirai K, Mitsuhashi S.
Norfloxacin resistance in a clinical isolate of Escherichia coli.
Antimicrob Agents Chemother. 1987 Oct;31(10):1640-1.
PMID: 2829712; UI: 88132699


1051: Ikeda S, Yazawa M, Nishimura C.
Antiviral activity and inhibition of topoisomerase by ofloxacin, a new quinolone
derivative.
Antiviral Res. 1987 Oct;8(3):103-13.
PMID: 2827566; UI: 88105342


1052: Landini P, Pagani L, Debiaggi L, Cereda PM, Romero E.
Modifications of DNA-gyrase and of permeability in a norfloxacin-resistant
clinical isolate of Providencia stuartii.
Microbiologica. 1987 Oct;10(4):403-11.
PMID: 2826973; UI: 88093823


1053: Gillespie SH, McEniry DW, Felmingham D.
In-vitro susceptibility of Pseudomonas pseudomallei to DNA gyrase inhibitors.
J Antimicrob Chemother. 1987 Oct;20(4):612-4. No abstract available.
PMID: 2824429; UI: 88058596


1054: Liu LF, Wang JC.
Supercoiling of the DNA template during transcription.
Proc Natl Acad Sci U S A. 1987 Oct;84(20):7024-7.
PMID: 2823250; UI: 88041043


1055: Jovanovich SB, Lebowitz J.
Estimation of the effect of coumermycin A1 on Salmonella typhimurium promoters
by using random operon fusions.
J Bacteriol. 1987 Oct;169(10):4431-5.
PMID: 2820924; UI: 88007378


1056: Lazarus GM, Henrich JP, Kelly WG, Schmitz SA, Castora FJ.
Purification and characterization of a type I DNA topoisomerase from calf thymus
mitochondria.
Biochemistry. 1987 Sep 22;26(19):6195-203.
PMID: 2825774; UI: 88077880


1057: Fiser-Littell RM, Hanas JS.
Novobiocin inhibits Xenopus transcription factor IIIA-DNA interactions.
J Biol Chem. 1987 Sep 5;262(25):11916-9.
PMID: 2442153; UI: 87308183


1058: Laffan J, Firshein W.
Membrane protein binding to the origin region of Bacillus subtilis.
J Bacteriol. 1987 Sep;169(9):4135-40.
PMID: 3114234; UI: 87307994


1059: Cavalier-Smith T.
Bacterial DNA segregation: its motors and positional control.
J Theor Biol. 1987 Aug 7;127(3):361-72.
PMID: 2828768; UI: 88120383


1060: Shibata T, Nakasu S, Yasui K, Kikuchi A.
Intrinsic DNA-dependent ATPase activity of reverse gyrase.
J Biol Chem. 1987 Aug 5;262(22):10419-21.
PMID: 3038879; UI: 87280089


1061: Nielsen B, Nielsen H.
Bactericidal effect of polymorphonuclear leukocytes on Pseudomonas aeruginosa
pre-incubated in ofloxacin.
Acta Pathol Microbiol Immunol Scand [B]. 1987 Aug;95(4):227-32.
PMID: 3118637; UI: 88045747


1062: Ihara M, Yamamoto K, Ohnishi T.
Induction of phr gene expression by irradiation of ultraviolet light in
Escherichia coli.
Mol Gen Genet. 1987 Aug;209(1):200-2.
PMID: 2823069; UI: 88038359


1063: Marians KJ.
DNA gyrase-catalyzed decatenation of multiply linked DNA dimers.
J Biol Chem. 1987 Jul 25;262(21):10362-8.
PMID: 3038875; UI: 87280066


1064: Esposito F, Sinden RR.
Supercoiling in prokaryotic and eukaryotic DNA: changes in response to
topological perturbation of plasmids in E. coli and SV40 in vitro, in nuclei and
in CV-1 cells.
Nucleic Acids Res. 1987 Jul 10;15(13):5105-24.
PMID: 3037487; UI: 87259989


1065: Maier H, Sziegoleit A, Merck S.
Penetration of ciprofloxacin into parotid gland tissue and parotid saliva.
Arzneimittelforschung. 1987 Jul;37(7):797-8.
PMID: 3675673; UI: 88049865


1066: Masai H, Arai K.
RepA and DnaA proteins are required for initiation of R1 plasmid replication in
vitro and interact with the oriR sequence.
Proc Natl Acad Sci U S A. 1987 Jul;84(14):4781-5.
PMID: 3037524; UI: 87260874


1067: Goldstein EJ.
Norfloxacin, a fluoroquinolone antibacterial agent. Classification, mechanism of
action, and in vitro activity.
Am J Med. 1987 Jun 26;82(6B):3-17. Review.
PMID: 3111257; UI: 87267707


1068: Van Dyke MW, Roeder RG.
Novobiocin interferes with the binding of transcription factors TFIIIA and
TFIIIC to the promoters of class III genes.
Nucleic Acids Res. 1987 Jun 11;15(11):4365-74.
PMID: 3588299; UI: 87231021


1069: Levine A, Henckes G, Vannier F, Seror SJ.
Chromosomal initiation in Bacillus subtilis may involve two closely linked
origins.
Mol Gen Genet. 1987 Jun;208(1-2):37-44.
PMID: 3039310; UI: 87286422


1070: Menzel R, Gellert M.
Modulation of transcription by DNA supercoiling: a deletion analysis of the
Escherichia coli gyrA and gyrB promoters.
Proc Natl Acad Sci U S A. 1987 Jun;84(12):4185-9.
PMID: 3035573; UI: 87231970


1071: Wickner SH, Chattoraj DK.
Replication of mini-P1 plasmid DNA in vitro requires two initiation proteins,
encoded by the repA gene of phage P1 and the dnaA gene of Escherichia coli.
Proc Natl Acad Sci U S A. 1987 Jun;84(11):3668-72.
PMID: 3035546; UI: 87231879


1072: Novak PD, Maier RJ.
Inhibition of hydrogenase synthesis by DNA gyrase inhibitors in Bradyrhizobium
japonicum.
J Bacteriol. 1987 Jun;169(6):2708-12.
PMID: 3034865; UI: 87222198


1073: Klietmann W, Focht J, Nosner K.
Comparative in vitro activity of ciprofloxacin against aerobic and anaerobic
bacteria from clinical isolates.
Arzneimittelforschung. 1987 Jun;37(6):661-6.
PMID: 2822054; UI: 88024306


1074: Shah PM, Just G, Weigand G, Stille W.
[Resistance against new gyrase inhibitors--1985/86].
Dtsch Med Wochenschr. 1987 May 29;112(22):903-4. German. No abstract available.
PMID: 3034545; UI: 87218153


1075: Baker TA, Funnell BE, Kornberg A.
Helicase action of dnaB protein during replication from the Escherichia coli
chromosomal origin in vitro.
J Biol Chem. 1987 May 15;262(14):6877-85.
PMID: 3032979; UI: 87194940


1076: Shishido K, Komiyama N, Ikawa S.
Increased production of a knotted form of plasmid pBR322 DNA in Escherichia coli
DNA topoisomerase mutants.
J Mol Biol. 1987 May 5;195(1):215-8.
PMID: 2821270; UI: 88011229


1077: Rosenthal ER, Calvo JM.
Effect of DNA superhelicity on transcription termination.
Mol Gen Genet. 1987 May;207(2-3):430-4.
PMID: 3302600; UI: 87286386


1078: Garner MM, Felsenfeld G, O'Dea MH, Gellert M.
Effects of DNA supercoiling on the topological properties of nucleosomes.
Proc Natl Acad Sci U S A. 1987 May;84(9):2620-3.
PMID: 3033656; UI: 87204182


1079: Inoue Y, Sato K, Fujii T, Hirai K, Inoue M, Iyobe S, Mitsuhashi S.
Some properties of subunits of DNA gyrase from Pseudomonas aeruginosa PAO1 and
its nalidixic acid-resistant mutant.
J Bacteriol. 1987 May;169(5):2322-5.
PMID: 3032915; UI: 87194631


1080: Hooper DC, Wolfson JS, Ng EY, Swartz MN.
Mechanisms of action of and resistance to ciprofloxacin.
Am J Med. 1987 Apr 27;82(4A):12-20. Review.
PMID: 3034057; UI: 87210199


1081: Horowitz DS, Wang JC.
Mapping the active site tyrosine of Escherichia coli DNA gyrase.
J Biol Chem. 1987 Apr 15;262(11):5339-44.
PMID: 3031051; UI: 87165975


1082: Schnuch A.
[Gyrase inhibitor: central nervous system side effects].
Dtsch Med Wochenschr. 1987 Apr 3;112(14):569. German. No abstract available.
PMID: 3030684; UI: 87161343


1083: Neuman M.
Comparative pharmacokinetic parameters of new systemic fluoroquinolones: a
review.
Chemioterapia. 1987 Apr;6(2):105-12. Review.
PMID: 3297363; UI: 87244472


1084: Georgopapadakou NH, Dix BA, Angehrn P, Wick A, Olson GL.
Monocyclic and tricyclic analogs of quinolones: mechanism of action.
Antimicrob Agents Chemother. 1987 Apr;31(4):614-6.
PMID: 3037999; UI: 87269490


1085: Bliska JB, Cozzarelli NR.
Use of site-specific recombination as a probe of DNA structure and metabolism in
vivo.
J Mol Biol. 1987 Mar 20;194(2):205-18.
PMID: 3039150; UI: 87283921


1086: Staib AH, Harder S, Mieke S, Beer C, Stille W, Shah P.
Gyrase-inhibitors impair caffeine elimination in man.
Methods Find Exp Clin Pharmacol. 1987 Mar;9(3):193-8. No abstract available.
PMID: 3037212; UI: 87256339


1087: Van der Auwera P, Joly P.
Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and
ciprofloxacin, alone and in combination with rifampicin or LM 427, against
Staphylococcus aureus.
J Antimicrob Chemother. 1987 Mar;19(3):313-20.
PMID: 3032884; UI: 87194380


1088: Menzel R, Gellert M.
Fusions of the Escherichia coli gyrA and gyrB control regions to the
galactokinase gene are inducible by coumermycin treatment.
J Bacteriol. 1987 Mar;169(3):1272-8.
PMID: 3029031; UI: 87137287


1089: Felts SJ, Weil PA, Chalkley R.
Novobiocin inhibits interactions required for yeast TFIIIB sequestration during
stable transcription complex formation in vitro.
Nucleic Acids Res. 1987 Feb 25;15(4):1493-506.
PMID: 3547336; UI: 87146476


1090: Rau DC, Gellert M, Thoma F, Maxwell A.
Structure of the DNA gyrase-DNA complex as revealed by transient electric
dichroism.
J Mol Biol. 1987 Feb 5;193(3):555-69.
PMID: 3035196; UI: 87226212


1091: Nix DE, DeVito JM.
Ciprofloxacin and norfloxacin, two fluoroquinolone antimicrobials.
Clin Pharm. 1987 Feb;6(2):105-17. Review.
PMID: 3311572; UI: 88028343


1092: Imamura M, Shibamura S, Hayakawa I, Osada Y.
Inhibition of DNA gyrase by optically active ofloxacin.
Antimicrob Agents Chemother. 1987 Feb;31(2):325-7.
PMID: 3032098; UI: 87183462


1093: Rietbrock N, Staib AH.
[Gyrase inhibitors: unwanted central nervous system effects].
Dtsch Med Wochenschr. 1987 Jan 30;112(5):201. German. No abstract available.
PMID: 3467948; UI: 87105131


1094: Thompson RJ, Mosig G.
Stimulation of a Chlamydomonas chloroplast promoter by novobiocin in situ and in
E. coli implies regulation by torsional stress in the chloroplast DNA.
Cell. 1987 Jan 30;48(2):281-7.
PMID: 3026640; UI: 87102875


1095: Kornberg A.
Enzyme systems initiating replication at the origin of the Escherichia coli
chromosome.
J Cell Sci Suppl. 1987;7:1-13.
PMID: 3332650; UI: 89034461


1096: Neuman M.
Comparative pharmacokinetic parameters of new systemic fluoroquinolones.
Int J Clin Pharmacol Res. 1987;7(3):173-9. Review.
PMID: 3298083; UI: 87249297


1097: Ennis DG, Amundsen SK, Smith GR.
Genetic functions promoting homologous recombination in Escherichia coli: a
study of inversions in phage lambda.
Genetics. 1987 Jan;115(1):11-24. Review.
PMID: 2951295; UI: 87163436


1098: Wang JC.
DNA topoisomerases: from a laboratory curiosity to a subject in cancer
chemotherapy.
NCI Monogr. 1987;(4):3-6. Review.
PMID: 2819727; UI: 87315464


1099: Altwegg M.
[Resistance patterns in Shigella].
Schweiz Med Wochenschr. 1986 Dec 27;116(52):1848-51. German.
PMID: 3823818; UI: 87148936


1100: Ganz H.
[Gyrase inhibitor in the local treatment of the chronically infected middle ear
following surgery].
HNO. 1986 Dec;34(12):511-4. German.
PMID: 3028994; UI: 87136803


1101: Sealy L, Cotten M, Chalkley R.
Novobiocin inhibits passive chromatin assembly in vitro.
EMBO J. 1986 Dec 1;5(12):3305-11.
PMID: 3028779; UI: 87133493


1102: Smith JT.
The mode of action of 4-quinolones and possible mechanisms of resistance.
J Antimicrob Chemother. 1986 Nov;18 Suppl D:21-9. Review.
PMID: 3542946; UI: 87108893


1103: Weisser J, Wiedemann B.
Elimination of plasmids by enoxacin and ofloxacin at near inhibitory
concentrations.
J Antimicrob Chemother. 1986 Nov;18(5):575-83.
PMID: 3542924; UI: 87108827


1104: Sato K, Inoue Y, Fujii T, Aoyama H, Inoue M, Mitsuhashi S.
Purification and properties of DNA gyrase from a fluoroquinolone-resistant
strain of Escherichia coli.
Antimicrob Agents Chemother. 1986 Nov;30(5):777-80.
PMID: 3026239; UI: 87098736


1105: Klein E, Trautmann M, Hoffmann HG.
[Ciprofloxacin in Salmonella infection and abdominal typhoid].
Dtsch Med Wochenschr. 1986 Oct 17;111(42):1599-602. German.
PMID: 3769803; UI: 87029939


1106: Huang WM.
Nucleotide sequence of a type II DNA topoisomerase gene. Bacteriophage T4 gene
39.
Nucleic Acids Res. 1986 Oct 10;14(19):7751-65.
PMID: 3022233; UI: 87040739


1107: Mitscher LA, Sharma PN, Chu DT, Shen LL, Pernet AG.
Chiral DNA gyrase inhibitors. 1. Synthesis and antimicrobial activity of the
enantiomers of 6-fluoro-7-(1-piperazinyl)-1-(2'-trans-phenyl-1'-cyclopropyl)-1,
4-dihydro-4-oxoquinoline-3-carboxylic acid.
J Med Chem. 1986 Oct;29(10):2044-7.
PMID: 3020253; UI: 87011620


1108: Pruss GJ, Franco RJ, Chevalier SG, Manes SH, Drlica K.
Effects of DNA gyrase inhibitors in Escherichia coli topoisomerase I mutants.
J Bacteriol. 1986 Oct;168(1):276-82.
PMID: 3019999; UI: 87008391


1109: Staib AH, Harder S, Mieke S, Beer C, Stille W, Shah PM, Frech K.
[Gyrase inhibitors can delay caffeine elimination].
Dtsch Med Wochenschr. 1986 Sep 26;111(39):1500. German. No abstract available.
PMID: 3463500; UI: 87004091


1110: Huang WM.
The 52-protein subunit of T4 DNA topoisomerase is homologous to the gyrA-protein
of gyrase.
Nucleic Acids Res. 1986 Sep 25;14(18):7379-90.
PMID: 3020513; UI: 87016377


1111: Minden JS, Marians KJ.
Escherichia coli topoisomerase I can segregate replicating pBR322 daughter DNA
molecules in vitro.
J Biol Chem. 1986 Sep 5;261(25):11906-17.
PMID: 3017951; UI: 86304327


1112: Shah PM.
[Side effects of gyrase inhibitors].
Fortschr Med. 1986 Sep 4;104(33):609. German. No abstract available.
PMID: 3021604; UI: 87031834


1113: Uemura T, Morikawa K, Yanagida M.
The nucleotide sequence of the fission yeast DNA topoisomerase II gene:
structural and functional relationships to other DNA topoisomerases.
EMBO J. 1986 Sep;5(9):2355-61.
PMID: 3023070; UI: 87053875


1114: Kranz RG, Haselkorn R.
Anaerobic regulation of nitrogen-fixation genes in Rhodopseudomonas capsulata.
Proc Natl Acad Sci U S A. 1986 Sep;83(18):6805-9.
PMID: 3018747; UI: 86313666


1115: Ross W, Shore SH, Howe MM.
Mutants of Escherichia coli defective for replicative transposition of
bacteriophage Mu.
J Bacteriol. 1986 Sep;167(3):905-19.
PMID: 3017919; UI: 86304182


1116: Bielinska A, Hulanicka D.
Effect of DNA gyrase inhibitors and urea on the expression of cysB, the
regulatory gene of the cysteine regulon.
J Gen Microbiol. 1986 Sep;132 ( Pt 9):2571-6.
PMID: 2432161; UI: 87085463


1117: Lynn R, Giaever G, Swanberg SL, Wang JC.
Tandem regions of yeast DNA topoisomerase II share homology with different
subunits of bacterial gyrase.
Science. 1986 Aug 8;233(4764):647-9.
PMID: 3014661; UI: 86261821


1118: Albright LM, Geiduschek EP.
Topoisomerization of plasmid DNA in Escherichia coli infected with bacteriophage
T4.
J Mol Biol. 1986 Aug 5;190(3):329-41.
PMID: 3023639; UI: 87060990


1119: Hirai K, Aoyama H, Suzue S, Irikura T, Iyobe S, Mitsuhashi S.
Isolation and characterization of norfloxacin-resistant mutants of Escherichia
coli K-12.
Antimicrob Agents Chemother. 1986 Aug;30(2):248-53.
PMID: 3532944; UI: 87024512


1120: Chen Y, Maxwell A, Westerhoff HV.
Co-operativity and enzymatic activity in polymer-activated enzymes. A
one-dimensional piggy-back binding model and its application to the
DNA-dependent ATPase of DNA gyrase.
J Mol Biol. 1986 Jul 20;190(2):201-14.
PMID: 3025451; UI: 87086759


1121: Gallagher M, Weinberg R, Simpson MV.
Effect of the bacterial DNA gyrase inhibitors, novobiocin, nalidixic acid, and
oxolinic acid, on oxidative phosphorylation.
J Biol Chem. 1986 Jul 5;261(19):8604-7.
PMID: 3013857; UI: 86250771


1122: Fisher LM, Barot HA, Cullen ME.
DNA gyrase complex with DNA: determinants for site-specific DNA breakage.
EMBO J. 1986 Jun;5(6):1411-8.
PMID: 3015604; UI: 86274646


1123: Plon SE, Wang JC.
Transcription of the human beta-globin gene is stimulated by an SV40 enhancer to
which it is physically linked but topologically uncoupled.
Cell. 1986 May 23;45(4):575-80.
PMID: 3011274; UI: 86218070


1124: Ogryz'ko VV, Mirkin SM, Shmerling ZhG, Siniakova RN, Zograf IuN.
[Effect of superhelical DNA on the transcription of cloned genes of the T4
phage].
Mol Biol (Mosk). 1986 May-Jun;20(3):745-50. Russian.
PMID: 3014315; UI: 86257133


1125: Funnell BE, Baker TA, Kornberg A.
Complete enzymatic replication of plasmids containing the origin of the
Escherichia coli chromosome.
J Biol Chem. 1986 Apr 25;261(12):5616-24.
PMID: 3514619; UI: 86168311


1126: Guinta D, Stambouly J, Falco SC, Rist JK, Rothman-Denes LB.
Host and phage-coded functions required for coliphage N4 DNA replication.
Virology. 1986 Apr 15;150(1):33-44.
PMID: 3006344; UI: 86153624


1127: Saavedra RA, Huberman JA.
Both DNA topoisomerases I and II relax 2 micron plasmid DNA in living yeast
cells.
Cell. 1986 Apr 11;45(1):65-70.
PMID: 3006927; UI: 86161697


1128: Baker TA, Sekimizu K, Funnell BE, Kornberg A.
Extensive unwinding of the plasmid template during staged enzymatic initiation
of DNA replication from the origin of the Escherichia coli chromosome.
Cell. 1986 Apr 11;45(1):53-64.
PMID: 3006926; UI: 86161696


1129: Guillemin MN, Miles HM, McDonald MI.
Activity of coumermycin against clinical isolates of staphylococci.
Antimicrob Agents Chemother. 1986 Apr;29(4):608-10.
PMID: 3707109; UI: 86213972


1130: Franco RJ, Drlica K.
Gyrase inhibitors and intracellular DNA supercoiling.
Biochem Soc Trans. 1986 Apr;14(2):499-501. No abstract available.
PMID: 3011555; UI: 86221217


1131: Fisher LM, Barot HA, Cullen ME, Hulton CS.
DNA breakage by Escherichia coli DNA gyrase in vitro and in vivo.
Biochem Soc Trans. 1986 Apr;14(2):493-6. No abstract available.
PMID: 3011553; UI: 86221215


1132: Hooper DC, Wolfson JS, Souza KS, Tung C, McHugh GL, Swartz MN.
Genetic and biochemical characterization of norfloxacin resistance in
Escherichia coli.
Antimicrob Agents Chemother. 1986 Apr;29(4):639-44.
PMID: 3010850; UI: 86213979


1133: Zweerink MM, Edison A.
Inhibition of Micrococcus luteus DNA gyrase by norfloxacin and 10 other
quinolone carboxylic acids.
Antimicrob Agents Chemother. 1986 Apr;29(4):598-601.
PMID: 3010848; UI: 86213970


1134: Herrin GL Jr, Bennett GN.
The effect of nalidixic acid on expression from related E. coli promoters.
Biochem Biophys Res Commun. 1986 Mar 13;135(2):411-8.
PMID: 3008718; UI: 86186766


1135: Pate PG, Wolfson JS, McHugh GL, Pan SC, Swartz MN.
Novobiocin antagonism of amastigotes of Trypanosoma cruzi growing in cell-free
medium.
Antimicrob Agents Chemother. 1986 Mar;29(3):426-31.
PMID: 3521485; UI: 86240833


1136: Domagala JM, Hanna LD, Heifetz CL, Hutt MP, Mich TF, Sanchez JP, Solomon
M.
New structure-activity relationships of the quinolone antibacterials using the
target enzyme. The development and application of a DNA gyrase assay.
J Med Chem. 1986 Mar;29(3):394-404.
PMID: 3005575; UI: 86143668


1137: Constantinou A, Voelkel-Meiman K, Sternglanz R, McCorquodale MM,
McCorquodale DJ.
Involvement of host DNA gyrase in growth of bacteriophage T5.
J Virol. 1986 Mar;57(3):875-82.
PMID: 2419589; UI: 86144064


1138: Janknegt R.
Fluorinated quinolones. A review of their mode of action, antimicrobial
activity, pharmacokinetics and clinical efficacy.
Pharm Weekbl Sci. 1986 Feb 21;8(1):1-21. Review.
PMID: 3515312; UI: 86176613


1139: Verbist L.
Quinolones: pharmacology.
Pharm Weekbl Sci. 1986 Feb 21;8(1):22-5.
PMID: 3008075; UI: 86176614


1140: Havlik J, Krcmery V.
[New quinoline chemotherapy. DNA gyrase inhibitors].
Cas Lek Cesk. 1986 Feb 14;125(7):211-4. Czech. No abstract available.
PMID: 3006917; UI: 86161589


1141: Traub WH, Spohr M, Bauer D.
Intraphagocytic bactericidal activity of ofloxacin compared with that of
aztreonam and ceftriaxone against Serratia marcescens.
Zentralbl Bakteriol Mikrobiol Hyg [A]. 1986 Feb;261(1):85-94.
PMID: 3518296; UI: 86210731


1142: Cohen J, McConnell JS.
Release of endotoxin from bacteria exposed to ciprofloxacin and its prevention
with polymyxin B.
Eur J Clin Microbiol. 1986 Feb;5(1):13-7.
PMID: 3009177; UI: 86192419


1143: Reusser F, Dolak LA.
Novenamine is the active moiety in novobiocin.
J Antibiot (Tokyo). 1986 Feb;39(2):272-4.
PMID: 3007416; UI: 86167803


1144: Ikeda H.
Bacteriophage T4 DNA topoisomerase mediates illegitimate recombination in vitro.
Proc Natl Acad Sci U S A. 1986 Feb;83(4):922-6.
PMID: 3006033; UI: 86149252


1145: Ritzerfeld W.
[Results of ofloxacin treatment of experimental urinary tract infections].
Infection. 1986;14 Suppl 1:S45-6. German.
PMID: 3514471; UI: 86166873


1146: Seydel JK, Rosenfeld M, Sathish M, Wiese M, Schaper KJ, Hachtel G, Haller
R, Kansy M, Dhople AM.
Strategies in the development of new drugs and drug combinations against
leprosy, demonstrated on the example of folate and gyrase inhibitors.
Lepr Rev. 1986;57 Suppl 3:235-53. No abstract available.
PMID: 3033412; UI: 87200718


1147: Sato K, Inoue Y, Fujii T, Aoyama H, Mitsuhashi S.
Antibacterial activity of ofloxacin and its mode of action.
Infection. 1986;14 Suppl 4:S226-30.
PMID: 3028966; UI: 87136232


1148: Mitsuhashi S.
International experiences with ofloxacin, a new quinolone.
Infection. 1986;14 Suppl 4:S223-5.
PMID: 3028965; UI: 87136231


1149: Fu KP, Grace ME, McCloud SJ, Gregory FJ, Hung PP.
Discrepancy between the antibacterial activities and the inhibitory effects on
Micrococcus luteus DNA gyrase of 13 quinolones.
Chemotherapy. 1986;32(6):494-8.
PMID: 3026740; UI: 87104503


1150: Weisser J, Wiedemann B.
[Inhibition of gyrase by 4-quinolones: effect on the structure of DNA].
Infection. 1986;14 Suppl 3:S183-5. German.
PMID: 3019897; UI: 87007151


1151: Benbrook DM, Miller RV.
Effects of norfloxacin on DNA metabolism in Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1986 Jan;29(1):1-6.
PMID: 3015000; UI: 86267508


1152: Van der Auwera P, Klastersky J.
In vitro activity of coumermycin alone or in combination against Staphylococcus
aureus and Staphylococcus epidermidis.
Drugs Exp Clin Res. 1986;12(4):307-11.
PMID: 3013562; UI: 86247079


1153: Palu G, Meloni GA, von Berger J, Masotti L.
On the complex nature of the antiviral activity of coumermycin A1: its
interference with the replication of herpes simplex virus type 1.
Antiviral Res. 1986 Jan;6(1):19-32.
PMID: 3008643; UI: 86185421


1154: Borner K, Lode H.
[Biotransformation of selected gyrase inhibitors].
Infection. 1986;14 Suppl 1:S54-9. German.
PMID: 3007367; UI: 86166875


1155: Verho M, Dagrosa EE, Malerczyk V.
[Clinical pharmacology of ofloxacin: a new chemotherapeutic agent belonging to
the gyrase inhibitor group].
Infection. 1986;14 Suppl 1:S47-53. German.
PMID: 3007366; UI: 86166874


1156: Glikin GC, Blangy D.
In vitro transcription by Xenopus oocytes RNA polymerase III requires a DNA
topoisomerase II activity.
EMBO J. 1986 Jan;5(1):151-5.
PMID: 3007112; UI: 86164251


1157: Hockwin O, Laser H, Wegener A.
Investigations on rat eyes with diabetic cataract and naphthalene cataract by
Zeiss-Scheimpflug measuring system SLC.
Graefes Arch Clin Exp Ophthalmol. 1986;224(6):502-6.
PMID: 2947831; UI: 87081397


1158: Smith JT.
[Mechanism of action of quinolones].
Infection. 1986;14 Suppl 1:S3-15. German.
PMID: 2420724; UI: 86166869


1159: Taylor DE, Ng LK, Lior H.
Susceptibility of Campylobacter species to nalidixic acid, enoxacin, and other
DNA gyrase inhibitors.
Antimicrob Agents Chemother. 1985 Nov;28(5):708-10.
PMID: 3004325; UI: 86129234


1160: Cabrera-Juarez E, Setlow JK.
Gyrase activity and number of copies of the gyrase B subunit gene in Haemophilus
influenzae.
J Bacteriol. 1985 Nov;164(2):535-8.
PMID: 2997116; UI: 86033605


1161: Setlow JK, Cabrera-Juarez E, Albritton WL, Spikes D, Mutschler A.
Mutations affecting gyrase in Haemophilus influenzae.
J Bacteriol. 1985 Nov;164(2):525-34.
PMID: 2997115; UI: 86033604


1162: Rubin AR.
[Gyrase inhibitor in pneumology. Ofloxacin--a new broad spectrum antibiotic in
acute and chronic respiratory tract infections].
Prax Klin Pneumol. 1985 Oct;39(10):360-1. German. No abstract available.
PMID: 2999748; UI: 86067688


1163: Forth W.
[Gyrase inhibitor].
Klin Wochenschr. 1985 Oct 1;63(19):1036-9. German. No abstract available.
PMID: 2999503; UI: 86063872


1164: Minden JS, Marians KJ.
Replication of pBR322 DNA in vitro with purified proteins. Requirement for
topoisomerase I in the maintenance of template specificity.
J Biol Chem. 1985 Aug 5;260(16):9316-25.
PMID: 2991240; UI: 85261320


1165: Dougherty TJ, Saukkonen JJ.
Membrane permeability changes associated with DNA gyrase inhibitors in
Escherichia coli.
Antimicrob Agents Chemother. 1985 Aug;28(2):200-6.
PMID: 3010837; UI: 86213929


1166: Gomez-Eichelmann MC, Alvarez G.
Genetic expression and gyrase dependence of methylated and undermethylated DNA
in Escherichia coli.
Biochim Biophys Acta. 1985 Jul 24;825(3):335-8.
PMID: 2990558; UI: 85252823


1167: Tse-Dinh YC.
Regulation of the Escherichia coli DNA topoisomerase I gene by DNA supercoiling.
Nucleic Acids Res. 1985 Jul 11;13(13):4751-63.
PMID: 2991845; UI: 85269606


1168: Kuznetsova EV, Koshcheenko NI, Filippovich IV.
[Effect of bacterial DNA gyrase inhibitors on the radiosensitivity of thymocytes
and on the utilization of exogenous adenine in these cells].
Radiobiologiia. 1985 Jul-Aug;25(4):457-61. Russian.
PMID: 2994169; UI: 85299329


1169: Kirchhausen T, Wang JC, Harrison SC.
DNA gyrase and its complexes with DNA: direct observation by electron
microscopy.
Cell. 1985 Jul;41(3):933-43.
PMID: 2988794; UI: 85228244


1170: Zylicz M, Yamamoto T, McKittrick N, Sell S, Georgopoulos C.
Purification and properties of the dnaJ replication protein of Escherichia coli.
J Biol Chem. 1985 Jun 25;260(12):7591-8.
PMID: 3889001; UI: 85207806


1171: Velikodvorskaia GA, Abdrashitova AI, Mirkin SM, Mogutov MA, Piruzian ES.
[Development of bacteriophage Mu in E. coli gyrBts mutant strain].
Mol Gen Mikrobiol Virusol. 1985 Jun;(6):15-20. Russian.
PMID: 3025711; UI: 87090062


1172: Heinhorst S, Cannon G, Weissbach A.
Chloroplast DNA synthesis during the cell cycle in cultured cells of Nicotiana
tabacum: inhibition by nalidixic acid and hydroxyurea.
Arch Biochem Biophys. 1985 Jun;239(2):475-9.
PMID: 2988450; UI: 85224249


1173: Raji A, Zabel DJ, Laufer CS, Depew RE.
Genetic analysis of mutations that compensate for loss of Escherichia coli DNA
topoisomerase I.
J Bacteriol. 1985 Jun;162(3):1173-9.
PMID: 2987184; UI: 85207436


1174: van der Ende A, Baker TA, Ogawa T, Kornberg A.
Initiation of enzymatic replication at the origin of the Escherichia coli
chromosome: primase as the sole priming enzyme.
Proc Natl Acad Sci U S A. 1985 Jun;82(12):3954-8.
PMID: 2408271; UI: 85216612


1175: Uhlin BE, Nordstrom K.
Preferential inhibition of plasmid replication in vivo by altered DNA gyrase
activity in Escherichia coli.
J Bacteriol. 1985 May;162(2):855-7.
PMID: 2985550; UI: 85182520


1176: Bartmann K, Tarbuc R.
Comparative determination of minimal inhibitory and bactericidal concentrations
of ciprofloxacin, cefotaxime and HR 810 for gram-negative bacteria either
sensitive or resistant to ureidopenicillins and/or gentamicin.
Zentralbl Bakteriol Mikrobiol Hyg [A]. 1985 May;259(3):378-89.
PMID: 2931927; UI: 86021498


1177: Birch RG, Patil SS.
Preliminary characterization of an antibiotic produced by Xanthomonas
albilineans which inhibits DNA synthesis in Escherichia coli.
J Gen Microbiol. 1985 May;131 ( Pt 5):1069-75.
PMID: 2410547; UI: 85263517


1178: Ogasawara N, Moriya S, Yoshikawa H.
Structure and function of the region of the replication origin of the Bacillus
subtilis chromosome. IV. Transcription of the oriC region and expression of DNA
gyrase genes and other open reading frames.
Nucleic Acids Res. 1985 Apr 11;13(7):2267-79.
PMID: 2987848; UI: 85215613

